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ABSTRACT 
 
XENOPUS ADAM13 AND ADAM19 ARE IMPORTANT FOR PROPER  
CONVERGENCE AND EXTENSION OF THE NOTOCHORD 
 
 
FEBRUARY 2011 
 
RUSSELL D. NEUNER, B.S., PENNSYLVANIA STATE UNIVERSITY 
 
Ph.D., UNIVERSITY OF MASSACHCUSETTS AMHERST 
 
Directed by:  Professor Dominique Alfandari 
 
 
 
 Gastrulation is a fundamental process that reorganizes the primary germ layers to 
shape the internal and external features of an early embryo.  Morphogenetic movements 
underlying this process can be classified into a variety of different types of cellular 
movements.  I will focus on investigating in this thesis two types of cell movements in 
the dorsal mesoderm; mediolateral cell intercalation and convergence and extension.  
During gastrulation, mesoderm cells send protrusions to gain traction on neighboring 
cells and the surrounding extracellular matrix; a process called mediolateral cell 
intercalation.  Mesoderm cells use this type of cell movement to converge and extend the 
dorsal mesoderm tissue during gastrulation; a process called convergence and extension.  
These morphogenetic movements are essential to form the early embryo and are 
important for later development. 
 There are a number of different proteins involved in regulating the morphogenetic 
movements during gastrulation.  The Planar Cell Polarity Signaling Pathway helps 
establish individual cell polarity and is activated in dorsal mesoderm cells undergoing 
convergence and extension.  In addition, dorsal mesoderm cells migrate by using integrin 
receptors and the surrounding extracellular matrix to correctly position the mesoderm in 
the embryo.  I will focus my efforts on analyzing the function of ADAM proteins during 
Xenopus laevis gastrulation.  The ADAM family of metalloproteases is important for a 
variety of biological processes.  ADAM proteins function as ectodomain sheddases by 
cleaving membrane bound proteins involved in signal transduction, cell-cell adhesion, 
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and cell-extracellular matrix adhesion.  I will focus on investigating the roles of two 
ADAM family members; ADAM13 and ADAM19 during gastrulation.  Both ADAM13 
and ADAM19 are expressed in the dorsal mesoderm during gastrulation.  Throughout 
early embryonic development, ADAM13 is expressed in the somitic mesoderm and 
cranial neural crest cells.  ADAM19 is expressed in dorsal, neural and mesodermal 
derived structures such as the neural tube, notochord, the somitic mesoderm, and cranial 
neural crest cells. 
Since ADAM13 and ADAM19 are expressed in similar tissues, I investigated if 
both proteins functionally interacted.  I show that a loss of ADAM13 protein in the 
embryo reduces the level of ADAM19 protein by 50%.  In the opposite experiment, a 
loss of ADAM19 protein in the embryo reduces the level of ADAM13 protein by 50%.  
This suggests that both ADAM13 and ADAM19 are required to maintain proper protein 
levels in the embryo.  This might be explained through their physical interaction in a cell.  
The ADAM19 Proform binds to the ADAM13 Proform in cultured cells.  Through 
domain analysis, I show that ADAM19 binds specifically to the cysteine-rich domain of 
ADAM13.  When co-overexpressed in a cell, the level of Mature ADAM13 (compared to 
the Proform) is reduced suggesting a complex form of regulation.  I propose a few 
models that discuss how ADAM19 may function as a chaperone to stabilize and regulate 
the further processing of ADAM13 protein.  
Some of the unpublished work discussed in this thesis focuses on the roles of 
ADAM13 and ADAM19 in the dorsal mesoderm during gastrulation.  Specific emphasis 
is made on investigating the axial mesoderm during notochord formation.  I show that 
ADAM19 affects gene expression important for the A-P polarity of the notochord while 
ADAM13 does not.  The changes in gene expression can be partially rescued by the EGF 
ligand Neuregulin1, a known substrate for ADAM19 in the mouse.  ADAM13 and 
ADAM19 are important for convergence and extension movements of the axial 
mesoderm during gastrulation.  Specifically, a loss of ADAM13 or ADAM19 causes a 
delay in mediolateral cell intercalation resulting in a significantly wider notochord 
compared to control embryos.  These defects occur without affecting dishevelled 
intracellular localization or the activation of the PCP signaling pathway.  However, a loss 
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of ADAM13 or ADAM19 reduces dorsal mesoderm cell spreading on a fibronectin 
substrate through 51 integrin.   
To conclude, the work presented in this thesis focuses on the similarities and 
differences of ADAM13 and ADAM19 in the early embryo.  Although ADAM13 and 
ADAM19 are required for normal morphogenetic movements during gastrulation, my 
data suggests they have different functions.  ADAM13 appears to function in regulating 
cell movements while ADAM19 appears to function in regulating cell signaling.  I 
propose a few models that discuss how each ADAM metalloprotease may function in the 
dorsal mesoderm and contribute to convergence and extension movements during 
gastrulation. 
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CHAPTER I 
 
INTRODUCTION 
 
Abstract 
 Gastrulation is a morphogenetic process that reorganizes the primary germ layers 
(ectoderm, mesoderm, and endoderm) to shape the internal and external features of an 
early embryo.  The morphogenetic movements that drive this process of early 
development are mediolateral cell intercalation and convergence and extension in the 
dorsal mesoderm.  As a result of these movements, the paraxial mesoderm and axial 
mesoderm develop during gastrulation to form the somites and notochord, respectively.  
This is important to properly lengthen the embryo along its anterior-posterior axis.  There 
are a large number of molecules that regulate convergence and extension during 
gastrulation.  I have focused my efforts on understanding how one protein family called 
ADAM metalloproteases contribute to these morphogenetic movements and function 
during gastrulation. 
   
SECTION I:  General Background of Gastrulation in Amphibians 
 
 Approximately 150 years ago, a German scientist named Ernst Haeckel observed 
and illustrated for the first time one of the earliest phases in Metazoan embryonic 
development called gastrulation.  Haeckel proposed the term “gastraea” to describe an 
early embryo that has a structurally simple hollow diploblastic ovoid embryonic shape 
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(Haeckel, 1875).  In the early 1920‟s, the Amphibian embryo became a prominent model 
organism for experimental embryologists.  This was largely due to the influence of 
another German scientist, Hans Spemann, and his discovery of the organizing center 
(Spemann and Mangold, 1924).  The organizing center is a group of cells that express 
specific molecules important for patterning the dorsal side of the embryo.  These 
experiments were performed by transplanting organizer cells into the ventral side of a 
host embryo.  What they observed was the formation of a two headed, dual-axis tadpole.  
Spemann‟s work had huge significance in the field of embryology by stimulating a 
search, which continues to this day, to investigate the identity of the organizer signals 
(Oelgeschlager et al., 2003).  Concurrently, the work of Walter Vogt helped establish an 
initial understanding of fate mapping in the early embryo (Vogt, 1925).  The work of 
these early pioneers paved the way for more modern scientists such as Pieter Nieuwkoop 
to investigate a more elaborate fate mapping in the early embryo (Nieuwkoop and Faber, 
1967) and for Ray Keller to investigate in detail the morphogenetic movements during 
Xenopus laevis gastrulation (Keller, 1975).  Today a lot of the same principles and 
methodology are still used extensively in the Xenopus gastrula.  Gastrulation can be 
defined as a morphogenetic process that reorganizes the primary germ layers (ectoderm, 
mesoderm, and endoderm) to shape the internal and external features of an early embryo. 
 After fertilization, the embryo undergoes a series of cleavages that divide a large 
single cell into a hollow ball of a few thousand cells called a blastula.  At this point, the 
process of gastrulation begins and is marked by the appearance of the dorsal blastopore 
lip.  The dorsal lip itself is the initial structure that forms a circular opening on the vegetal 
pole of the embryo called the blastopore.  The blastopore closes through a variety of 
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different cell movements during gastrulation (Figure 1.1).  The four evolutionarily 
conserved movements include internalization, epiboly, convergence and extension 
(Solnica-Krezel, 2005).  Internalization marks the beginning of gastrulation and in 
amphibians, creates the dorsal blastopore lip.  The dorsal lip is composed of large 
“bottle” cells that apically constrict to initiate the involution of the prospective mesoderm 
(Hardin and Keller, 1988).  The involuting mesoderm enters through the blastopore and 
migrates inside the embryo.  This process is essential to correctly position the three germ 
layers for proper embryonic development.  Epiboly movements spread tissue by 
increasing the surface area and decreasing thickness.  The driving force behind epiboly 
occurs when cells interdigitate themselves between deep and superficial layers; a process 
known as radial intercalation (Keller, 1980). 
 The dorsal mesoderm undergoes dynamic movements to converge and extend the 
tissue along the anterior-posterior axis; a process called convergence and extension 
(Keller et al., 1985).  Dorsal mesoderm cells undergo this type of movement by forming 
mediolateral polarized protrusions to gain traction on neighboring cells and the 
surrounding extracellular matrix (ECM).  This cellular behavior is known as mediolateral 
cell intercalation.  The dorsal mesoderm can be microdissected from a gastrulating 
embryo and cultured ex vivo in a „Keller Sandwich‟ (Keller and Danilchik, 1988) and an 
„Open Face Explant‟ (Wilson et al., 1989).  When cultured ex vivo, the dorsal mesoderm 
retains the ability to undergo convergence and extension movements.  On the ventral side 
of the gastrulating embryo, the lateral and ventral mesoderms undergo dynamic 
movements to converge the tissue without extension; a process called convergence and 
thickening (Keller and Danilchik, 1988).  These two complementary morphogenetic 
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movements during gastrulation cause the blastopore to close asymmetrically towards the 
ventral side of the embryo (Figure 1.2) (Keller and Shook, 2008). 
 Once gastrulation is complete, the developing embryo enters the neurulation 
phase as the neural tube forms.  The neural tube develops from the neuroectoderm on the 
dorsal side of the embryo.  In addition to neural tube closure, the paraxial mesoderm 
forms the developing somites and the axial mesoderm continues to form the developing 
notochord during this phase.  Mediolateral cell intercalation continues during neurulation 
in the paraxial mesoderm, axial mesoderm and the neural tissue.  This drives the process 
of convergence and extension to properly lengthen the embryo along the anterior-
posterior axis.  These cellular movements are essential for the embryo to develop and 
survive to the tailbud stage.   
At the molecular level, the major signaling pathways important for mesoderm 
induction are Fibroblast Growth Factor (FGF) signaling (Kimelman et al., 1988) and 
Transforming Growth Factor  (TGF) signaling (Thomsen et al., 1990).  FGF and TGF 
are known as morphogens because they are signaling molecules that produce specific 
responses in a cell.  How morphogens act on a cell depends on their concentration in the 
cellular microenvironment.  The addition of either FGF or TGF to naïve animal cap 
cells isolated from the blastula stage will cause cells to develop into mesoderm tissue, 
such as muscle and notochord.  FGF or TGF treated explants are not only induced to 
express mesoderm specific genes but can also undergo convergence and extension 
movements (Kimelman and Maas, 1992; Thomsen et al., 1990).  There are a large 
number of molecules that regulate convergence and extension during gastrulation (Table 
1 in (Solnica-Krezel, 2005)).  The major signaling pathway that is critical for regulating 
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convergence and extension is the Non-canonical Wnt signaling pathway (or Planar Cell 
Polarity (PCP) Pathway) (Yin et al., 2008).  The PCP signaling pathway is extensively 
studied in the fly and shown to be evolutionarily conserved in vertebrates.  This signaling 
pathway is important for establishing individual cell polarity in the dorsal mesoderm 
(Tada and Kai, 2009).  Cell polarity is established through the localization of specific 
PCP components to the medial and lateral edges of cells undergoing mediolateral cell 
intercalation (Jiang et al., 2005; Zallen and Wieschaus, 2004).  A gain or loss of function 
to any of the signaling components in the PCP pathway results in convergence and 
extension defects (Roszko et al., 2009).  An observed feature of these embryos is a 
shortened anterior-posterior body axis. 
Convergence and extension movements also involve the regulation of cell 
adhesion molecules.  During gastrulation, the involuting mesoderm enters the blastopore 
and migrates on the inner surface of the blastocoel roof.  This migration event is highly 
dependent upon the extracellular matrix protein, fibronectin, which localizes along the 
blastocoel roof (Boucaut and Darribere, 1983; Lee et al., 1984).  The interaction between 
fibronectin and its integrin receptor, 51, also contributes to convergence and extension 
movements (Davidson et al., 2006; Rozario et al., 2009).  For example, depletion of 
fibronectin by an antisense morpholino randomizes mediolateral cell protrusions resulting 
in convergence and extension defects (Davidson et al., 2006).  In addition, the disruption 
of fibronectin to 51 integrin by the microinjection of a function blocking antibody 
randomizes mediolateral cell protrusions resulting in convergence and extension defects 
(Davidson et al., 2006).  Furthermore, it is suggested that the interaction between 51 
integrin and fibronectin may cross talk with the PCP signaling pathway to regulate 
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convergence and extension movements (Marsden and DeSimone, 2001).  In particular, 
disruption of the PCP components Vangl2 and Frizzled7 by dominant negative RNA 
injection impairs proper fibronectin matrix assembly during gastrulation (Goto et al., 
2005).   
 Convergence and extension movements also involve the regulation of cell-cell 
adhesion proteins such as cadherins and protocadherins (Hammerschmidt and Wedlich, 
2008).  For example, the Xenopus paraxial protocadherin C (PAPC) regulates cell-cell 
adhesion by downregulating the adhesive activity of C-cadherin (Chen and Gumbiner, 
2006).  PAPC can also physically interact with Sprouty2, a known inhibitor of the PCP 
signaling pathway, to promote convergence and extension movements during gastrulation 
(Wang et al., 2008).  Recent work in zebrafish has also analyzed the role of matrix 
metalloproteases in cell movements during gastrulation (Coyle et al., 2008).  Membrane-
type I matrix metalloprotease (MT1-MMP/MMP14) regulates mediolateral cell 
intercalation by affecting dorsal mesoderm cell polarity.  Loss of MMP14 results in 
convergence and extension defects without affecting mesoderm patterning.  Furthermore, 
MMP14 can degrade a fibronectin matrix in a gastrulating zebrafish embryo (Latimer and 
Jessen, 2009).  This suggests that fibronectin remodeling via MMP14 may be important 
for regulating cell polarity and mediolateral cell intercalation in the zebrafish embryo. 
 Our lab studies another zinc metalloprotease protein family called ADAM 
metalloproteases.  I will focus my efforts on analyzing the function of ADAM proteins 
during Xenopus laevis gastrulation. 
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SECTION II:  Introduction to the ADAM Family of Metalloproteases  
 
General ADAM background 
 
 Members of the A Disintegrin And Metalloprotease (ADAM) family of zinc 
metalloproteases are best characterized for their enzymatic processing of other membrane 
bound proteins; a process called ectodomain shedding (Alfandari et al., 2009; 
Schlondorff and Blobel, 1999).  Members of the ADAM family function in signal 
transduction through their cleavage of signaling molecules such as epidermal growth 
factor (EGF), tumor necrosis factor- (TNF- and Notch (Dyczynska et al., 2007; Ohtsu 
et al., 2006; Pan and Rubin, 1997; Yan et al., 2002).  ADAM members also function in 
cell-cell adhesion through their cleavage of cadherins (Maretzky et al., 2005; McCusker 
et al., 2009; Reiss et al., 2005; Uemura et al., 2006), and cell-extracellular matrix 
adhesion through their processing of ECM molecules (Alfandari et al., 2001; Millichip et 
al., 1998).  ADAM metalloproteases exist in two main states; an enzymatically inactive 
state called the Proform and an enzymatically active state called the Mature form (Figure 
1.3).  The difference between the two forms is that a Prodomain is present in the N-
terminus of the Proform.  The Prodomain interacts with the metalloprotease active site 
rendering the ADAM catalytically inactive.  The prodomain is cleaved by a Furin-like 
enzyme in the Golgi complex which releases the inhibition on the active site (Loechel et 
al., 1998).  This allows the ADAM Mature form to become catalytically active (Figure 
1.3). 
 There are more than 30 members in the ADAM family of metalloproteases and 
they can be divided into three major classes.  The first class contains the principle 
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sheddases (ADAM10 and ADAM17) that are known to cleave the majority of the ADAM 
substrates.  For example, ADAM10 cleaves heparin-binding EGF (HB-EGF) to activate 
the EGF signaling cascade and resultant gene expression (Yan et al., 2002).  The second 
class is the mesenchymal ADAMs or the meltrin subfamily (ADAM9, 12, 13, 19, 33) that 
are known to be involved in skeletal muscle, bone and heart development.  For example, 
ADAM19 knockout mice exhibit severe defects in heart morphogenesis leading to their 
perinatal death (Zhou et al., 2004).  The third class is the non-proteolytic ADAMs 
(ADAM11, 22, 23) because they lack a conserved sequence within the active site of their 
metalloprotease domain rendering these members catalytically inactive.  Members of this 
class have an important role in neural development.  For example, ADAM22 forms a 
complex with the epilepsy-related ligand and its receptor in neurons to regulate synaptic 
transmissions in the brain (Fukata et al., 2006). 
 In addition to their main role as ectodomain sheddases, ADAM members can 
physically interact with integrin receptors in a cell via their disintegrin domains (Lu et al., 
2007).  This interaction affects cell-extracellular matrix adhesion (Huang et al., 2005) and 
cell migration (Chen et al., 2008).  Recently, a potential function of the cytoplasmic 
domain of ADAM members has emerged.  Numerous proline-rich and SH3 binding 
motifs contained within the cytoplasmic domain are found to interact with intracellular 
proteins such as the cytoplasmic domains of ADAM12, ADAM15 and ADAM19 with 
FISH (Abram et al., 2003) and the cytoplasmic domain of ADAM22 with 14-3-3 (Zhu 
et al., 2002).  The cytoplasmic domain can function independently of the extracellular 
region for ADAM10 (Tousseyn et al., 2009) and ADAM13 (Cousin et al., submitted 
2010).  For ADAM10, it was proposed that a two-step processing event occurs.  The first 
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cleavage by another ADAM member occurs within the cysteine-rich domain releasing the 
extracellular fragment of ADAM10.  This triggers a second cleavage by -secretase at the 
plasma membrane for the intracellular release of the ADAM10 cytoplasmic domain.  The 
released cytoplasmic domain translocates into the nucleus where it is believed to function 
(Tousseyn et al., 2009).  For ADAM13, our lab has shown that -secretase also cleaves 
the cytoplasmic domain of ADAM13.  The released cytoplasmic domain translocates into 
the nucleus to regulate gene transcription of approximately 2000 different genes.  
Furthermore, our lab is the first to show that the ADAM13 cytoplasmic domain functions 
in vivo and is essential for proper cranial neural crest cell migration in Xenopus laevis 
embryos (Cousin et al., submitted 2010). 
 
ADAM Family Members Function in Xenopus Gastrulation 
 
 Members of the meltrin subfamily of ADAMs, specifically ADAM9, ADAM13 
and ADAM19, are expressed during gastrulation (Alfandari et al., 1997; Cai et al., 1998; 
Neuner et al., 2009).  ADAM12 and ADAM15 have not been cloned yet in Xenopus 
laevis but are expressed during gastrulation of a closely related phylogenic species; 
Xenopus tropicalis (Wei et al., 2010).  ADAM9 is ubiquitously expressed in all cells, 
while ADAM13 and ADAM19 are restricted to the dorsal mesoderm.  Through a loss of 
function approach by microinjection of an antisense morpholino oligonucleotide, our lab 
has shown that single knock down of ADAM9 or ADAM19 does not affect blastopore 
closure.  However, knock down of ADAM13 delays gastrulation by approximately two 
hours.  This suggests that ADAM9 and ADAM19 do not function in regulating 
blastopore closure during gastrulation, while ADAM13 does.  ADAM19 does however 
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affect early gene expression at the gastrula stage and will be discussed further in Chapter 
II of this thesis (Figure 2.4). 
 ADAM10 is also expressed during gastrulation; however a potential function has 
never been investigated (Pan and Rubin, 1997).  ADAM10 is one of the most studied 
ADAM family members because of its essential role in the Notch/Delta signaling 
pathway (Pan and Rubin, 1997).  The Notch/Delta signaling pathway has recently been 
shown to regulate morphogenetic movements as both activation or inhibition of this 
pathway delays blastopore closure and affects the segregation of the three germ layers 
(Revinski et al., 2010).  Thus, it is possible that ADAM10 functions in segregating the 
three germ layers during gastrulation.   
This thesis will focus on investigating the role of two ADAM family members, 
ADAM13 and ADAM19, during gastrulation.  Specific emphasis will be on analyzing the 
morphogenetic movements that form the notochord.  In final, I will attempt to understand 
whether ADAM13 and ADAM19 function independently of each other or whether they 
have overlapping functions during gastrulation. 
 
SECTION III: Overview of the Work Presented in this Thesis 
 
  I began this project five years ago with the initial characterization of ADAM19.  
The goal at the onset of the project was to identify another meltrin subfamily member 
that could compensate for ADAM13 function, specifically in the cranial neural crest.  Of 
the other meltrin subfamily members, ADAM19 had the highest sequence homology at 
the amino acid level to ADAM13 making it an ideal candidate.  At the time there was 
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nothing known about the role of ADAM19 in Xenopus laevis.  Therefore, the second goal 
of this project was broad and it was to characterize ADAM19 in the early embryo.  This 
was critical in order to identify a biologically relevant substrate to ADAM19 proteolytic 
activity in the embryo.  The initial experiments were to clone full length Xenopus laevis 
ADAM19 and determine its expression pattern.  At the time there were no ADAM19 
antibodies available that could be used to study the endogenous protein in Xenopus.  
Thus, one of the first major objectives was to generate a number of antibodies that could 
recognize different structural domains of the ADAM19 protein.  I successfully made 
three antibodies to the ADAM19 protein and they are briefly described: 
1. 2C5 E1: Mouse monoclonal antibody directed against the cytoplasmic domain of 
ADAM19. 
2. C2 and C3: Rabbit polyclonal antibody directed against both variants (C2 and C3) 
of the cytoplasmic domain of ADAM19. 
3. DC19: Goat polyclonal antibody directed against the disintegrin-cysteine rich 
domains of ADAM19. 
The cytoplasmic domain was selected because this domain amongst other ADAM family 
members is the most variable at the amino acid level.  This would minimize the potential 
of cross reactivity with other ADAM family members.  The disintegrin-cysteine rich 
domain was selected because this domain amongst other ADAM family members is the 
most conserved at the amino acid level and would increase our chances of ADAM19 
detection.  The generation and screening of all three antibodies is described in Appendix 
I.   
12 
 
 Chapter II describes the results of the initial characterization of ADAM19 in the 
early embryo.  I show that ADAM19 is expressed in dorsal, neural and mesodermal 
derived structures during early embryogenesis.  Through a loss of function approach 
using an antisense morpholino oligonucleotide to ADAM19, I show that ADAM19 
affects gene expression important for the anterior-posterior (A-P) polarity of the 
notochord during gastrulation.  The changes in gene expression are accompanied by a 
decrease in phosphorylated AKT, a downstream target of the EGF signaling pathway.  At 
the neurula stage, loss of ADAM19 affects neural crest induction by a reduction in Sox8 
and Slug gene expression.  At the tailbud stage, loss of ADAM19 affects muscle 
differentiation by a reduction in myosin light chain (MLC) gene expression and a 
reduction in 12/101 protein level.  Lastly, I show that loss of ADAM19 affects somite 
organization and perturbs fibronectin localization at the intersomitic boundary.     
 Chapter III focuses on ADAM13 and ADAM19 protein regulation in cultured 
cells and in the embryo.  I show that a loss of ADAM13 protein reduces the level of 
ADAM19 protein by 50%.  In addition, a loss of ADAM19 protein reduces the level of 
ADAM13 protein by 50%.  This suggests that both ADAM13 and ADAM19 are required 
to maintain a proper protein level in the embryo.  I propose this outcome may be 
explained by the physical interaction of ADAM13 and ADAM19 in a cell.  When co-
overexpressed the ADAM19 Proform binds to the ADAM13 Proform in a cell.  Through 
protein domain analysis, I show that ADAM19 binds specifically to the Cysteine-Rich 
Domain of ADAM13.  When co-overexpressed in a cell, the level of Mature ADAM13 
(compared to the Proform) is reduced suggesting a complex form of regulation.  Lastly, I 
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describe a few models that could explain how ADAM19 regulates the level of ADAM13 
in a cell. 
 Chapter IV describes ADAM13 and ADAM19 function in the dorsal mesoderm, 
with specific emphasis on the notochord.  Through a loss of function approach using 
antisense morpholino oligonucleotides to ADAM13 or ADAM19, I show that ADAM19 
affects gene expression important for the A-P polarity of the notochord while ADAM13 
does not.  The changes in gene expression can be partially rescued by the EGF ligand 
Neuregulin1, a known substrate for ADAM19 in the mouse.  I show that a loss of 
ADAM13 or ADAM19 affects convergence and extension movements during notochord 
formation.  Specifically, a loss of ADAM13 or ADAM19 causes a delay in mediolateral 
cell intercalation resulting in significantly wider notochords compared to control 
embryos.  This defect occurs without affecting dishevelled intracellular localization or the 
activation of the PCP signaling pathway.  However, a loss of ADAM13 or ADAM19 
reduces dorsal mesoderm cell spreading on a fibronectin substrate through 51 integrin. 
Chapter V will explore the similarities and differences of ADAM13 and 
ADAM19 in the dorsal mesoderm during gastrulation.  Although both ADAM13 and 
ADAM19 affect convergence and extension movements, I hypothesize their contribution 
may involve different mechanisms.  ADAM19 mediated shedding of Neuregulin1 
maintains Brachyury expression in the notochord.  ADAM13 affects dorsal mesoderm 
cell adhesion to fibronectin through 51 integrin.  In final, a few models will explain 
how ADAM13 and ADAM19 function in the dorsal mesoderm and contribute to 
convergence and extension movements. 
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Figure 1.1:  The Different Types of Cell Movement during Gastrulation.  (A) 
Diagrams the four main types of cell movements; Epiboly, Internalization, Convergence 
and Extension.  The final tissue shape is compared to the original (dashed rectangle).  (B) 
Radial Intercalation.  Mesoderm cells from deep tissue layers interdigitate between deep 
and superficial cell layers to thin the overall tissue.  (C) Directed Migration.  Involuting 
mesoderm cells respond to an environmental signal via a net migration or displacement in 
a single direction.  (D) Involution.  Mesoderm cells of the dorsal blastopore lip turn in 
upon themselves to create this type of cell movement.  (E) Invagination.  This is the 
beginning step to involution where cells change shape in order to fold inward.  (F) 
Ingression.  Involuting mesoderm cells undergo an EMT and migrate along the blastocoel 
roof through this type of cell movement.  (G) Mediolateral Cell Intercalation.  Dorsal 
mesoderm cells become polarized in the mediolateral axis to gain traction in order to 
converge and extend a tissue.  This figure was taken from (Solnica-Krezel, 2005). 
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Figure 1.2: Illustration of Gastrulation in the Xenopus laevis Embryo.  (A)  
The vegetal view of the early Xenopus gastrula (left) compared to the early 
neurula (right).  The morphogenetic movements during gastrulation to properly 
form the notochord (dark grey) and somitic mesoderm (light grey) along the 
anterior-posterior axis (A-P arrow) are shown.  The overall directionality of 
blastopore closure is depicted (black arrows inside blastopore).  (B)  The process 
of convergence and extension in the dorsal mesoderm of an open face explant 
cultured ex vivo.  This figure is modified from (Keller and Shook, 2008). 
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Figure 1.3: Schematic Diagram of an ADAM Family Member.  The 
extracellular region of an ADAM protein contains five amino acid domains.  The 
prodomain (Pro, grey) binds to the Metalloprotease domain through a cysteine 
switch mechanism rendering the enzyme inactive called the ADAM Proform (A).  
The prodomain is cleaved by a Furin-like enzyme which releases the inhibition 
allowing for the ADAM to become proteolytically active called the ADAM Mature 
form (B) (Loechel et al., 1998).  The Metalloprotease domain (Met, yellow) 
contains the zinc active site (green dot).  A glutamic acid mutation to an alanine 
(E/A) at residue #341 renders the ADAM Metalloprotease proteolytically inactive.  
This can act as a “dominant negative” form by competitively binding to substrates 
and sequestering them from the endogenous ADAM.  The Disintegrin domain (Dis, 
red) interact with integrins, an important property for cell adhesion.  Together with 
the Cysteine-rich domain (CR, blue) interacts directly with protein substrates.  The 
EGF-like domain contains a number of EGF amino acid repeats, yet its function has 
not been determined.  Most ADAM family members have a single pass 
transmembrane domain (TM, black) containing a Cytoplasmic domain (Cyto, 
orange).  The Cytoplasmic domain contains proline-rich and SH3 binding motifs 
that function within intracellular signaling.   
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CHAPTER II 
 
 XENOPUS ADAM19 IS INVOLVED IN NEURAL, NEURAL CREST AND 
MUSCLE DEVELOPMENT 
 
Most of the work presented in this chapter is published in the journal  
Mechanism of Development (Neuner et al., 2009) 
*Data generated by myself are depicted in Figures 2.2 (A-D); 2.3; 2.4; 2.5A; 2.6A; 2.7A; 
2.8G; 2.8A,B; Table 2.1 
*Data generated by other members of the Alfandari Lab are depicted in Figures 2.1; 
2.2(E-I); 2.3B; 2.4B, C; 2.7B; 2.8(A-F, H); 2.9C 
*The only unpublished figures are Figure 2.2(A, B) and 2.9(A, B). 
 
Abstract 
ADAM19 is a member of the meltrin subfamily of ADAM metalloproteases.  In 
Xenopus, ADAM19 is present as a maternal transcript.  Zygotic expression begins during 
gastrulation in the dorsal blastopore lip and increases through neurulation and tailbud 
formation.  ADAM19 is expressed in dorsal, neural and mesodermal derived structures 
such as the neural tube, the notochord, and the somites.  Using a Morpholino knock down 
approach, I show that a reduction of ADAM19 protein in gastrula stage embryos reduces 
Brachyury expression in the notochord concomitant with an increase in the dorsal 
markers, Goosecoid and Chordin.  The changes in gene expression are accompanied by a 
decrease in phosphorylated AKT, a downstream target of the EGF signaling pathway.  
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The changes in gene expression occur while the blastopore closes at the same rate as the 
control embryos.  During neurulation and tailbud formation, ADAM19 knock down 
reduces neural fates as determined by the expression of N-tubulin and NRP1 but not 
Sox2.  In the somitic mesoderm, the expression of MLC is also decreased while MyoD is 
not.  ADAM19 knock down affects neural crest induction as determined by the reduction 
in Sox8 and Slug gene expression prior to cell migration.  Neural crest induction is also 
decreased in embryos treated with an EGF receptor inhibitor suggesting that this pathway 
is necessary for neural crest cell induction.  Using targeted knock down of ADAM19 I 
show that ADAM19 function is required in the neural crest and that the migration of the 
cranial neural crest is perturbed.  In addition, I show that a reduction in ADAM19 protein 
affects somite organization, reduces 12-101 protein expression and perturbs fibronectin 
localization at the intersomitic boundary.  There was nothing known about ADAM19 in 
Xenopus laevis development prior to our published work described in this Chapter. 
 
SECTION I: Introduction 
 
Post-translational modification of proteins is a critical step in most biological 
processes.  Among these modifications, cleavage of cell surface proteins controls a 
diverse range of cellular processes such as cell signaling, cell adhesion and cell 
migration.  Members of the ADAM family function in signal transduction through their 
cleavage of signaling molecules such as epidermal growth factor (EGF), tumor necrosis 
factor- (TNF- and Notch (Dyczynska et al., 2007; Ohtsu et al., 2006; Pan and Rubin, 
1997; Yan et al., 2002).  ADAM members also function in cell-cell adhesion through 
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their cleavage of cadherins (Maretzky et al., 2005; McCusker et al., 2009; Reiss et al., 
2005; Uemura et al., 2006), and cell-extracellular matrix adhesion through their 
processing of ECM molecules (Alfandari et al., 2001; Millichip et al., 1998).   
ADAM19 is a member of the meltrin subfamily and is shown, in mouse, to cleave 
TNF-, Kit1 Ligand, TRANCE, HB-EGF, and Neuregulin-1 (Chesneau et al., 2003; 
Horiuchi et al., 2005; Kawaguchi et al., 2007; Shirakabe et al., 2001).  The knockout 
(KO) of ADAM19 causes defects in heart development, believed to be due to defective 
HB-EGF signaling (Kurohara et al., 2004; Zhou et al., 2004).  Conditional KO of 
ADAM19 specifically in the cardiac neural crest cells reproduced the heart phenotype, 
suggesting that ADAM19 is critical for cardiac neural crest cell specification but not 
migration (Komatsu et al., 2007).  In mouse, the major enzyme responsible for the 
cleavage of both HB-EGF and Neuregulin-1 appears to be ADAM17.  In addition, mice 
lacking ADAM17 show very similar heart defects to ADAM19 KO mice (Sahin et al., 
2004).  Furthermore, a double knock out of both ADAM17 and ADAM19 results in a 
more severe phenotype, demonstrating a possible overlapping function of these ADAMs 
during embryonic development (Horiuchi et al., 2005).  Fibroblasts derived from 
ADAM19 KO mice are able to process both Neuregulin-1 and HB-EGF, suggesting that 
the ADAM19 substrate responsible for the cardiac defects remains to be identified.   
 To test whether ADAM19 has a unique role during early embryonic development, 
I cloned the Xenopus laevis homologue and analyzed its expression pattern.  ADAM19 is 
present at low levels as a maternal transcript with zygotic expression beginning during 
gastrulation and localizing to the dorsal blastopore lip.  During later stages of embryonic 
development, ADAM19 is expressed in the dorsal mesoderm, neuroectoderm and neural 
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crest cells.  Loss of function experiments using an antisense morpholino knock down 
approach reveal that ADAM19 is essential for the specification of the dorsal mesoderm, 
neuronal derivatives and cranial neural crest cells.  The apparent lack of an overlapping 
function for ADAM19 in Xenopus laevis may help resolve the biologically relevant 
substrate for ADAM19 during early embryonic development. 
 
Results 
 
SECTION II:  ADAM19 Expression Pattern in Xenopus laevis 
 
I cloned the Xenopus laevis homologue of ADAM19 using degenerate 
oligonucleotides to human, mouse, quail, and the genomic sequence of Xenopus 
tropicalis.  The full-length sequence was generated by 5‟ and 3‟ RACE PCR and 
assembled from multiple PCR amplicons.  The deduced amino acid sequence is 49% 
identical to human ADAM19 and 84% identical to Xenopus tropicalis ADAM19.  I found 
two variants in the cytoplasmic domain at the amino acid level, one of which is most 
common to the Xenopus tropicalis sequence (Genbank accession # EU770696). 
I investigated ADAM19 expression throughout development using real-time PCR.  
I used poly(A) purified messenger RNA to eliminate any trace of genomic DNA in our 
samples.  ADAM19 is expressed as a maternal transcript with zygotic expression 
beginning from gastrulation through early tailbud formation (Figure 2.1).  The expression 
level of ADAM19 at gastrulation is low but is confirmed by in situ hybridization where it 
appears restricted to the dorsal lip of the blastopore (Figure 2.2A).  
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Using whole mount in situ hybridization, I investigated the distribution of 
ADAM19 mRNA during gastrulation, neurulation and tailbud formation (Figure 2.2).  To 
avoid background staining due to either antibody or substrate precipitation in the 
blastocoel cavity, I performed in situ hybridization on bisected gastrula embryos.  At the 
late gastrula (stage 12), the mRNA encoding ADAM19 is localized to the dorsal lip of the 
blastopore where the dorsal mesoderm invaginates (Figure 2.2A).  During early tailbud 
stages, ADAM19 is expressed in the dorsal region of the embryo including the neural 
tissue and the dorsal mesoderm.  ADAM19 is detected in the neural tube, the notochord, 
and the cement gland (Figure 2.2B, C and F).  In the mesoderm, ADAM19 is expressed 
both in the segmented (somite) and non-segmented (caudal) dorsal mesoderm (Figure 
2.2G and H).  When stained embryos are observed in PBS rather than Murray‟s clear to 
visualize superficial staining, ADAM19 is detected in the segments of the cranial neural 
crest cells (CNC) (Figure 2.2I).  The expression in the CNC cells was confirmed by 
Reverse Transcriptase PCR on explants dissected from stage 17 embryos (Figure 2.2I 
insert).  At stage 26, ADAM19 expression is evident in the cement gland, the brain, the 
somites, the otic vesicle and the branchial arches (Figure 2.2D).  At late tailbud (stage 
36), ADAM19 is still expressed in the entire head, the branchial arches, the somites and 
the pronephros (Figure 2.2E).  The staining intensity decreases in the somite and by 
contrast appears stronger in the neural tube. 
To determine the role of ADAM19 in early development, I designed antisense 
morpholino oligonucleotides corresponding to the sequence near the ATG start codon for 
ADAM19 and common to all amplicons identified (Table 2.2).  I also generated two 
ADAM19 polyclonal antibodies in order to study the ADAM19 protein (Appendix I).  
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One antibody was directed against the disintegrin-cysteine rich domains of ADAM19 and 
raised in the goat called DC19.  The other antibody was directed against both variants of 
the cytoplasmic domain of ADAM19 and raised in rabbit called C2 and C3.  All 
antibodies recognized the cloned full length ADAM19 protein in transfected Cos-7 
extract and embryos injected with the ADAM19 mRNA (Figure 2.3C and data not 
shown).  When the antibodies are used in combination by immunoprecipitation in 
embryos at stage 22, a 120 kilodalton (kDa) polypeptide and a 90 kDa polypeptide are 
recognized.  Based on the predicted molecular weights, the 120 kDa polypeptide 
corresponds to the endogenous ADAM19 Proform and the 90 kDa polypeptide 
corresponds to the endogenous ADAM19 Mature form.  In embryos injected with 
ADAM19 MO (MO19) both polypeptides recognized by the antibody are reduced by 90 
to 100%, depending on the injection, when normalized to GAPDH (Figure 2.3A and B). 
In addition to the endogenous protein, MO19 prevents translation of the 
ADAM19 mRNA while a morpholino to ADAM13 (MO13) does not (Figure 2.3C, lane 
5 versus lane 6).  Mutation of four nucleotides in the ADAM19 mRNA allows translation 
of the protein in injected embryos (Figure 2.3C, lane 4).  While translation of ADAM19 
mRNA is still affected by the MO19 (Figure 2.3C, lane 2 versus lane 4), the mRNA 
translates into an excess amount of ADAM19 protein compared to the endogenous 
protein level (Figure 2.3C, lane 4 versus lane 1).  I believe that the four nucleotides 
changes (out of 26 total) may still allow partial binding of the morpholino to the mRNA 
when both are concentrated in a tube before the injection. This construct is named 
ADAM19 Rescue (A19R) and is used in all of the rescue experiments described in this 
thesis.  Before performing knock down analysis in MO19 injected embryos, I tested by 
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microinjection for toxicity of 1, 5, 10, 25 and 50 nanogram (ng) dosages of MO19 per 
embryos.  At the highest dose of 50 ng per embryos, I observed that early cleavage and 
gastrulation movements were unaffected.  However, at the end of neurulation a 
significant percentage failed to close their neural tube and died (data not shown).  While 
the 50 ng MO19 dose produced significant death, I did not see a more significant 
decrease in the level of ADAM19 protein compared to the 10 ng MO19 dose.  For this 
reason I selected 10 ng as an optimal dosage to use in all subsequent experiments 
described in this thesis. 
 
SECTION III: ADAM19 Affects Early Patterning during Gastrulation 
 
ADAM19 is expressed in the dorsal mesoderm during gastrulation.  The dorsal 
mesoderm undergoes dynamic cell movements to close the blastopore during 
gastrulation.  To investigate the role of ADAM19 in blastopore closure, I measured the 
size of the blastopore during gastrulation in MO19 embryos compared to controls.  Using 
the average diameter of the blastopore, I found that embryos injected with MO19 closed 
the blastopore at the same rate as embryos injected with a control morpholino (CMO) 
(Figure 2.4).  
Although ADAM19 does not affect blastopore closure, I investigated the role of 
ADAM19 in early gene expression during gastrulation.  I performed whole mount in situ 
hybridization for Brachyury (Xbra), Chordin, and Goosecoid expression to visualize the 
mesoderm in MO19 injected embryos at the late gastrula stage (Figure 2.5).  Brachyury is 
a T-box transcription factor that is expressed in all mesoderm tissues during gastrulation 
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(Cunliffe and Smith, 1992).  Brachyury is critical for gastrulation movements and for 
establishing the anterior-posterior axis in the early embryo.  Our results show that Xbra is 
expressed in the ventral and lateral mesoderm but is absent in the notochord of 63% of 
the embryos with reduced ADAM19 protein (n=30) (Figure 2.5A).  To test whether the 
dorsal mesoderm was entirely missing, I assessed Chordin and Goosecoid expression in 
the notochord and cephalic mesenchyme, respectively.  Goosecoid is a paired homeobox 
transcription factor that is expressed in anterior, dorsal mesoderm during gastrulation 
(Cho et al., 1991).  As a homeobox gene, goosecoid is critical for the early patterning of 
anterior dorsal mesoderm in the embryo.  Chordin is a secreted Bone Morphogenetic 
Protein (BMP) antagonist that is expressed in the axial mesoderm during gastrulation 
(Sasai et al., 1994).  Chordin is a dorsalizing factor because it binds and inhibits proteins 
that induce ventral tissue such as BMP in the early embryo (Sasai et al., 1994).  At the 
late gastrula stage, I found that most MO19 embryos (65% n=30) had a wider, more 
anterior shift in the localization of Chordin expression while 35% showed a similar 
staining to the controls.  A more detailed analysis into Xbra and Chordin expression will 
be presented in Chapter IV of this thesis.  Furthermore, 76% of the embryos injected with 
MO19 had the same level of Goosecoid staining while the remaining 24% (n=20) showed 
a wider expression.  Another notochord marker (not-1) was not affected by the knock 
down of ADAM19 (data not shown).  These results show that the dorsal mesoderm and 
the notochord are present in embryos with a reduced level of ADAM19 but that the 
patterning of the notochord may be altered.  
Using quantitative real-time PCR, I tested the level of expression of these genes in 
embryos injected with a CMO, MO19 and a combination of MO19 and ADAM19 Rescue 
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mRNA (Figure 2.5B).  The results confirm a small reduction of Xbra expression (16% 
decrease) possibly due to the absence of expression in the notochord.  In contrast, I found 
that both Chordin and Goosecoid levels were increased by approximately two fold in 
embryos with reduced ADAM19 protein suggesting that there is an increase in specific 
dorsal mesoderm markers. These changes in gene expression were all rescued by the co-
injection of ADAM19 Rescue mRNA.  
Since the expression of Xbra in the notochord is absent, I performed a targeted 
injection at the 8-cell stage with -galactosidase as a lineage tracer.  The cells with a 
reduced level of ADAM19 were still able to incorporate into the notochord and the 
somites, suggesting that ADAM19 expression is not essential for the formation of these 
tissues (data not shown). 
 
SECTION IV:  ADAM19 Affects Neural Patterning and Neural Crest Induction 
 
To investigate the role of ADAM19 in neural induction, I performed in situ 
hybridization using Sox2 as a general neural marker in gastrula stage embryos.  The 
results show that MO19 does not prevent neural induction (Figure 2.5A).  While the 
overall expression of Sox2 was not affected, careful analysis revealed some subtle 
changes.  For example, Sox2 expression in control embryos is lighter in the neural plate 
directly above the notochord (future floor plate, Figure 2.5A, red arrowhead).  This 
decrease of Sox2 at the midline is not visible in 30% of the embryos injected with MO19 
(n=30), suggesting that a reduction in ADAM19 protein may affect axial tissue patterning 
across the mesoderm/neuroectoderm tissue boundary.  However at that point, it is not 
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clear whether the affect on the neural plate is direct or an indirect result of defective 
signaling from the notochord. 
To further investigate the role of ADAM19 in the neural tissue, I performed in 
situ hybridization using N-tubulin, Sox2, and NRP-1 at the tailbud stage (stage 24).  Sox2 
and NRP1 were used as general neural markers and N-tubulin as a marker of neuronal 
precursors.  Embryos were injected in one blastomere of the two-cell stage with 10 ng of 
either CMO or MO19 with mRNA encoding -galactosidase (Figure 2.7A).  The 
expression of Sox2 was unaffected by a reduction in ADAM19 protein while both N-
tubulin and NRP1 appear reduced on the injected side (Figure 2.7A).  The reduction of 
N-tubulin expression was confirmed by quantitative real-time PCR at both stage 17 and 
stage 24 (Figure 2.7B).  While the decrease was small (30%), it was highly reproducible 
(p-value<0.05) and was fully rescued by the injection of ADAM19 Rescue mRNA.  This 
suggests that only a fraction of neurons expressing N-tubulin are affected by the 
ADAM19 knock down.  In contrast to N-tubulin, ADAM19 knock down had no effect on 
Sox2 expression at both stage 17 or stage 24 confirming the in situ hybridization results. 
ADAM19 is also expressed in the CNC cells.  I investigated the role of ADAM19 
in neural crest induction at the open neural plate stage (Stage 15) before CNC migration.  
I performed in situ hybridization and real time PCR for the expression of two early neural 
crest markers, Sox8 and Slug (Figure 2.6).  Our results show that both Sox8 and Slug 
expression are reduced in the MO19 injected half of the embryos compared to the 
uninjected half serving as an internal control (Figure 2.6A).  Real time PCR shows a 
reduction of approximately two fold for Sox8 (50% reduction) and Slug (40% reduction; 
Figure 2.6B).  In contrast, the neural marker Sox2 increased at this stage.  Since the 
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neural crest is induced at the border of the neural plate, it is likely that the cells that are 
not induced to become neural crest will remain neural and maintain Sox2 expression. 
To investigate the role of ADAM19 in CNC cell migration, I performed targeted 
injection of the MO19 together with GFP mRNA at the 16-cell stage in a dorso-lateral 
animal blastomere.  The dorso-lateral animal blastomere will give rise to the cranial 
neural crest.  Cell migration was evaluated by observing the distribution of GFP in the 
different CNC segments (Figure 2.6C).  Our results show that, while GFP is present in all 
segments of the CNC that migrate in control embryos, no migration was observed in 33% 
of the embryos injected with MO19.  Together these results show that ADAM19 is 
required for neural crest cell induction and affects CNC cell migration.  Moreover, our 
results show that there is a significant reduction of xTwist expression in the MO19 
injected side (Figure 2.7A, arrowhead).  To investigate if ADAM19 affects CNC 
specification or solely xTwist expression, I determined ADAM11 expression as a marker 
of CNC by quantitative PCR.  While Twist is a widely used marker for CNC by in situ 
hybridization, it also labels other cells at the tailbud stage.  On the other hand, ADAM11 
is more restricted with expression in both the CNC and one line of dorsal neurons (Cai et 
al., 1998). Confirming the in situ hybridization, I observed a decrease of ADAM11 
expression at both stage 17 (58%) and stage 24 (50%) (Figure 2.7B).  This expression can 
be rescued with ADAM19 rescue mRNA.  
To investigate whether the reduction of the neural and neural crest markers were 
due to the reduction of ADAM19 in these tissues or a secondary effect of the dorsal 
mesoderm patterning, I injected MO19 in both dorsal animal blastomeres at the 8-cell 
stage to target only ectodermal derivatives (Figure 2.7B, right graph).  Only 1 ng of 
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MO19 was injected in each cell at the 8-cell stage to adjust for the reduction in cell size.  
The results show that a reduction of ADAM19 protein in the ectoderm is sufficient to 
reduce N-tubulin and ADAM11 in the same proportion as those observed when the 
MO19 is injected at the one cell stage.  In contrast no change was observed in the somitic 
mesoderm marker Myosin Light Chain (MLC), confirming the proper targeting of our 
injection.  These results suggest that ADAM19 is required in the neural ectoderm and 
neural crest cells to perform its function. 
 
SECTION V:  Role of ADAM19 in Somitic Cell Organization and Muscle 
Differentiation 
 
The expression of ADAM19 increases at neurula and tailbud stages and is mainly 
concentrated in the dorsal mesoderm and neural tissue.  To determine if ADAM19 plays 
a role in somite development, I performed in situ hybridization using MLC and MyoD at 
the tailbud stage (st.24) (Figure 2.7A).  The results show that ADAM19 knock down 
dramatically reduces MLC expression in the somites.  In contrast, MyoD, which is also 
expressed in the somites, did not appear to be reduced on the injected side.  Furthermore, 
MyoD staining shows that the correct segmentation of the somites is achieved even in 
embryos with reduced ADAM19 protein.  The reduction of MLC expression was 
confirmed by quantitative PCR at stage 17 (93% decrease) and at stage 24 (58% 
decrease) (Figure 2.7B).  Expression of MLC was rescued by the co-injection of 
ADAM19 mRNA (Figure 2.7B).  In fact, the same pattern of gene expression (reduction 
of MLC but no changes in MyoD) was also observed at stage 15 (data not shown).  These 
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results suggest that a reduction in the ADAM19 protein level does not affect early 
induction and segmentation (MyoD) of the somitic mesoderm but may interfere with the 
differentiation of the muscle (MLC). 
To further investigate the role of ADAM19 in somite formation, I used our 
ADAM19 antibody (C3) to detect the protein localization on sections of tailbud stage 
embryos (Figure 2.8). I found that ADAM19 localizes to the notochord, the intersomitic 
boundary and the ventral half of the neural tube (Figure 2.8A-C).  In addition, I found 
staining within the branchial arches (Figure 2.8A).  The distribution of the protein is 
consistent with the mRNA expression pattern (Figure 2.2) and provides new information 
about where the protein may be functioning in these tissues.  I performed the same 
staining on embryos injected in one side with MO19.  The most dramatic change is the 
complete absence of ADAM19 staining at the intersomitic junction (Figure 2.8D).  As 
seen for the in situ hybridization with MyoD (Figure 2.7A), the segmentation of the 
somites is apparent in both sides of the embryos.  While the segmentation is unaffected, 
the organization of the cells within each somite is abnormal in embryos with reduced 
ADAM19 protein.  Furthermore, the nuclei on the control side are aligned at the center of 
each cell, however this alignment is disrupted on the side with reduced ADAM19 protein 
(Figure 2.8D).  In addition to these somite defects, staining with the mAb 12-101, a 
marker of muscle differentiation, is decreased on the MO19 injected side (Figure 2.8E).  
This decrease was observed in the posterior somites but not in the most anterior somites 
suggesting a delay in 12-101 expression rather than a complete inhibition (data not 
shown).  Moreover, the decrease of 12-101 expression was confirmed by western blot on 
embryos injected at the one cell stage with MO19 (Figure 2.8G).   
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To visualize the intersomitic boundary of embryos injected with MO19, I 
performed staining with antibodies to fibronectin (FN).  The staining confirms the 
presence of somite boundaries in the injected side similar to the control side.  
Interestingly, I also found that some of the intersomitic boundaries lacked FN (Figure 
2.8F).  This was confirmed by whole mount immunostain where the entire embryo can be 
visualized at once (Figure 2.8H).  Using this technique, I found that the fibronectin 
staining was present but slightly abnormal.  The defect was seen only in the somites 
located between the “chevron” and the “straight” shaped somites (approximately 7th 
somite).  Compared to this mild and restricted FN defect, the abnormal distribution of the 
nuclei affected a larger number of somites.  Together, the results presented in Figure 2.7 
and 2.8 show that a reduction of the ADAM19 protein affects both the organization and 
differentiation of somite cells into muscle but not the initial induction of the paraxial 
mesoderm or the segmentation. 
 
SECTION VI:  ADAM19 Affects EGF Signaling during Gastrulation 
 
In mouse, ADAM19 can cleave members of the EGF family of ligands, including 
Neuregulin-1 (Chesneau et al., 2003; Horiuchi et al., 2005; Kawaguchi et al., 2007; 
Shirakabe et al., 2001).  Upon cleavage the EGF ligands bind to the EGF receptor and 
activate a signaling cascade involving AKT/PKB (protein kinase B).  To investigate if 
Xenopus ADAM19 plays a role in the EGF signaling pathway, I performed western blot 
analysis of late gastrula stage embryos injected with either CMO or MO19.  Our results 
show that phosphorylated AKT (AKTp) is decreased significantly in embryos with 
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reduced ADAM19 protein (Figure 2.9).  In contrast, neither phosphorylated MAPK 
(MAPKp) nor the cytoplasmic adaptor protein PACSIN2 was reduced.  To investigate 
whether the EGF signaling pathway was involved in neural crest cell induction, I used a 
pharmacological inhibitor of the EGF receptor (AG1478, 100 µM).  I treated embryos 
during gastrulation between stage 10 and stage 12 with AG1478 compared to a DMSO 
control treatment.  In addition, I also used a broad-spectrum inhibitor of metalloproteases 
called Marimastat (10 µM) to inhibit most ADAM protease activity (Orth et al., 2004).  
Based on the blastopore size, neither inhibitor affected gastrulation movements (data not 
shown).  However using real time PCR, I found that Marimastat and AG1478 
significantly decreased Slug expression (Figure 2.9C).  This result confirms the 
importance of the EGF signaling pathway and metalloprotease activity in neural crest cell 
induction.  As a control, I performed western blot with the AKTp antibody and found a 
50% reduction in embryos treated with the EGF receptor inhibitor confirming its activity 
in vivo.  Similar to what was observed with MO19 (Figure 2.9B), I also found that 
Marimastat reduced the level of phosphorylated AKT (data not shown), suggesting that 
metalloprotease activity, possibly of ADAM19, is important for EGF signaling during 
gastrulation. 
SECTION VII:  Discussion 
 
ADAM19 Expression and Function in the Early Embryo 
 
This chapter describes the cloning and molecular analysis of the Xenopus laevis 
homologue of ADAM19.  Maternal ADAM19 mRNA is present during the initial 
cleavage stages.  Zygotic expression is first detected during gastrulation in the dorsal 
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mesoderm of the dorsal blastopore lip.  During later development, ADAM19 mRNA is 
localized to dorsal, neural and mesodermal derived structures including the neural tube, 
the notochord, and the somites.  Loss of function experiments using antisense morpholino 
oligonucleotides shows a reduction of Brachyury in the notochord of gastrula stage 
embryos and an increase in the dorsal mesoderm markers Goosecoid and Chordin.  
During neurulation and tailbud formation a reduction of ADAM19 protein results in the 
reduction of neuronal, neural crest and somitic markers.  The segmentation of somites is 
not perturbed but the organization of cells within an individual somite is disrupted.  
Lastly, I present evidence that the EGF signaling pathway is affected by ADAM19 knock 
down. 
ADAM19 mRNA is expressed during early mouse embryonic development in a 
pattern similar to the one described here for Xenopus.  ADAM19 is present in dorsal 
tissues including the spinal cord, the craniofacial and dorsal root ganglia, and the 
peripheral nervous system.   In the mouse, ADAM19 is also present in mesenchymal 
condensation of the tailbud and the heart (Kurisaki et al., 1998).  ADAM19 KO mice die 
perinatally due to defects observed in heart formation (Kurohara et al., 2004; Zhou et al., 
2004), confirming the importance of ADAM19 in heart morphogenesis.  The heart 
defects were shown to be due to a lack of the ADAM19 protein in cardiac neural crest 
cells rather than in the endothelial cells (Komatsu et al., 2007).  The cardiac neural crest 
cell migration was not affected by the lack of ADAM19; however the ability of the cells 
to participate in heart morphogenesis was perturbed.  In Xenopus, a reduction of 
ADAM19 protein affects early gene expression in the gastrula, neurula and early tailbud 
stage.  I have also observed a decrease in the expression of three cardiac specific genes 
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during heart formation (Appendix II), suggesting that ADAM19 is also involved in heart 
morphogenesis in amphibians.  It is interesting to note that ADAM12 (meltrin-) was not 
found during early embryogenesis in Xenopus laevis, while ADAM9 and ADAM13 are 
both expressed in overlapping patterns with ADAM19 (Alfandari et al., 1997; Cai et al., 
1998).  This suggests that ADAM9, ADAM13 and ADAM19 may have overlapping 
functions during Xenopus laevis gastrulation. 
In addition to the prominent role of ADAM19 in cardiac morphogenesis, the 
ADAM19 KO mice also have minor defects found in other tissues.  Most of the 
ADAM19 KO mice (~80%) die perinatally due to defects shown in heart development.  
However, approximately 20% survive to adulthood and appear healthy and fertile.  If the 
adult ADAM19 KO mice become pregnant, they die late in pregnancy due to an inability 
to compensate for the increased circulatory demands (Zhou et al., 2004).  ADAM19 is 
highly enriched in the placenta during pregnancy and believed to be involved in 
trophoblast invasion of rhesus monkeys, Macaca mulatta, (Wang et al., 2005) and in 
humans (Zhao et al., 2009).  This strongly suggests that ADAM19 may function in the 
placenta during pregnancy.  Another group has reported that some ADAM19 KO mice 
carrying a mixed genetic background of 129/Sv and C57BL/6 survive to adulthood but 
have defects in the peripheral nervous system (Kurohara et al., 2004).  The differentiation 
of Schwann cells from promyelin to myelinating stages is drastically delayed in 
ADAM19 KO mice upon sciatic nerve injury.  It is interesting to note, that this defect is 
due to a delay in the AKT-dependent upregulation of Krox20.  These results further 
support the role of ADAM19 in the AKT signaling pathway. 
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Role of ADAM19 in Early Patterning of the Embryo 
 
A reduction of ADAM19 in gastrula stage embryos results in a decrease of 
Brachyury expression in the notochord and an increase of the dorsal mesoderm markers, 
Goosecoid and Chordin.  This result is consistent with the observation that the 
upregulation of Goosecoid can repress Brachyury expression (Boucher et al., 2000).  
Thus ADAM19, which is expressed in the dorsal mesoderm, may participate in restricting 
Goosecoid gene expression.  On the other hand, ADAM19 may be important to maintain 
Brachyury expression in the notochord.  At the moment, it is not clear whether Goosecoid 
overexpression is preventing Brachyury expression in the notochord or if these are 
independently affected by ADAM19.  Further analysis into ADAM19 function on 
Brachyury expression will be investigated in Chapter IV of this thesis.  Previous work 
has shown that high doses of TGF- can induce Goosecoid and Chordin at the same time 
repress Brachyury expression (Latinkic and Smith, 1999; Latinkic et al., 1997).  Thus 
ADAM19 knock down may increase TGF- signaling in the early embryo.  This suggests 
that ADAM19 function is to negatively regulate TGF- signaling.  In mouse, ADAM12 
promotes TGF- signaling by interacting with the TGF- type II receptor to control its 
subcellular localization (Atfi et al., 2007).  Therefore ADAM19 may also interact with 
the TGF- receptor but decrease rather than increase TGF- signaling.  In addition, the 
EGF-CFC/FLR1 protein was shown to modulate TGF- signaling via nodal related 
proteins (Cheng et al., 2003; Dorey and Hill, 2006; Yabe et al., 2003).  Cleavage of FLR-
1 by ADAM19 may reduce TGF- signaling at the end of gastrulation coinciding with 
the disappearance of FLR-1 mRNA expression.  Thus there are several possible ways that 
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ADAM19 may control TGF- signaling during gastrulation.  Furthermore, the expression 
patterns of Brachyury and Chordin in the axial mesoderm, as been shown to control the 
anterior-posterior (A-P) polarity of the notochord.  Chordin localizes to the anterior 
notochord while Brachyury localizes to the posterior notochord (Ninomiya et al., 2004).  
This suggests that embryos with reduced ADAM19 protein have notochords that are 
“anterior-ized” compared to control embryos.  Further analysis into the A-P polarity of 
the notochord will be investigated in Chapter IV of this thesis. 
Through various gene expression patterns for the notochord, paraxial mesoderm 
and neural ectoderm, I have found that the separation between the axial and paraxial 
tissues may be delayed or impaired in embryos with reduced ADAM19 protein.  ADAM 
metalloproteases can cleave cell-cell adhesion molecules such as cadherins or 
protocadherins (Maretzky et al., 2005; McCusker et al., 2009; Reiss et al., 2005).  The 
role of the protocadherins AXPC and PAPC in notochord and somite formation is 
elegantly demonstrated in Xenopus (Chen and Gumbiner, 2006; Kim et al., 2000; Kim et 
al., 1998; Kuroda et al., 2002; Unterseher et al., 2004; Wang et al., 2008) and it is 
possible that the activity of these proteins is regulated by proteolytic processing.  
Therefore, ADAM19 may be involved in separating the axial mesoderm from paraxial 
mesoderm by cleaving cell adhesion molecules such as protocadherins. 
 
Role of ADAM19 in EGF Signaling of the Embryo 
 
The EGF signaling pathway is the best characterized signaling pathway involving 
ADAM19 (Blobel, 2005).  In mice, ADAM19 can cleave some members of the EGF 
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ligand family including Neuregulin1- (NRG1).  In Xenopus, NRG1 is expressed as a 
maternal transcript with zygotic expression beginning during gastrulation through tailbud 
formation (Chung and Chung, 1999; Yang et al., 1999; Yang et al., 1998a).  Purified 
recombinant NRG1 can induce naïve animal cap cells to become mesoderm and express 
Brachyury (Chung and Chung, 1999).  Therefore, ADAM19 mediated cleavage of 
NRG1 in the dorsal mesoderm may be important for maintaining Brachyury expression 
in the notochord.  NRG1signals through the EGF receptors ErbB3/B4 tyrosine kinases 
to activate the MAPK and PI3K/AKT signaling pathways (Esper et al., 2006).  
Furthermore, the ErbB signaling pathway also contributes to convergence and extension 
movements during gastrulation (Nie and Chang, 2007b).  However, a knock down of 
ErbB3 or ErbB4 did not inhibit Brachyury expression in the notochord, suggesting that 
ADAM19 function may act through a different signaling pathway (Nie and Chang, 
2007a; Nie and Chang, 2007b).  I have found that ADAM19 knock down decreases 
AKTp, a downstream component of the EGF signaling pathway.  In addition, the EGF 
receptor inhibitor AG1478 affects neural crest gene expression similar to the ADAM19 
knock down.  These results suggest that ADAM19 is important for EGF receptor 
activation and that the EGF signaling pathway is important for neural crest cell induction.  
 
Role of ADAM19 in Neural, Neural Crest and Muscle Development 
 
During neurulation and tailbud formation, embryos with reduced ADAM19 
protein show a reduction of N-tubulin and NRP1 in the neural tissue and MLC in the 
somites.  Interestingly, for both the dorsal mesoderm and neural tissue, the overall 
37 
 
induction is not affected as shown by the expression of Sox2 in the neural tube and 
MyoD in the dorsal mesoderm.  This suggests that ADAM19 may function only as a 
modifier rather than a master regulator of cell fate.  ADAM19 knock down reduces the 
expression of CNC cell markers xTwist, Sox8, Slug and ADAM11.  In situ hybridization 
using xTwist reveals that at least some CNC maintain xTwist expression and are capable 
of migration.  However, our lab has shown that CNC with a reduced level of ADAM19 
do not migrate as efficiently as wild type cells in vivo.  Together with the conditional 
ADAM19 KO mice in the cardiac neural crest, ADAM19 may be required for both neural 
crest cell induction and function.  This could be due to either a direct affect on migration 
or the observed defect in neural crest induction. Additional experiments are required to 
test these two hypotheses.  Once again, Neuregulin appears as an attractive candidate as a 
substrate for ADAM19 because Neuregulin can induce both neural and muscle specific 
markers in Xenopus animal cap assays (Chung and Chung, 1999).  Moreover, the role of 
NRG1 in neuronal cell specification has been studied extensively (Britsch et al., 1998; 
Cameron et al., 2001). 
 In the paraxial mesoderm, a reduction of ADAM19 protein does not prevent 
muscle induction or somite segmentation.  In addition, the fibronectin rich extracellular 
matrix is deposited at the intersomitic boundary.  While the general organization of the 
somites does not depend on ADAM19, cell organization within each somite appears to be 
affected by a reduction of ADAM19 protein.  Specifically, the morphotype suggests that 
cell rotation may be delayed or abnormal.  Together with somite organization, at least 
two markers of muscle differentiation (MLC and 12-101) are reduced in ADAM19 knock 
down embryos.  It is not clear at the moment whether the effects on cell organization and 
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muscle differentiation are linked.  As for the early gastrulation defects, either a signaling 
role for ADAM19 or a structural role via cleavage of a cell adhesion molecule could 
account for the defects seen following ADAM19 knock down.  Loss of function and 
complementation experiments using the putative substrates for ADAM19 will be 
necessary to determine which of the signaling pathways ADAM19 regulates.  The 
Xenopus system may provide a unique way to dissect in vivo the role of ADAM19 in 
early embryonic development. 
 
SECTION VIII:  Materials and Methods 
 
Embryo Culture 
Xenopus laevis eggs were fertilized and the resultant embryos were de-jellied in 2% 
cysteine and cultured as previously described (Newport and Kirschner, 1982a; Newport 
and Kirschner, 1982b).  Staging of embryos was according to (Nieuwkoop, 1967a; 
Nieuwkoop, 1967b). 
 
Cloning of ADAM19 
Degenerate oligonucleotide primers were designed from sequences conserved in human, 
mouse, quail, and Xenopus tropicalis.  PCR was carried out with cDNA from stage 20, 
stage 36 and adult liver using S1 (amino acids LNIRIAL) and AS3 (amino acids 
CNNNKN) at an annealing temperature of 50C. The corresponding PCR product was 
cloned into TOPO-TA (Invitrogen) and sequenced. Specific primers were designed and 
used in 5‟ and 3‟ RACE-PCR with the Generacer kit (Invitrogen) according to the 
39 
 
manufacturer‟s instructions. Clones from at least 3 independent PCR reactions were 
sequenced to obtain the full length ADAM19.  
 
Quantitative PCR 
Total RNA was isolated from 5 embryos according to (Chomczynski and Sacchi, 1987) 
followed by LiCl precipitation and poly A purification using the Oligotex kit (Qiagen) 
according to the manufacturer instructions. The cDNA was reversed transcribed using the 
Quantum Qscript kit (Quanta Biosciences). All PCR reactions were carried out using 
SYBR green (Takara) on a MX3005P light cycler (Stratagene). All experiments were 
repeated at least 3 times on separate injection days and the real time PCR was also 
performed in triplicate on separate days to maximize variation due to PCR efficiency.  
The results were analyzed using the 2
-CT
 method (Livak and Schmittgen, 2001) and are 
presented as the Log2 fold change. All data were normalized using alpha tubulin.  The 
list of the real time PCR primers is shown in Table 2.1. 
 
Plasmid Constructs and mRNA Microinjection 
Full-length Xenopus ADAM19 was amplified by PCR using 2.5 units of Pfu DNA 
polymerase (Stratagene) and cloned into the pCS2
+
 vector (Turner and Weintraub, 1994).  
Rescue ADAM19 mRNA was generated using a sense oligonucleotide containing 4 
nucleotide silent mutations at the MO binding site (5‟ – 
CATGGAAGGTGCAACAGGAGTC – 3‟, mutation are in bold).  Non-rescue ADAM19 
mRNA corresponds to the original cDNA sequence. The pCS2-ADAM19 construct was 
linearized by NotI and transcribed by SP6 RNA polymerase. All mRNA was prepared for 
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microinjection as described in (Cousin et al., 2000).  Transcripts were injected close to 
the animal pole region at the indicated dosages and embryo stages stated in the figure 
legends.  For embryos where one blastomere at the two-cell stage was injected, the 
uninjected half of the embryo served as an internal control for each embryo. 
 
Antisense Morpholino experiments 
An antisense Morpholino (MO) was synthesized (Gene Tools Carvalis, OR) just 
upstream of the ATG start codon for ADAM19 (MO19).  The sequence was selected to 
be complementary with all the 5‟ cDNA clone obtained by RACE PCR and is also a 
perfect match to the published sequence for ADAM19 in Xenopus tropicalis. A control 
MO (CMO) was used to test for non-specific toxicity in the dose response experiments.  
The sequences of the morpholinos used in this dissertation are in Table 2.1.  Serial 
dilutions of MO19 (50 ng to 1 ng) were injected in 5 nl volume into wild-type embryos to 
test for toxicity.  A dosage of 10 ng of MO19 was selected and was shown to inhibit 
translation of 1 ng of the wild type ADAM19 mRNA in embryos while allowing 
translation of a messenger containing the 4 nt mismatch. When the MO where injected in 
a subset of cells to target specific tissues, -galactosidase or GFP-myc RNA was injected 
to trace the lineage with reduced ADAM19 protein.  
 
Whole Mount -galactosidase Detection and In Situ Hybridization 
Embryos were fixed in MEMFA (0.1 M MOPS pH 7.4, 2 mM EGTA pH 8, 1 mM 
MgSO4, and 3.7% formaldehyde) for 1hr at 20
o
C.  They were washed in PBS and stained 
at 37
o
C in PBS solution containing 1 mg/ml X-gal, 20 mM K3Fe(CN)6, 20 mM 
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K4Fe(CN)6, and 2 mM MgCl2.  The embryos were dehydrated in methanol and stored at -
20
o
C.  Whole mount in situ hybridization was performed exactly as described previously 
using albino or wild-type embryos (Harland, 1991).   
 
Western Blot Analysis 
Embryo protein extraction and western blot analysis were performed exactly as described 
previously (Alfandari et al., 1997).  Monoclonal antibody to PACSIN2 (3D8) and 
GAPDH (Millipore) was used as a loading control as described previously (Cousin et al., 
2000). For quantification, blots were detected using chemiluminescence on a G-Box 
HR16 (Syngene) and analyzed using the Genetool analysis software. Alternatively for 
weaker signals, the blots were exposed on X-ray films for various time points and the 
films were scanned and analyzed by densitometry using the same software. 
 
Immunofluorescence and Whole Mount Immunostain 
Embryos were fixed using either MEMFA or DENTS (20% DMSO in 80% Methanol) 
and stored in methanol before sectioning. Embedding was performed by increasing doses 
of 15% fish skin gelatin (Sigma) and 15% sucrose in PBS. After a final impregnation 
overnight at 4
 o
C, embryos were mounted in OCT (Tissue Teck). Cryosections (14 to 16 
µm) were blocked in PBS containing 20% goat serum and 1% BSA (Sigma). Primary 
antibodies were used at 10 µg/ml and secondary antibodies (Jackson Immunoresearch) 
were used at 5 µg/ml. Slides were mounted using Vectashield (Vector) and imaged using 
a Zeiss Axiovert 200M inverted microscope equipped with a Ludl XY-stage control and a 
Hamamatsu Orca camera. Images were taken using the ApoTome structured light 
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illumination system (Zeiss) and the AxioVision software (Zeiss). Whole mount 
immunostaining was performed as previously described (Dent et al., 1989). 
 
 
Time Lapse Imaging 
 
Embryos at late blastula stage were individually placed in holes made in an agarose 
coated plastic dish. Time lapse movies were made using an Axiovert inverted microscope 
(Zeiss) equipped with a Ludl XY-stage control and an Orca camera (Hamamatsu) and 
controlled by the OpenLab software (Improvision). Measurements were done using the 
same software.  
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Figure 2.1: ADAM19 expression.  Quantitative real-time PCR expression 
of ADAM19 during early Xenopus development.  Polyadenylated RNA 
from 2.5 embryos was used to make cDNA. PCR amplification was 
performed on a light cycler for 40 cycles. (A) The amplification product 
from both the control (-RT) and the experimental (+RT) were separated on 
a 2% agarose gel. (B) The relative abundance of the ADAM19 mRNA 
was measured by the 2
(-CT)
 method (Livak and Schmittgen, 2001) using 
stage 10 as a value of 1. Values are not adjusted to a control gene but to 
identical number of embryos.  The CT values for each reaction are given 
below the graph.  No CT values were obtained for the -RT control of each 
stage.  ADAM19 mRNA is present as a maternal transcript at stage 2.  
Zygotic transcription starts during gastrulation and increases during 
neurulation (Stage 16) continuing into early tailbud stage (Stage 21).  
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Figure 2.2: ADAM19 mRNA distribution.  Whole mount in situ hybridization using a 
probe corresponding to Xenopus ADAM19. (A) Lateral view of a bisected gastrula with 
the dorsal side to the left and the animal pole at the top (ap). (B; G) Dorsal views of early 
tailbud stage embryos with the anterior at the top. (C; D; E; I) Lateral views of tailbud 
stage embryos with anterior to the left. (F) Ventral view of an early tailbud stage embryo. 
Photographs in A, F and I were taken with embryos in PBS to visualize superficial rather 
than internal staining. All other embryos were imaged in Murray‟s clear. (A) ADAM19 is 
first expressed in the dorsal mesoderm of the gastrula, with the most intense signal in the 
dorsal blastopore lip (dbl). (B; F; G; H) At early tailbud stage, ADAM19 is found in the 
dorsal mesoderm including the notochord (n), somites (s), the cement gland (cg) and the 
neural tube (nt). (C; D; I) ADAM19 expression in these tissues persists during tailbud 
formation. In the anterior, ADAM19 is expressed in the brain (br), the otic (ot) and optic 
(o) vesicles as well as CNC segments and branchial arches (ba). (E) At stage 36, the 
expression in the pronephros (p) is also detected.  
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Figure 2.3:  Morpholino oligonucleotide knock down of ADAM19.  Western blot of 
protein extract from embryos injected with a control morpholino or a morpholino to 
either ADAM13 (MO13) or ADAM19 (MO19).  The morpholinos (10 ng) were injected 
at the one cell-stage and embryos were extracted at stage 22. (A) Immunoprecipitation of 
ADAM19 using the goat DC19 antibody separated by SDS-PAGE and probed with a 
rabbit polyclonal antibody to the ADAM19 cytoplasmic domain (AP ADAM19 C3). A 
monoclonal antibody to GAPDH was used as a loading control. (B) The densitometric 
analysis of the blot depicted in A shows that the ADAM19 protein is reduced by 
approximately 100% by the MO19 when normalized to the GAPDH expression level. (C) 
The MO19 is capable of preventing translation of 1 ng of ADAM19 mRNA when co-
injected in embryos (A19NR) but not a messenger with 4 mutations in the sequence 
corresponding to the MO19 (A19R). The ADAM13 morpholino does not affect 
ADAM19 translation.  
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Figure 2.4:  ADAM19 is not required for blastopore closure.  Time-
lapse imaging of gastrula stage embryos injected with either a control MO 
(CMO) or MO19.  Embryos were microinjected with 10 ng of MO at the 
one-cell stage and allowed to develop through the end of gastrulation.  The 
blastopore size in micrometers was measured using the OpenLab software 
at three different time points during gastrulation. The values represent the 
average of three different experiments using 8 embryos each for the 
control and the experimental.  Error bars correspond to standard deviation 
from the mean.  Representative images are shown below the histogram. 
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Figure 2.5:  Gene Expression analysis of ADAM19 knock down at the gastrula stage.  
(A) Embryos were microinjected with 10 ng of either the MO19 or a control MO at the 
one-cell stage and allowed to develop until gastrula stage (stage 12 and 13). Whole 
mount in situ hybridization were performed using the markers Brachyury, Sox2 (Xbra 
Sox2, stage 12), and Chordin and Goosecoid (Chd and Gsc, stage 13). For all embryos, 
the dorsal view is presented with the anterior up. The red arrowheads point to the 
notochord. The number of embryos and the frequency of the phenotype depicted in the 
photographs are indicated in the text. (B) Quantitative real-time PCR was performed on 
embryos injected with either MO19 alone or together with ADAM19 Rescue mRNA 
(MO19+A19R).  The relative abundance of Chordin (Chd), Goosecoid (Gsc) and 
Brachyury (XBra) gene expression was measured by the 2
-CT
 method using either 
embryos injected with the control MO or non-injected and normalized to alpha-tubulin.  
There was no effect of the control MO to gene expression. The asterisks represent 
statistical significance at P<0.05 using a student t test. There is a small decrease in Xbra 
(16%, not significant) and a robust increase in both Chd (187%) and Gsc (230%) which 
are rescued by the injection of the ADAM19 mRNA. 
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Figure 2.6: ADAM19 is critical for neural crest induction.  (A) Whole mount in situ 
hybridization of neurula (stage 15) embryos using Slug and Sox8 to detect neural crest 
cells.  The injected side is to the left.  Embryos injected with MO19 show a decrease in 
expression of both neural crest markers (red arrowhead). (B) Real time PCR analysis at 
stage 15.  The level of gene expression was measured by the 2
CT
 method and 
normalized to alpha-tubulin.  Results are presented as the Log2 of the fold change 
compared to non injected embryos.  Variation of Sox2, Sox8, and Slug are all significant 
(p<0.01) in embryos injected with MO19 when compared to the control MO. (C) Lateral 
view of tailbud stage embryos (stage 24) visualizing GFP.  Embryos were injected at the 
16-cell stage in a dorso-lateral-animal blastomere to target neural crest cells. In the 
control, GFP is found in all CNC segments (white arrows). This is absent in 33% of the 
embryos injected with MO19. 
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Figure 2.7:  Gene Expression analysis of ADAM19 knock down at the tailbud stage.  
(A) Whole-mount in situ hybridization of tailbud stage embryos (stage 22-24). Embryos 
were injected in one blastomere of the two-cell stage with 10 ng of CMO or MO19 with 
mRNA encoding beta-galactosidase (-Gal) as a lineage tracer.  The embryos were 
processed by whole mount in situ hybridization with the markers Myosin Light Chain 
(MLC), N-tubulin, NRP1, Sox2 and ADAM11.  The injected side, as detected by -Gal 
activity (light blue), is on the left side for all embryos. The percentages of embryos 
displaying these phenotypes are indicated and represent the average of 3 independent 
experiments.  The black arrowheads point to the area of decreased gene expression. For 
Twist the embryo heads are presented as a side view and the injected side of each embryo 
is to the left.  A decrease in xTwist expression is visible (arrowhead) in embryos injected 
with MO19. (B) Quantitative real-time PCR was performed on embryos injected at the 
one-cell stage with either the MO19 alone or with the ADAM19 rescue mRNA 
(MO19+A19R) and allowed to develop until neurula (stage 17) and tailbud stage (stage 
24).  On the right, the MO19 was injected in two dorsal-animal blastomeres at the 8-cell 
stage (MO19 Ectoderm) to target dorsal ectoderm but not mesoderm derivatives. All 
genes were compared to non-injected control embryos. The relative abundance of MLC, 
N-tubulin, Sox2 and ADAM11 gene expression was measured by the 2
-CT
 method and 
normalized to alpha-tubulin.  Results are presented as the Log2 of the fold change and 
error bars correspond to the standard error. Asterisks represent a p<0.05 using a standard 
t test assuming unequal variance. 
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Figure 2.8: ADAM19 is essential for somite organization and muscle differentiation.  
Histological and molecular analysis of embryos with reduced ADAM19 protein. (A-F) 
Frozen sections of tailbud stage embryos. (A-D) Immunofluorescence using the rabbit 
polyclonal antibody to the ADAM19 cytoplasmic domain (AP C3).  (A) Frontal section, 
anterior is to the left. The ADAM19 protein is localized to the intersomitic boundary 
(arrowhead), the notochord (n), the neural tube (nt) and in the branchial arches (ba).  (B) 
Transverse section. ADAM19 is in red, the muscle marker 12-101 in green and the nuclei 
(DAPI) in blue. ADAM19 staining appears associated with the ventral basal side of the 
neural tube (arrowhead) and the notochord (n). (C) Magnification of the somite from a 
frontal section, ADAM19 is in red, the arrowhead points to the intersomitic boundary.  
(D-F) Frontal sections of tailbud stage embryos injected at the two-cell stage in one cell 
with 5 ng of MO19.  The injected side is labeled (yellow dots) and was detected either by 
using the ADAM19 antibody C3 (D and E) or GFP-myc (F) that was co-injected with the 
MO19. The injection of MO19 completely abolished staining of the intersomitic 
boundary by the ADAM19 antibody. While the intersomitic boundary is still visible, the 
nuclei are not aligned on the injected side (white line). (E) ADAM19 is in green (left), 
12-101 in red (center) and the merge presented with DAPI staining (right). There is a 
clear reduction of 12-101 staining on the injected side (MO19).  (F) The MO19 was co-
injected with GFP-myc to detect the cells that were targeted using the 9E10 mAb.  
Positive cells are visible in the right somites and some of the cells that contribute to the 
notochord (n).  Fibronectin was detected using a rabbit polyclonal antibody (32F).  Some 
of the FN staining is absent in part of the intersomitic boundary (arrowhead).  (G) 
Western blot using 12-101 on total protein extract. Stage 7 extract is used as a negative 
control.  At stage 22, MO19 injected embryos but none of the other injected embryos 
have less 12-101 protein.  (H) Whole mount immunostain using mAb 4H2 to detect 
fibronectin.  The injected side was detected prior to fixation using GFP fluorescence.  
The side injected with the MO19 shows an abnormal pattern of FN staining at some of 
the intersomitic boundaries (arrowhead).  
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Figure 2.9: ADAM19 may interfere with EGF signaling.  (A) Western blot using an 
antibody to phosphorylated AKT, -catenin, phosphorylated MAP kinase, and PACSIN2.  
Embryos were injected at the one-cell stage with either the control MO (CMO) or MO19 
and developed to late gastrula (stage 12).  Total protein 0.5 embryo equivalent were used 
for each blot. (B) Histogram representing the quantification of the western blot from 3 
independent injection experiments.  All measures were normalized to PACSIN2. 
Variations in pMAPK were not significant while the decrease in pAKT and -catenin 
was significant (p<0.05). (C) Real time PCR analysis of Slug expression. Embryos were 
treated with 10 µM of Marimastat (Mar), 100 µM of AG1478 or DMSO (1/1000) as a 
control, between stage 10 and stage 12, based on the blastopore size (none of the 
treatment affected gastrulation timing in these conditions).  Marimastat decreased Slug 
expression by an average of 34% while AG1478 decrease Slug by 60%.   
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Primer Sense Antisense 
Xbrachyury TTCTGAAGGTGAGCATGTCG GTTTGACTTTGCTAAAAGAGACAGG 
ADAM11 AGAGGATTCGTGGGCTGCTATTT AAGAGGTGAGTGGTGTCGCTATG 
Chordin CCTCCAATCCAAGACTCCAGCAG GGAGGAGGAGGAGCTTTGGGACAA 
Goosecoid CACACAAAGTCGCAGAGTCTC GGAGAGCAGAAGTTGGGGCCA 
SOX2 GAGGATGGACACTTATGCCCAC GGACATGCTGTAGGTAGGCGA 
MLC CCAGAACCAGAAAAGCCCAAAGCA TCCTCTTGGCGTTCATCTCCTCAG 
N-tubulin GATCTACGCAAACTGGCTGTCAAC GCATCTGTTCATCTACCTCCTTCA 
Alpha-tubulin TACAGGCAGTTATTCCACCCAGAG ACAGCAGAGAGGTGAATCCAGAAC 
ADAM19 ACGGAACCAGATTTGCTTTGATG AATGCTGCCCCCGTTACCTGTCT 
Slug AAACACTTCAACACGACCAAAAA GCTGACCCGACCTAAAGATGAA 
SOX8 AAGGTCTCTGGTGGCTGAAA CACCGCCACATTTCAGAGTA 
HNF3beta CCATCCAGCAGTCCCCCAACAA ATCAGGGTGTAGGGTCCAGAAG 
 
Table 2.1: Quantitative Real Time PCR Primer Sets used in Chapter II. 
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Target Morpholino Sequence 
Control (CMO) CCTCTTACCTCAGTTACAATTTATA 
xADAM13 GTCCCAGCCGACCCTCCGACCCCAT 
xADAM19 GAGTCCTGTAGCTCCTTCCATCCGA 
 
Table 2.2:  Morpholino Sequences used in this Thesis 
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CHAPTER III 
 
ADAM13 AND ADAM19 PROTEIN REGULATION 
 
All of the work presented in this chapter is data completed by myself and is unpublished. 
 
Abstract 
 
 This chapter focuses on ADAM13 and ADAM19 protein regulation in cultured 
cells and in the embryo.  I show that a loss of ADAM13 protein reduces the level of 
ADAM19 protein by 50%.  In addition, a loss of ADAM19 protein reduces the level of 
ADAM13 protein by 50%.  This suggests that both ADAM13 and ADAM19 are required 
to maintain a proper protein level in the embryo.  I propose this outcome may be 
explained by physical interactions of ADAM13 and ADAM19 in a cell.  The ADAM19 
Proform binds to the ADAM13 Proform in cultured cells.  Through domain analysis, I 
show that ADAM19 binds specifically to the cysteine-rich domain of ADAM13.  When 
co-overexpressed in a cell, the level of Mature ADAM13 (compared to the Proform) is 
reduced suggesting a complex form of regulation.  Lastly, I propose a few models that 
could explain how ADAM19 regulates the level of ADAM13 in a cell. 
 
SECTION I:  Introduction 
 
 Cell surface membrane bound proteins undergo a number of post-translational 
modifications before reaching their final destination in a cell.  The importance of these 
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modifications allows a cell to have a rapid response to changes within its 
microenvironment.  Members of the ADAM family of metalloproteases are known to 
function as rapid responders to cellular events, such as inflammation (Murphy, 2009).  
ADAM proteins are synthesized in the endoplasmic reticulum where a number of 
glycosylations occur post-translationally.  The proper folding of an ADAM protein, based 
on data for ADAM10 and ADAM17, involves the ER chaperone ERp57 in conjunction 
with calnexin and calreticulin (Jessop et al., 2007).  Once folded, the ADAM protein is 
transported from the ER and through the Golgi network.  Newly synthesized ADAM 
proteins emerge in an inactive state called a Proform.  The ADAM Proform is kept 
catalytically inactive through a „cysteine switch‟ mechanism where a single cysteine 
residue in their prodomain interacts with the Zinc atom located in the active site of their 
Metalloprotease domain (Van Wart and Birkedal-Hansen, 1990).  This mechanism keeps 
the Prodomain in close contact with the Metalloprotease domain rendering the enzyme 
inactive.  Further maturation occurs in the Trans Golgi compartment where a proprotein 
convertase, specifically Furin, cleaves the prodomain of an ADAM at the consensus 
recognition site, RxKR (Loechel et al., 1998).  This processing event is shown for some 
ADAM members to be a key step toward ADAM “activation” into the active state called 
a Mature form (Figure 1.3).  At this point, the Mature ADAM protein can be transported 
to the cell surface to carry out its function.  This is the „classical‟ post-translational 
modification route for an ADAM protein.   
Not all ADAM proteins can function at the cell surface and depending on the cell 
type; many ADAM proteins are stored in a perinuclear compartment believed to be the 
ER-Golgi complex (Schlondorff et al., 2000).  Furthermore, potential ADAM substrates 
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localize to various cellular compartments as well as travel a similar post-translational 
modifications route in a cell.  It is determined that two ADAM members, ADAM17 and 
ADAM19, cleave the EGF ligand Neuregulin1 (NRG1) in a cell (Horiuchi et al., 
2005).  ADAM19 cleaves NRG1 in the Golgi complex while ADAM17 cleaves NRG1 
at the cell surface (Yokozeki et al., 2007).  These experiments were carried out by 
western blotting for ADAM17 and ADAM19 on subcellular fractionation extracts 
(Yokozeki et al., 2007).  Additionally for ADAM19, experiments using a NRG1 
construct that is N-terminally fused to GFP were analyzed under fluorescence correlation 
spectroscopy (FCS).  FCS is used to detect fluctuations of fluorescent intensity in a 
confocally defined volume in living cells.  Thus, the trafficking and subcellular 
localization of ADAM proteins and their substrates may provide spatial and temporal 
control of how and where an ADAM protein functions within a cell (Murphy, 2009).   
 The overexpression of an ADAM and a potential substrate protein in cell culture 
results in the ectodomain shedding of the substrate into the cell supernatant.  This 
technique generated an initial list of potential biologically relevant substrates to ADAM 
family members (Table 1 in (Huovila et al., 2005)).  In addition, multiple ADAM 
proteins can cleave the same substrate in a cell, showing that ADAM family members 
have overlapping functions (Schlondorff and Blobel, 1999).  Studies done on knockout 
mice have provided some clues into ADAM protein function during embryogenesis.  
However, single knockout of many ADAM members (ADAM8, ADAM9, ADAM12, 
ADAM15) result in viable mice with no observable phenotype (Horiuchi et al., 2003; 
Kelly et al., 2005; Kurisaki et al., 2003; Weskamp et al., 2002).  Even the double 
(ADAM 9/15
-/-
) and triple (ADAM 9/12/15
-/-
) knockout mice are viable with no 
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observable phenotype (Sahin et al., 2004).  It is highly unlikely that these ADAM 
members do not function during embryogenesis because they have broad expression 
patterns in the embryo.  Therefore, it is more likely that ADAM family members have 
overlapping functions during embryogenesis in vivo (Alfandari et al., 2009). 
 Since multiple ADAM members are capable of cleaving the same substrates, it is 
suggested that ADAM proteins may work as a team in a tissue specific manner 
(Hartmann et al., 2002).  The idea that two ADAM family members can function together 
may be an integral part of ADAM metalloprotease regulation.  For example, the first two 
ADAM family members discovered were ADAM1 and ADAM2, also known as Fertilin-
 and Fertilin- respectively.  Both proteins form a heterodimer complex on the plasma 
membrane of sperm and are important for sperm migration into the oviduct and binding 
to the zona pellucida of the oocyte (Nishimura et al., 2007; Yamaguchi et al., 2009).  In 
this chapter I will show that both ADAM13 and ADAM19 are required to maintain a 
proper protein level in the embryo.  Furthermore, this regulation may occur at the protein 
level through their physical interaction in a cell. 
 
Results 
 
SECTION II:  ADAM13 and ADAM19 Regulation in the Embryo 
 
 Xenopus ADAM13 and ADAM19 are members of the meltrin subfamily of 
ADAM metalloproteases (Alfandari et al., 1997; Neuner et al., 2009).  The full length 
proteins share 41% identity at the amino acid level with the Disintegrin domain sharing 
the highest identity (64%) and the Cytoplasmic domain sharing the lowest identity (13%) 
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(Table 3.1).  ADAM13 and ADAM19 have predicted N-glycosylation sites (NxS/T) 
located in their extracellular region (Gooley et al., 1991).  N-glycosylation occurs in the 
ER and, based on data for ADAM10 and ADAMTS13, is important for further 
processing and stability of the full length protein (Escrevente et al., 2008; Zhou and Tsai, 
2009).  In addition, N-glycosylation of ADAM10 is important for enzymatic activity in 
vitro (Escrevente et al., 2008).  A conserved Metalloprotease active site 
(HExGHxxGxxHD) is found in the Metalloprotease domain.  The Disintegrin domain 
contains a “Disintegrin Loop” motif that, in its three-dimensional structure, is shown to 
fold into a -turn believed to bind directly to integrin receptors (McLane et al., 1998; 
Norris et al., 2003).  The Cysteine-rich domain is important for substrate selectivity and 
for ADAM13, is the site for autocatalysis or self-shedding (Gaultier et al., 2002).  The 
cytoplasmic domain contains a number of SH3 binding motifs capable of protein-protein 
interactions.  In addition, a number of Serine and Threonine phosphorylation sites are 
predicted throughout ADAM13 and ADAM19 cytoplasmic domains, as well as, a 
predicted Tyrosine phosphorylation site in the cytoplasmic domain of ADAM19 (Blom et 
al., 1999) (Figure 3.1).  Phosphorylation of membrane bound proteins is a form of 
regulation that modifies their intrinsic properties or creates a docking site for interacting 
with other proteins (Deribe et al., 2010). 
 ADAM13 is expressed as a maternal transcript with zygotic expression beginning 
from early gastrulation through tailbud formation.  During gastrulation, ADAM13 and 
ADAM19 are expressed in the dorsal mesoderm of the dorsal blastopore lip (Neuner et 
al., 2009; Wei et al., 2010).  Throughout early embryonic development, ADAM13 has a 
more restricted expression pattern, compared to ADAM19, being localized to the somitic 
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mesoderm and cranial neural crest cells (Alfandari et al., 1997).  Since ADAM13 and 
ADAM19 are expressed in similar tissues, I investigated whether ADAM13 and 
ADAM19 functionally interacted. 
Antisense Morpholino oligonucleotides corresponding to the sequence near the 
ATG start codon for ADAM13 (MO13) and ADAM19 (MO19) were used to prevent 
protein translation (Table 2.1).  Embryos injected with MO13 showed a clear absence of 
ADAM13 protein at the tailbud stage (st. 22) confirming the specificity of both our 
morpholino sequence and our antibodies (Figure 3.2).  This result was shown by 
glycoproteins purified on Concanavalin-A agarose beads and by immunoprecipitation for 
ADAM13.  Embryos injected with MO13 showed a 50% reduction in the level of 
ADAM19 at the tailbud stage (st. 22) (Figure 3.3).  In the reverse experiment, embryos 
injected with MO19 showed a clear absence of ADAM19 protein at the tailbud stage 
confirming the specificity of both our morpholino sequence and our antibodies (Figure 
3.3).  Embryos injected with MO19 showed a 50% reduction in the level of ADAM13 at 
the tailbud stage (Figure 3.2).  The results suggest that both ADAM13 and ADAM19 
need to be present in the embryo in order to maintain a proper protein level. 
I propose two hypotheses explaining why ADAM13 and ADAM19 are both 
required to maintain a proper protein level in the embryo.  One hypothesis is that 
ADAM13 and ADAM19 regulate each other‟s gene expression.  Our lab has shown that 
the cytoplasmic domain of ADAM13 is cleaved off and translocates into the nucleus to 
regulate gene expression important for CNC cell migration (Cousin et al., 2010).  In 
addition, the cytoplasmic domain of ADAM19 can also modulate gene expression and 
promote CNC cell migration (Cousin et al., 2010).  A loss of ADAM19 affects the 
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expression of a number of genes involved in CNC induction and muscle differentiation 
(Neuner et al., 2009).  Since the expression pattern of ADAM13 is restricted to these 
tissues and that ADAM11 expression is reduced in CNC cells; it is possible that 
ADAM19 regulates ADAM13 gene expression.  Therefore, ADAM13 and ADAM19 
could regulate gene expression through the function of their cytoplasmic domain in the 
nucleus.  To investigate gene expression, I will extract RNA from embryos injected with 
MO13 or MO19 for real time PCR.  In embryos lacking ADAM13, ADAM19 gene 
expression will be measured.  In embryos lacking ADAM19, ADAM13 gene expression 
will be measured.  Since both ADAM13 and ADAM19 are required in the embryo to 
maintain a proper protein level, my second hypothesis is that ADAM13 and ADAM19 
act as chaperones for each other.  This is important to regulate their protein stability in a 
cell.  The second hypothesis will be investigated next in Section III of this chapter. 
 
SECTION III:  ADAM13 and ADAM19 Physical Interaction in Cultured Cells 
 
 To determine if ADAM13 and ADAM19 act as chaperones for protein stability, I 
transfected 293T cells with ADAM13, ADAM19, or in combination.  Total protein 
extracts were used to determine ADAM13 and ADAM19 protein levels.  When 
ADAM13 and ADAM19 are cotransfected together, the level of ADAM13 is 
significantly reduced compared to ADAM13 alone (Figure 3.4A, left middle gel lane 2 
versus lane 4).  However, there is no change in the level of ADAM19 (Figure 3.4A, left 
middle gel lane 3 versus lane 4).  Although the overall level of ADAM13 is reduced, 
there is a stronger reduction in the Mature form (100kD).  The ratio of Proform to Mature 
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form is approximately 2:1 when compared to ADAM13 alone with an approximate ratio 
of 1:1.  This suggests that the transition from Proform to Mature form of ADAM13 may 
be regulated by ADAM19. 
 To determine if ADAM13 and ADAM19 physically interact, I transfected 293T 
cells with ADAM13, ADAM19, or in combination and total protein extracts were 
prepared for coimmunoprecipitation.  Using an antibody to immunoprecipitate ADAM13 
(6615F), a 120kD band was detected by the ADAM19 antibody (2C5 E1) in the 
cotransfected sample (Figure 3.4A, left).  This band corresponds to the Proform of 
ADAM19.  In the reverse experiment, using an antibody to immunoprecipitate ADAM19 
(2C5 E1), a 120kD band was detected by the ADAM13 antibody (6615F) in the 
cotransfected sample (Figure 3.4A, left).  This band corresponds to the Proform of 
ADAM13.  The results suggest that both ADAM13 Proform and ADAM19 Proform 
physically interact when overexpressed in 293T cells.   
 The coimmunoprecipitation experiment was repeated using the frog cell line, 
XTC.  This cell line endogenously expresses ADAM13 (Alfandari et al., 1997), but does 
not express ADAM19.  I transfected XTC cells with GFP alone or ADAM19 alone and 
total protein extracts were prepared for coimmunoprecipitation.  Using an antibody to 
immunoprecipitate ADAM13 (6615F), the Proform of ADAM19 (120kD) was detected 
by the ADAM19 antibody (2C5 E1) only in the ADAM19 transfected sample.  In the 
reverse experiment, using an antibody to immunoprecipitate ADAM19 (2C5 E1), the 
Proform of ADAM13 and the Mature form of ADAM13 were detected by the ADAM13 
antibody (6615F) only in the ADAM19 transfected sample.  As a control, ADAM13 was 
immunoprecipitated from red fluorescent protein (RFP) expressing XTC cells to detect 
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endogenous ADAM13 in our experiment (Figure 3.4B).  The results show that 
endogenous ADAM13 Proform and Mature form physically interact with overexpressed 
ADAM19 Proform in XTC cells. 
 To identify the domain of interaction between ADAM13 and ADAM19, I 
transfected 293T cells that overexpress different myc-tagged ADAM13 constructs.  The 
Disintegrin Domain alone (D13), the Cysteine Rich Domain alone (CR13), or the 
Disintegrin-Cysteine Rich Domain (DC13) were cotransfected with full length ADAM19 
and total protein extracts were prepared for coimmunoprecipitation.  Using an antibody to 
immunoprecipitate the myc-tagged ADAM13 constructs (9E10), the Proform of 
ADAM19 was detected by the ADAM19 antibody (C3) (Figure 3.5, first gel).  In the 
reverse experiment, using an antibody to immunoprecipitate ADAM19 (C3), both DC13 
and CR13 were detected by the myc-tag antibody (9E10) (Figure 3.5, second gel).  
Interestingly, DC13 and CR13 strongly interacted with ADAM19 while D13 showed a 
weaker interaction with ADAM19 (Figure 3.5, second gel).  Total cell extract was probed 
for the myc-tagged ADAM13 constructs and ADAM19 to ensure proper transfections.  
The results show that ADAM19 binds preferentially to the Cysteine Rich Domain of 
ADAM13. 
 Previous work has suggested that ADAM19 may function primarily within a cell 
at a perinuclear compartment with very little ADAM19 at the cell surface (Murphy, 2009; 
Yokozeki et al., 2007).  To determine where in a cell Xenopus ADAM19 may function, I 
investigated the subcellular localization of ADAM19 by immunofluorescence.  
Transfected XTC cells that overexpress ADAM19 were fixed and processed for 
immunofluorescence.  Using an antibody to ADAM19 (2C5 E1) and an antibody to the 
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ER-specific protein Calnexin, I observed strong colocalization of ADAM19 and Calnexin 
in the ER (Figure 3.6).  Very little to no expression of ADAM19 was found at the plasma 
membrane in lamellipodia.  Since the outer membrane of the nucleus is continuous with 
the ER, some punctuate expression of Calnexin was observed in the nucleus and this is 
consistent with previous observations (Gilchrist and Pierce, 1993; Wada et al., 1991).  
The results show that overexpressed ADAM19 localizes to the endoplasmic reticulum of 
XTC cells.   
 Since ADAM13 and ADAM19 physically interact in XTC cells, I investigated 
where in a cell ADAM13 and ADAM19 interact.  Transfected XTC cells that overexpress 
ADAM19 were fixed and processed for immunofluorescence.  Using an antibody to 
ADAM19 (2C5 E1) and an antibody to ADAM13 (6615F), I observed strong 
colocalization of overexpressed ADAM19 and endogenous ADAM13 (Figure 3.7).  The 
colocalization occurs within a perinuclear compartment, possibly the endoplasmic 
reticulum.  Endogenous ADAM13 was also observed at the cell surface in lamellipodia 
(white arrows) consistent with previous observations (Cousin et al., 2000).  The results 
show that ADAM13 and ADAM19 colocalize to a perinuclear compartment of XTC 
cells. 
 
SECTION IV:  Discussion 
 
ADAM Metalloprotease ER Retention  
 
Protein subcellular localization is a major part of the post translational 
modification mechanism.  The sorting process begins in the endoplasmic reticulum 
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immediately upon protein folding and is further refined in the Golgi complex.  A protein 
can be retained in the endoplasmic reticulum if it contains a specific amino acid sequence 
known as an ER retention signal (Wieland et al., 1987).  Arginine motifs such as „RR‟ or 
RxR‟ (where „x‟ is any amino acid) are one class of ER retention signals that do not need 
to be exposed at the C-terminus of a membrane protein but rather incorporated into the 
intracellular domain (Michelsen et al., 2005; Zhou et al., 2002).  For example, ER 
retention mediated by an RxR motif is shown for the NMDA receptor (Scott et al., 2001).  
Upon cell treatment with PMA, a known PKC activator, cell surface expression of the 
NMDA receptor increased.  When two predicted PKC phosphorylation sites adjacent to 
the RxR motif were mutated to alanine, it completely abolished the affects of PMA.  
Thus no cell surface expression of the NMDA receptor was observed.  Therefore, the 
receptors release from the endoplasmic reticulum is regulated by PKC phosphorylation of 
serine residues adjacent to the ER retention signal.  This class of ER retention signals has 
also been found in the cytoplasmic domains of a number of ADAM family members 
(Table 3.2).   
In addition to phosphorylation regulating ER exit, the recruitment of 14-3-3 
proteins to the cytoplasmic tail of the KATP channel  subunit, Kir6.2 is shown to be 
important for regulating ER retention (Nufer and Hauri, 2003; Yuan et al., 2003).  Upon 
phosphorylation at a serine residue adjacent to the RxR motif, 14-3-3 is recruited and 
binds to the cytoplasmic tail of Kir6.2.  This masks the ER retention signal allowing for 
anterograde transport through the secretory pathway and increases the level of Kir6.2 at 
the cell surface.  Furthermore, the authors show that -COPI directly competes with 14-
3-3 binding at this motif to regulate retrograde transport back to the endoplasmic 
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reticulum.  The same mechanism for the regulation of a protein at the cell surface is 
reported for the MHCII chain, lip35 (Khalil et al., 2003), the HIV co-receptor GPR15 
(Shikano et al., 2005), and the neuronal 4 acetylcholine receptor (O'Kelly et al., 2002).  
Therefore, at least for some membrane bound proteins, their regulation to the cell surface 
involves both phosphorylation of residues close to the RxR motif and 14-3-3 interaction. 
14-3-3 proteins are involved in similar biological functions as ADAM 
metalloproteases such as cell signaling (Radhakrishnan and Martinez, 2010; van Hemert 
et al., 2001), cell migration (Deakin et al., 2009; Hou et al., 2010; Lu et al., 2009), and 
cell-cycle regulation (Douglas et al., 2010; Kasahara et al., 2010).  The consensus binding 
motif for 14-3-3 proteins as well as SH3 binding motifs are present in the cytoplasmic 
domain of a number of ADAM family members (Table 3.2).  For example, 14-3-3 
proteins bind to the cytoplasmic domain of ADAM22.  This interaction masks the 
adjacent ER retention signal (RxR) to regulate the level of ADAM22 at the cell surface 
(Godde et al., 2006).  In addition, -COPI was identified as a binding partner to the 
cytoplasmic domain of ADAM19 in fetal brain tissue (Huang et al., 2002).  For 
ADAM10 and ADAM12, it is hypothesized that adaptor proteins bind to their 
cytoplasmic domains to regulate their exit from the endoplasmic reticulum to the cell 
surface (Cao et al., 2002; Hougaard et al., 2000; Marcello et al., 2010).  Therefore, it is 
believed that the regulation of an ADAM protein to the cell surface is regulated through 
the interaction of adaptor proteins such as 14-3-3 with the ADAM cytoplasmic domain.  
More importantly, this might contribute to the deregulation of an ADAM protein in 
disease such as cancer.   
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How Does ADAM19 Regulate ADAM13 in a Cell? 
 
When overexpressed the Proforms of ADAM13 and ADAM19 physically interact 
in a cell.  Both ADAM13 Proform and ADAM19 Proform can still physically interact, 
via coimmunoprecipitation, without the cytoplasmic domain of ADAM13 
(ADAM13cyto) or their metalloprotease activity (ADAM13 E/A and ADAM19 E/A) 
(data not shown).  Therefore, the physical interaction is independent of the ADAM13 
cytoplasmic domain and the proteolytic activity of ADAM13 or ADAM19.  ADAM19 
binds to the Cysteine-rich Domain of ADAM13 within a perinuclear compartment, 
possibly the endoplasmic reticulum.  Previous work has suggested that ADAM19 may 
function primarily within a cell at a perinuclear compartment with very little ADAM19 at 
the cell surface (Murphy, 2009; Yokozeki et al., 2007).  Our observations show that 
overexpressed ADAM19 strongly localizes to the endoplasmic reticulum.  The 
cytoplasmic domain of ADAM19 contains four ER retention signals (RxR) suggesting 
that ADAM19 may localize and function primarily in the endoplasmic reticulum.  When 
ADAM13 and ADAM19 are co-overexpressed in a cell, the overall level of ADAM13 is 
reduced.  Furthermore, there is a strong reduction specifically in the Mature form of 
ADAM13.  This occurs without changing the protein level of ADAM19.  Previously, our 
lab has shown that only the Mature form of ADAM13 is expressed at the cell surface 
(Alfandari et al., 1997).  Therefore, the results suggest that ADAM19 may regulate the 
protein stability of ADAM13 and possibly, the level of Mature ADAM13 that localizes to 
the cell surface.   
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I propose that ADAM19 regulates ADAM13 through two different hypotheses.  
One hypothesis is that ADAM19 cleaves ADAM13 in its extracellular domain.  This 
cleavage event would shed a soluble form of ADAM13 outside of the cell.  When 
ADAM13 is detected in the embryo by western blot four molecular weight bands are 
observed; the Proform (120kD), the Mature form (100kD), soluble ADAM13 (50kD) and 
the cytoplasmic tail (17kD).  The different forms of ADAM13 are deduced from their 
predicted molecular weights and are considered to be functional in the embryo.  
Previously our lab has shown that ADAM13 is autocatalytic by cleaving itself within the 
Cysteine-rich Domain (Gaultier et al., 2002).  The shed fragment of ADAM13 (50kD) 
retains biological function outside of a cell.  Soluble ADAM13 binds to the HepII domain 
of fibronectin and cleaves fibronectin in vitro (Gaultier et al., 2002).  Additionally, an 
autocatalytic processing event is important in vitro for the proteolytic function of 
ADAMTS4 (Flannery et al., 2002), ADAM8 (Schlomann et al., 2002) and ADAM19 
(Kang et al., 2002). 
Therefore, the working hypothesis model is that ADAM19 cleaves ADAM13 into 
a soluble form to promote an interaction between soluble ADAM13 and fibronectin.  This 
cleavage event would be important for remodeling the fibronectin matrix outside of a cell 
and more importantly, the cells ability to adhere and migrate on fibronectin (Figure 3.8).  
To investigate if ADAM19 cleaves ADAM13, I would detect soluble ADAM13 from the 
cell supernatant of co-transfected cultured cells compared to ADAM13 alone and 
ADAM13E/A alone.  Since ADAM13 is autocatalytic, the ADAM13 alone sample is a 
positive control and the ADAM13E/A alone sample is a negative control to determine 
baseline levels of soluble ADAM13 shed into the supernatant.   
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It is possible that ADAM19 does not cleave ADAM13.  Since ADAM19 binds 
specifically to the Cysteine-Rich Domain of ADAM13, this physical interaction could 
directly perturb ADAM13 cleavage.  My second hypothesis is that ADAM19 binds to 
ADAM13 in a perinuclear compartment and functions to sequester ADAM13 from 
further processing.  ADAM19 could function by preventing the autocatalysis of 
ADAM13 into soluble ADAM13 by masking the cleavage site in the Cysteine-Rich 
Domain (Figure 3.8).  This would reduce soluble ADAM13 from being shed outside of 
the cell to interact with fibronectin.  As a result, this would affect fibronectin matrix 
remodeling and the cells ability to adhere and migrate on fibronectin.   
The above models only address the in vitro results on ADAM13 and ADAM19 
co-overexpression.  However in the embryo, a loss of ADAM13 protein reduces the level 
of ADAM19 protein by 50%.  In addition, a loss of ADAM19 protein reduces the level of 
ADAM13 protein by 50%.  This suggests that both ADAM13 and ADAM19 are required 
to maintain a proper protein level in the embryo.  This conclusion was also seen 
previously for ADAM13 expression (Figure 4 in (McCusker et al., 2009)).  However, the 
level of ADAM19 was not reduced because the conditions using a combination of the 
ADAM19 antibodies had not been determined yet (Figure 4 in (McCusker et al., 2009)).  
I propose an alternative hypothesis where ADAM13 and ADAM19 proteins function as 
chaperones to stabilize each other in a perinuclear compartment.  This is important to 
regulate the level of each ADAM protein that translocates to the cell surface.  Once at the 
cell surface, the ADAM protein carries out its proteolytic function by cleaving a potential 
substrate (Figure 3.8).  For example, ADAM19 could regulate the level of ADAM13 
protein that translocates to the cell surface of CNC cells.  This would regulate cell-cell 
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adhesion by affecting the ability of ADAM13 to cleave the cell adhesion molecule 
Cadherin-11 (McCusker et al., 2009).  To investigate if ADAM19 affects the level of 
ADAM13 at the cell surface in vivo, I would detect ADAM13 by western blot from cell 
surface biotinylated CNC cells (or dorsal mesoderm cells) from embryos that were 
injected with CMO or MO19.  Embryos injected with MO13 would be used as a negative 
control.  The ADAM13 Mature form will only be analyzed since it is the only form of 
ADAM13 present on the cell surface. 
 
SECTION V:  Materials and Methods used in Chapter III 
 
Cell Culture 
293T cells were cultured in RPMI media supplemented with 10U/ml Pen/Strep, 2mM L-
Glutamine, 0.11mg/ml Sodium Pyruvate and 10% Fetal Bovine Serum (Hyclone).  
Transient transfections were performed using Fugene 6 reagents (Roche) following the 
manufacturer‟s instructions.  XTC cells were cultured in L15 media supplemented with 
10U/ml Pen/Strep, 2mM L-Glutamine and 10% Fetal Bovine Serum (Hyclone).  
Transient transfections for XTC cells were performed using Fugene HD reagents (Roche) 
following the manufacturer‟s instructions. 
 
Immunofluorescence 
After 48 hours of expression, XTC cells were trypsinized and seeded onto glass 
coverslips coated with 10g/ml of Fibronectin for 12 hours.  Cells were fixed for 20 
minutes in 3.7% formaldehyde in MBS at room temperature, permeablized in PBS 0.5% 
Triton X100 for 5 minutes at room temperature and blocked in 1% BSA in PSB 0.1% 
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Tween20 overnight at 4C.  Antibody incubations were performed sequentially (one hour 
at room temperature for each antibody) in 1% BSA in PBS 0.1% Tween20.  The primary 
antibodies used:  ADAM13 (6615F) 1:200; ADAM19 (2C5 E1) 1:200; and Calnexin 
(Assay Designs, Stressgen) 1:200.  DAPI was used at 1:1000 to stain the nuclei.  All 
secondary antibodies were used at 1:500 and purchased from Jackson Labs. 
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Figure 3.1:  Amino Acid Alignment of Xenopus ADAM13 to Xenopus ADAM19.  
The individual amino acid domains are labeled.  The consensus N-glycosylation sites 
(NxS/T) are shown in red (Gooley et al., 1991), the consensus Furin cleavage site of the 
Prodomain is shown in blue, the Metalloprotease active site is shown in yellow, the 
Disintegrin Loop is shown in grey (McLane et al., 1998), the Transmembrane domain is 
boxed, the SH3 Binding Motif (RPxPxxP) is shown in green (Cicchetti et al., 1992), and 
the Predicted Serine/Threonine/Tyrosine Phosphorylation sites (NetPhos 2.0) are shown 
in pink (Blom et al., 1999). 
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Table 3.1:  Amino Acid Percent 
Identity of Xenopus ADAM13 to 
Xenopus ADAM19.  Each amino 
acid domain is aligned and the 
percent identity is shown. 
  
Amino Acid Percent Identity  
of Xenopus ADAM13 to 
Xenopus ADAM19 
  
Full Length Protein 41% 
  
Prodomain 31% 
Metalloprotease 
Domain 
56% 
Disintegrin Domain 64% 
Cysteine-Rich Domain 47% 
EGF-like Domain 58% 
Transmembrane 
Domain 
18% 
Cytoplasmic Domain 13% 
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Figure 3.2:  ADAM13 Expression in ADAM19 Knockdown Embryos.  Western blot 
of protein extract from embryos injected with a control morpholino (CMO) or a 
morpholino to either ADAM13 (MO13) or ADAM19 (MO19).  The morpholinos (10 ng) 
were injected at the one cell-stage and embryos were extracted at stage 22.  (A) 
Glycoproteins from 10 embryos were purified on Concanavalin A-agarose beads, 
separated by SDS-PAGE and probed with a rabbit polyclonal antibody to the ADAM13 
cytoplasmic domain (6615F from (Alfandari et al., 1997)).  (B) The densitometric 
analysis of the blot depicted shows that the ADAM13 protein is reduced by 
approximately 50% in MO19 embryos when normalized to Integrin 1 expression level 
(8C8 from (Gawantka et al., 1992)).  (C) Immunoprecipitation of ADAM13 using the 
goat ADAM13 antibody from five embryos (St. 22), separated by SDS-PAGE and probed 
with a rabbit polyclonal antibody to the ADAM13 cytoplasmic domain (6615F). A 
monoclonal antibody to GAPDH was used as a loading control. 
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Figure 3.3:  ADAM19 Expression in ADAM13 Knockdown 
Embryos.  Western blot of protein extract from embryos injected with a 
control morpholino (CMO) or a morpholino to either ADAM13 (MO13) 
or ADAM19 (MO19).  The morpholinos (10 ng) were injected at the one 
cell-stage and embryos were extracted at stage 22.  Immunoprecipitation 
of ADAM19 using the goat DC19 antibody from 20 embryos (St. 22), 
separated by SDS-PAGE and probed with a rabbit polyclonal antibody 
to the ADAM19 cytoplasmic domain (C3). A monoclonal antibody to 
GAPDH was used as a loading control.  The densitometric analysis of 
the blot depicted shows that the ADAM19 protein is reduced by 
approximately 50% in MO13 embryos when normalized to the GAPDH 
expression level. 
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Figure 3.4:  ADAM13 and ADAM19 Physically Interact in Transfected 293T and 
XTC Cells.  (A) Transfected 293T cells (left panel) that overexpress ADAM13 alone 
(A13+CS2), ADAM19 alone (A19+CS2) or ADAM13 and ADAM19 (A13+A19) were 
extracted for coimmunoprecipitation.  A 120kD band was detected in the cotransfected 
(A13+A19) sample, corresponding to the Proform of ADAM13 (second blot) or the 
Proform of ADAM19 (top blot).  Total cell extract was separated by SDS-PAGE and 
probed with an antibody to ADAM13 (6615F), ADAM19 (C3), and GAPDH as a loading 
control.  Transfected XTC cells (right panel) that overexpress GFP-myc tagged (GFPmt) 
or ADAM19 were extracted for coimmunoprecipitation.   XTC cells endogenously 
express ADAM13 (Alfandari et al., 1997).  A 120kD band was detected for the Proform 
of ADAM19 (top blot) and ~120kD and 90kD bands was detected for the Proform and 
Mature form of ADAM13 (second blot).  Total cell extract was separated by SDS-PAGE 
and probed with an antibody to ADAM13 (6615F), ADAM19 (C3), GAPDH as a loading 
control, 9E10 (myc-tag), and PACSIN2 as a second loading control.  (B)  
Immunoprecipitation of endogenous ADAM13 from RFP-expressing XTC cells as a 
control. 
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Figure 3.5:  ADAM19 Binds to the Cysteine-Rich Domain of ADAM13.  Transfected 
293T cells that overexpress RFP or ADAM19 with full length ADAM13 (A13+A19), a 
myc tagged disintegrin-cysteine-rich domains of ADAM13 (DC13), a myc tagged 
disintegrin domain of ADAM13 (D13), or a myc tagged cysteine-rich domain of 
ADAM13 (CR13) were extracted for coimmunoprecipitation.  A 120kD band was 
detected in the cotransfected (A13+A19) sample, corresponding to the Proform of 
ADAM13 (second blot) or the Proform of ADAM19 (top blot).  The 
coimmunoprecipitation with an antibody to ADAM19 (C3) (second blot) showed a strong 
physical interaction to DC13 and to CR13.  Total cell extract was separated by SDS-
PAGE and probed with an antibody to ADAM13 (6615F), ADAM19 (C3), 9E10 (myc-
tag) and GAPDH as a loading control.   
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Figure 3.6:  ADAM19 Localizes to the Endoplasmic Reticulum in XTC Cells.  
Immunofluorescence of transfected XTC that overexpress ADAM19 (red) was visualized 
using an antibody to the cytoplasmic domain of ADAM19 (2C5 E1).  Localization to the 
endoplasmic reticulum is shown by using an antibody to the ER-specific protein, 
Calnexin (green).  Strong colocalization of ADAM19 with Calnexin is shown in the 
Merge (yellow).  DAPI (blue) was used to stain the nuclei.  Very little to no expression 
was seen for ADAM19 at the plasma membrane. 
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Figure 3.7:  ADAM13 and ADAM19 Colocalize to a Perinuclear Compartment in 
XTC Cells.  Immunofluorescence of transfected XTC that overexpress ADAM19 (red) 
was visualized using an antibody to the cytoplasmic domain of ADAM19 (2C5 E1).  
Immunofluorescence of endogenous ADAM13 (green) was visualized using an antibody 
to the cytoplasmic domain of ADAM13 (6615F).  Colocalization of ADAM19 with 
ADAM13 is shown in the Merge (yellow).  DAPI (blue) was used to stain the nuclei.  
ADAM13 colocalizes with ADAM19 within a perinuclear compartment.  Endogenous 
ADAM13 also localizes to the cell surface in lamellipodia (white arrowheads). 
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Cytoplasmic 
Domain 
Amino 
Acids 
ER Retention 
Signals 
SH3 Binding 
Motifs 
14-3-3 
Binding 
Motifs 
Xenopus   (RxR) (RR) (RPxPxxP) (Rxx(S/T)xP) 
A9-Cyto 158 0 2 1 0 
A10-Cyto 55 2 0 0 0 
A13-Cyto 196 1 0 3 1 
A19-Cyto 160 4 2 2 0 
Mouse           
A10-Cyto 55 2 1 0 0 
A12-Cyto 176 0 0 2 3 
A19-Cyto 192 1 1 2 2 
A33-Cyto 71 0 2 0 0 
Human           
A10-Cyto 53 3 1 0 0 
A12-Cyto 180 0 1 2 1 
A19-Cyto 194 1 1 2 2 
A33-Cyto 88 0 1 0 0 
 
Table 3.2:  Amino Acid Analysis of Different ADAM Cytoplasmic Domains.  
Consensus ER Retention signals are described in (Wieland et al., 1987).  Consensus SH3 
Binding Motifs are described in (Ren et al., 1993).  Consensus 14-3-3 Binding Motifs are 
described in (Uchida et al., 2006). 
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Figure 3.8:  Models Explaining How ADAM19 Regulates ADAM13 in a Cell.  (A) 
Hypothesis 1: ADAM19 binds and cleaves ADAM13 into a soluble form.  Soluble 
ADAM13 is shed into the extracellular environment as an active protease to remodel a 
fibronectin matrix.  This is important to regulate cell adhesion and migration on 
fibronectin.  (B) Hypothesis 2: ADAM19 binds to ADAM13 and sequesters ADAM13 in 
a perinuclear compartment.  This interaction inhibits the autocatalysis of ADAM13 into a 
soluble form and prevents remodeling of a fibronectin matrix.  This is important to 
regulate cell adhesion and migration on fibronectin.  Alternatively in (C), ADAM19 
regulates the processing of ADAM13.  More importantly, ADAM19 regulates the level of 
Mature ADAM13 at the cell surface.  This interaction regulates cell-cell adhesion and 
cell migration.  14-3-3 dimers may be a key adaptor protein involved in this process.  
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CHAPTER IV 
 
XENOPUS ADAM13 AND ADAM19 ARE IMPORTANT FOR  
PROPER CONVERGENCE AND EXTENSION OF THE NOTOCHORD 
 
All of the work presented in this chapter is data completed by myself and is unpublished. 
 
Abstract 
 This chapter focuses on the role of ADAM13 and ADAM19 in the dorsal 
mesoderm during gastrulation.  Through a loss of function approach using antisense 
morpholino oligonucleotides to ADAM13 or ADAM19, I show that ADAM19 affects 
gene expression important for the A-P polarity of the notochord while ADAM13 does 
not.  The changes in gene expression can be partially rescued by the EGF ligand 
Neuregulin1, a known substrate for ADAM19 in the mouse.  I show that a loss of 
ADAM13 or ADAM19 affects convergence and extension movements during notochord 
formation.  Specifically, a loss of ADAM13 or ADAM19 causes a delay in mediolateral 
cell intercalation resulting in a significantly wider notochord compared to control 
embryos.  These defects occur without affecting dishevelled intracellular localization or 
the activation of the PCP signaling pathway.  However, a loss of ADAM13 or ADAM19 
reduces dorsal mesoderm cell spreading on a fibronectin substrate through 51 integrin. 
 
85 
 
 
SECTION I:  Introduction 
 
 Cellular movements are essential during gastrulation and can be classified into 
four evolutionary conserved movements; internalization, epiboly, convergence and 
extension (Solnica-Krezel, 2005).  Internalization marks the beginning of gastrulation and 
in amphibians, creates the dorsal blastopore lip.  The involuting mesoderm enters through 
the blastopore and migrates on the inner surface of the blastocoel roof.  This migration 
event is highly dependent upon the extracellular matrix protein fibronectin, which is 
expressed along the blastocoel roof (Boucaut and Darribere, 1983 41; Lee et al., 1984 2).  
Epiboly movements spread tissue by increasing the surface area and decreasing thickness.  
The driving force behind epiboly occurs when cells interdigitate themselves between 
deep and superficial layers; a process known as radial intercalation (Keller, 1980).   
 The dorsal mesoderm undergoes dynamic movements that converge the tissue 
while extending along the anterior-posterior axis; a process called convergence and 
extension (Keller et al., 1985).  Dorsal mesoderm cells undergo this type of movement by 
displaying mediolateral polarized protrusions to gain traction on neighboring cells and 
the surrounding extracellular matrix.  These cellular behaviors are known as mediolateral 
cell intercalation.  On the ventral side of the gastrulating embryo, both the lateral and 
ventral mesoderms undergo dynamic movements to converge the tissue without 
extension; a process called convergence and thickening (Keller and Danilchik, 1988).  As 
a result of these morphogenetic movements during gastrulation, the physical forces 
generated cause the blastopore to close asymmetrically towards the ventral side of the 
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embryo (Figure 1.2) (Keller and Shook, 2008).  Mediolateral cell intercalation continues 
after gastrulation in both the paraxial (somites) and axial (notochord) mesoderm.  This 
drives the process of convergence and extension in order to properly lengthen the embryo 
along the anterior-posterior axis.  These cellular movements are essential for the embryo 
to develop and survive to the tailbud stage.   
 Members of the ADAM family of metalloproteases play an active role in the 
process of cell migration.  ADAM proteins can function in cell migration either directly 
through cleavage of cell surface adhesion molecules such as cadherins (Kohutek et al., 
2009; McCusker et al., 2009; Schulz et al., 2008) or indirectly through cleavage of cell 
signaling molecules such as EGF ligands involved in activating cell migration signaling 
pathways (Bakken et al., 2009; Sun et al., 2010; Zheng et al., 2009).  ADAM10 can 
cleave E-cadherin (Maretzky et al., 2005) and N-cadherin (Reiss et al., 2005) in the 
extracellular domain affecting both cell-cell adhesion and cell migration in the embryo.  
Our lab has shown that both ADAM9 and ADAM13 cleave cadherin-11 in the 
extracellular domain affecting CNC cell migration in Xenopus embryos (McCusker et al., 
2009).  The ADAM mediated cleavage of cadherin-11 promotes CNC cell migration and 
shows that the cadherin-11 cleavage product retains biological activity in the embryo.  It 
is hypothesized that the cadherin-11 cleavage product promotes CNC cell migration by 
acting as a signaling molecule; however an exact mechanism remains to be determined 
(unpublished work, communication with Catherine McCusker 2009).   
 Recent work has uncovered a new role for ADAM13 in the closely related frog 
species Xenopus tropicalis, for neural crest development (Wei et al., 2010).  During 
gastrulation, ADAM13 cleaves ephrinB1 and ephrinB2 ligands in the dorsal mesoderm.  
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This cleavage event is important to regulate forward ephrin signaling through the Eph 
receptor.  The ADAM13 cleavage of ephrinB1/B2 upregulates canonical Wnt signaling 
and in turn, activates the expression of the CNC marker snail2.  Reduction of the 
ADAM13 protein reduces CNC induction by the suppression of the Canonical Wnt/snail2 
signaling pathway.  This mechanism is important for the initial induction of the CNC and 
provides a functional role for ADAM13 during gastrulation.   
Similar to the role in normal development, ADAM proteins are upregulated in 
disease such as cancer and are involved in the epithelial-to-mesenchymal transition 
(EMT) during cancer metastasis (Dittmer et al., 2009; Duffy et al., 2009; Fry and Toker, 
2010).  This further supports their prominent role in cell adhesion and cell migration 
events.  In this chapter I will investigate the contribution of ADAM13 and 
ADAM19 to convergence and extension movements of the notochord during gastrulation. 
 
Results 
 
SECTION II:  Role of ADAM19 in Establishing the A-P Polarity of the Notochord 
 
 Previously I observed alterations in gene expression at the gastrula stage in 
ADAM19 knock down embryos (Neuner et al., 2009).  Gene expression analysis shows a 
specific loss of Xbrachyury expression concomitant with an upregulation of Chordin 
expression in the notochord (Figure 2.4).  These two genes are expressed in a 
countergradient along the anterior-posterior axis in the axial mesoderm (Ninomiya et al., 
2004).  Chordin is a marker of anterior notochord polarity and Xbrachyury is a marker of 
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posterior notochord polarity.  Together, these two genes establish the anterior-posterior 
(A-P) polarity of the developing notochord.  Therefore, I investigated how ADAM19 is 
disrupting the A-P polarity of the notochord.  In addition, I determined if ADAM13 is 
involved in establishing notochord A-P polarity.  Using whole mount in situ 
hybridization for Xbrachyury (Xbra), I observed a loss of Xbra expression (40%) 
specifically in the notochord in MO19 injected embryos when compared to control 
embryos (0%) (Figure 4.1).  The defect could be partially rescued by co-injection of full 
length ADAM19 RNA, but not the catalytically inactive mutant ADAM19 E/A.  This 
suggests that the proteolytic activity of ADAM19 is important for maintaining Xbra 
expression in the notochord.   
 In mice, ADAM19 can cleave some members of the EGF family of ligands 
including Neuregulin1NRG1 (Shirakabe et al., 2001).  In Xenopus, NRG1 
expression begins during gastrulation and continues through tailbud formation (Yang et 
al., 1999; Yang et al., 1998a; Yang et al., 1998b).  Purified recombinant NRG1 can 
induce naïve animal cap cells to become mesoderm and express Xbrachyury (Chung and 
Chung, 1999).  Therefore, I investigated whether overexpression of NRG1 could rescue 
gene expression in MO19 injected embryos.  Co-injection of full length NRG1 RNA 
(NRG-FL) did not rescue Xbra expression in the notochord.  However, co-injection of the 
extracellular region of NRG1 (NRG-EC), a form that mimics a potential cleavage 
product of ADAM19, did rescue Xbra expression in the notochord.  Therefore, our data 
suggests that ADAM19 mediated shedding of NRG1 is important to maintain Xbra 
expression in the notochord.   
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 Using whole mount in situ hybridization for Chordin, I observed a shift to a more 
anterior localization of Chordin expression (50%) in MO19 injected embryos when 
compared to control embryos (0%) (Figure 4.2).  The defect could be partially rescued by 
co-injection of full length ADAM19 RNA, but not the catalytically inactive mutant 
ADAM19 E/A.  Furthermore, gene expression could be partially rescued by co-injection 
of NRG-EC RNA, but not full length NRG-FL RNA.  Therefore, our data suggests that 
ADAM19 mediated shedding of NRG1 is important to maintain Chordin expression in 
the posterior notochord.   
To determine if ADAM13 is important for notochord A-P polarity, I observed 
Xbra and Chordin expression in MO13 injected embryos.  Xbrachyury expression 
appeared normal compared to control embryos (Figure 4.3).  Chordin expression was 
wider compared to control embryos, but did not shift to a more anterior localization 
similar to MO19 injected embryos.  In addition, ADAM13 RNA could not rescue gene 
expression in MO19 injected embryos (Figure 4.3).  These results suggest that ADAM19 
(not ADAM13) mediated shedding of Neuregulin1 is important to establish the A-P 
polarity of the developing notochord (Figure 4.4).  Interestingly, I observed that the 
expression patterns of Chordin and Xbrachyury appear to be wider in MO13 and MO19 
injected notochords compared to control notochords.  This suggests that the notochord 
morphology might be perturbed as a result of a loss of ADAM13 or ADAM19.  The 
morphology of the notochord will be investigated next in Section III of this chapter. 
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SECTION III:  ADAM13 and ADAM19 Delay Convergence and Extension  
in the Notochord 
 
 The notochord is a temporary, rod-shaped structure that provides mechanical 
support for the developing embryo.  It is located directly below the neural tube dictating 
the primary body axis.  In addition, the notochord is important for patterning the 
surrounding tissues such as the ventral half of the neural tube (floor plate), the paraxial 
mesoderm (somites), and in controlling L-R asymmetry (Stemple, 2005).  To visualize 
the morphology of the notochord, I performed a double whole mount immunostain using 
the monoclonal antibody Tor70 to stain the notochord.  In addition, the monoclonal 
antibody 12/101 was used to visualize the surrounding somites (Figure 4.5).  Embryos 
were injected with MO13 or MO19 at the one-cell stage and allowed to develop until the 
tailbud stage (stage 24).  The notochord appears morphologically wider in MO13 and 
MO19 injected embryos compared to control embryos.  In MO19 injected embryos, the 
notochord was frequently bent or misshapen and is thus likely to contribute to the 
embryos overall shorter and wider body size.  The wide notochords observed in embryos 
lacking ADAM13 or ADAM19 could be explained by defects in convergence and 
extension movements of the axial mesoderm.  The somites appear morphologically 
normal in MO13 injected embryos but have gross defects in MO19 injected embryos.  
The overall segmentation of each somite is not affected in embryos lacking ADAM19; 
however some of the individual somitic cells are mislocalized and protrude into the 
intersomitic boundary (Figure 2.8 and 4.4).  In addition, the overall level of 12/101 
91 
 
expression is lower in MO19 injected embryos confirming previous results where a 
reduction of this marker was observed (Figure 2.8, (Neuner et al., 2009)).  These results 
support the role of ADAM19 in muscle differentiation.  In final, I observed that the 
archenteron or internal cavity is significantly larger in MO19 injected embryos.  At this 
point, it is unclear whether this is a direct result of defects in endoderm formation or an 
indirect result of the embryo being shorter and wider due to defects in the dorsal 
mesoderm.  For the remainder of this chapter I will focus my efforts on exploring the 
defects observed in the notochord. 
 To investigate if convergence and extension movements are affected in MO13 or 
MO19 injected embryos, I analyzed the axial mesoderm ex vivo by fluorescence time 
lapse microscopy.  The microdissection of the dorsal mesoderm from a late gastrula stage 
embryo is a well established assay called an „Open Face Explant‟ (Wilson et al., 1989).  
The explants are dissected from embryos that were microinjected twice.  The first 
injection is at the one-cell stage with either a control Morpholino, MO13 or MO19.  The 
second injection is with RNA encoding for a fluorescent membrane-bound Cherry protein 
(mbCherry) into one blastomere at the two cell stage (Figure 4.6).  Since the first 
cleavage bisects the embryo into left and right halves, the second injection with 
mbCherry RNA enabled us to visualize the contribution of the axial mesoderm from one 
half of the embryo to the non-injected half.  More importantly, I could observe axial 
mesoderm cell movements during notochord formation.  The dorsal mesoderm was 
dissected into an Open Face Explant at the end of gastrulation once the blastopore has 
closed (stage 12.5/13) and observed by fluorescence time lapse microscopy.  In all three 
explants (CMO, MO13, MO19), the axial mesoderm cells can be seen undergoing 
92 
 
convergence and extension movements to lengthen the embryo along the anterior-
posterior axis.  Time lapse montages of the recorded movies are shown for CMO in 
Figure 4.7, MO13 in Figure 4.8 and MO19 in Figure 4.9. 
To investigate axial mesoderm cell morphology, the mbCherry localization of 
four cells was pseudo-colored black to improve visualization.  Axial mesoderm cells in 
the control explant have a bipolar morphology and show directed protrusions along the 
mediolateral axis (Figure 4.10A).  This type of cell morphology is essential for proper 
mediolateral cell intercalation.  The axial mesoderm cells in explants lacking ADAM13 
or ADAM19 have a multipolar morphology without directed protrusions along the 
mediolateral axis.  This type of cell morphology suggests that the axial mesoderm will 
not undergo proper mediolateral cell intercalation.  The length-to-width (L:W) ratio of an 
individual axial mesoderm cell was quantified by measuring the mediolateral length and 
anterior-posterior width (Figure 4.10B).  Axial mesoderm cells lacking ADAM13 or 
ADAM19 have reduced L:W ratios compared to control cells, suggesting cell 
morphology is being affected.  To determine if mediolateral cell intercalation is being 
perturbed, I traced three axial mesoderm cells in six explants to follow the cell 
movements over an eight hour time course in three independent experiments.  Control 
axial mesoderm cells properly extend from one side of the notochord-somite boundary to 
the opposite side (Figure 4.11A).  This allows for each cell to align in a row along the 
anterior-posterior axis as the notochord forms.  However, axial mesoderm cells from 
explants lacking ADAM13 or ADAM19 do not properly extend from one side of the 
notochord-somite boundary to the opposite side.  This suggests that there is a delay in the 
process of mediolateral cell intercalation.  Moreover, the delay in mediolateral cell 
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intercalation may explain why the notochords are wider in embryos lacking ADAM13 or 
ADAM19.   
 To investigate notochord morphology, the length and width of the notochord was 
measured at three different time points during notochord formation.  These measurements 
were used to calculate a length-to-width (L:W) ratio from fourteen different cell pairs in 
three independent experiments.  The length of the notochord was measured between two 
axial mesoderm cells approximately 150m apart.  The width of the notochord was 
measured between both notochord-somite boundaries.  In control notochords, the L:W 
ratio increased over time, showing that the notochord tissue converged and extended 
properly (Figure 4.11B).  However in explants lacking ADAM13 or ADAM19, the 
notochord L:W ratios were reduced at all three time points.  The notochords from 
explants lacking ADAM13 or ADAM19 do converge and extend, just not at the same rate 
as the control explants.  Therefore, there is a delay in axial mesoderm convergence and 
extension movements in embryos lacking ADAM13 or ADAM19 resulting in a 
significantly wider notochord compared to control embryos. 
 
SECTION IV:  The Mislocalization of ECM Proteins in the Notochord 
 
 Axial mesoderm cells begin the process of mediolateral cell intercalation after 
coming in contact with one side of the notochord-somite boundary.  This is described as 
the mechanism of „boundary capture‟ (Keller and Tibbetts, 1989; Shih and Keller, 1992).  
This mechanism occurs when the border of the cell in contact becomes quiescent and no 
longer sends protrusions in its lateral direction.  Therefore, the cell forms a stable contact 
94 
 
or is „captured‟ by the extracellular matrix proteins that make up the notochord-somite 
boundary.  This event is critical for the proper convergence and extension of the 
notochord (Keller et al., 2000).  To investigate if the notochord-somite boundary is intact, 
I performed a double immunostain on open face explants.  I visualized two extracellular 
matrix (ECM) proteins fibronectin and laminin for their localization at the notochord-
somite boundary by fluorescence microscopy.  In control explants, both ECM proteins 
localized to either side of notochord and at the intersomitic boundaries (Figure 4.12).  In 
explants lacking ADAM13, both ECM proteins are localized on either side of the 
notochord and at the intersomitic boundaries.  However, punctate localization of both 
ECM proteins was also found mislocalized in the notochord (arrows).  In explants lacking 
ADAM19, strong mislocalization of both ECM proteins is found throughout the 
notochord.  This result was seen previously for fibronectin expression in MO19 injected 
embryos (Figure 2.8, (Neuner et al., 2009)).  Therefore, the notochords of embryos 
lacking ADAM13 or ADAM19 appear to have normal notochord-somite boundaries but 
an abnormal presence of ectopic fibronectin and laminin in the notochord.  Since the 
notochord-somite boundary is formed simultaneously as the notochord develops, it is 
unclear whether the mislocalization of fibronectin and laminin cause the delay in 
mediolateral cell intercalation or that their mislocalization is a result.  Previously, 
fibronectin localization by confocal microscopy showed that fibronectin fibrils are 
cleared from the dorsal (floor plate) and ventral (archenteron) sides of the developing 
notochord during gastrulation (Davidson et al., 2004).  As the fibronectin fibrils are 
remodeled they become enriched along the lateral notochord-somite boundaries.  Our lab 
has previously shown that ADAM13 can cleave and remodel a fibronectin matrix in 
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cultured cells (Alfandari et al., 2001).  Therefore if the dorsal mesoderm cells from 
embryos lacking ADAM13 or ADAM19 actively secrete fibronectin into the extracellular 
environments, not having a proper level of ADAM13 at the cell surface to remodel the 
fibronectin matrix could cause a delay in mediolateral cell intercalation.  Future 
experiments should repeat the double immunostain for fibronectin and laminin in open 
face explants utilizing a confocal microscope.  A Z-stack reconstruction of the entire 
notochord will determine if the ECM proteins are being mislocalized inside of the 
notochord or to the dorsal and ventral sides where they are normally absent (Davidson et 
al., 2004).  The mislocalization of fibronectin in the somites of explants lacking 
ADAM19 is evident of the strong defects occurring in this tissue.  Previously, I observed 
that cell organization within each somite is affected and that two muscle differentiation 
markers are reduced in embryos lacking ADAM19 (Neuner et al., 2009).  Future 
experiments should investigate whether individual somitic cell organization and the 
formation of the intersomitic boundary are linked to muscle differentiation. 
 The major signaling pathways that are critical for establishing convergence and 
extension movements during gastrulation are the Planar Cell Polarity Pathway (or the 
Non-canonical Wnt signaling pathway) (Yin et al., 2008) and the interaction between 
Integrins and the extracellular matrix, specifically fibronectin (Davidson et al., 2006; 
Rozario et al., 2009).  The PCP Signaling Pathway is essential for establishing dorsal 
mesoderm cell polarity.  The interaction between integrin receptors such as 51 integrin 
and fibronectin are critical for dorsal mesoderm cell adhesion.  I propose that ADAM13 
and ADAM19 function in convergence and extension movements by regulating dorsal 
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mesoderm cell polarity or cell adhesion to fibronectin.  These two hypotheses will be 
investigated in the next section of this chapter.  
 
SECTION V:  Does ADAM13 and ADAM19 Affect Dorsal Mesoderm Cell Polarity  
or Cell Adhesion to Fibronectin? 
 
Role of ADAM13 and ADAM19 in Dorsal Mesoderm Cell Polarity 
 
 The Planar Cell Polarity pathway is functionally conserved from flies to 
vertebrates and is essential for the morphogenetic movements during gastrulation.  In 
Drosophila, components of this pathway are specifically localized to cell borders in order 
to establish cell polarity and coordinate cell motility (Adler, 2002; Zallen and Wieschaus, 
2004).  Vertebrate counterparts of the PCP pathway are required for convergence and 
extension movements during gastrulation (Goto and Keller, 2002; Keller, 2002).  A loss 
of any of the pathway components results in the failure of the dorsal mesoderm to 
undergo convergence and extension (Roszko et al., 2009; Torban et al., 2004).  
Moreover, it is khown that activation of the PCP pathway can be visualized through the 
translocation of dishevelled (Dsh), an intracellular signaling component, from the cytosol 
to the plasma membrane in dorsal mesoderm undergoing convergence and extension 
(Wallingford et al., 2000).  This translocation event was not observed in the posterior 
dorsal mesoderm because this tissue does not undergo convergence and extension.  
Therefore, there is a direct link between the PCP signaling pathway in establishing cell 
polarity with the convergence and extension movements of gastrulation.   
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To investigate if the activation of the PCP signaling pathway is affected, I 
analyzed the localization of dishevelled in the axial mesoderm of embryos lacking 
ADAM13 or ADAM19.  This technique was performed on embryos that were 
microinjected twice.  The first injection is at the one-cell stage with either a control 
Morpholino, MO13 or MO19.  The second injection is with RNA encoding for 
dishevelled fused to green fluorescent protein (GFP-dishevelled) into the two dorsal 
blastomeres at the four cell stage.  Overexpression of dishevelled can block convergence 
and extension movements (Sokol, 1996).  However, if the level of RNA is titrated down 
to a small finite dosage (50pg) of GFP-Dishevelled RNA this does not affect normal 
development.  More importantly, this assay can be used as a tool for visualizing the 
activation of the PCP signaling pathway in vivo (Marsden and DeSimone, 2001; 
Wallingford et al., 2000).  The injected embryos were allowed to develop until the late 
gastrula stage.  Open face explants were dissected and analyzed for dishevelled 
localization by confocal microscopy.  In explants lacking ADAM13 or ADAM19, the 
localization of dishevelled is found at the plasma membrane similar to control explants 
(Figure 4.13).  To determine if there is a quantitative difference in dishevelled 
localization, I normalized the level of GFP-dishevelled by co-injecting RNA encoding 
monomeric red fluorescent protein (RFP) (Figure 4.14A).  The same dose of RFP RNA 
and GFP-dishevelled RNA were coinjected into one dorsal blastomere at the four cell 
stage.  In the open face explants, the fluorescence profile of GFP-dishevelled was 
measured using Axiovision software along the anterior-posterior axis and the medio-
lateral axis of the notochord.  The fluorescence profiles of GFP-dishevelled were 
normalized to the fluorescence profiles of RFP (Figure 4.14B).  Compared to control 
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notochords, there was no significant difference in the GFP-dishevelled fluorescence 
profiles of notochords lacking ADAM13 or ADAM19.  Therefore, these results suggest 
that ADAM13 and ADAM19 do not affect the activation of the PCP signaling pathway of 
the dorsal mesoderm during gastrulation. 
 
Role of ADAM13 and ADAM19 in Dorsal Mesoderm Cell Adhesion to Fibronectin 
 
 During gastrulation, the involuting mesoderm enters through the blastopore and 
migrates on the inner surface of the blastocoel roof.  This migration event is highly 
dependent upon the extracellular matrix protein fibronectin (FN), which is expressed 
along the blastocoel roof (Boucaut and Darribere, 1983; Lee et al., 1984; Ramos and 
DeSimone, 1996).  Cell adhesion to FN involves many cell-extracellular matrix 
interactive sites (Hynes, 2009; Rozario and DeSimone, 2010).  The central binding 
domain for many cell types to FN is found at the tripeptide sequence RGD site 
(Pierschbacher and Ruoslahti, 1984).  Together with an adjacent site called the synergy 
site, these two domains act cooperatively to support cell adhesion (Aota et al., 1994; 
Bowditch et al., 1994).  Cell attachment to the RGD site, in cooperation with the synergy 
site, is mediated through the 51 integrin receptor that recognizes fibronectin at the cell 
surface (Pytela et al., 1985).  During dorsal mesoderm cell migration on the blastocoel 
roof, the notochord-somite boundary is formed and cells begin to undergo convergence 
and extension.  To investigate if the dorsal mesoderm cells can properly spread on a 
fibronectin substrate, I dissociated the dorsal mesoderm cells from MO13 or MO19 
injected embryos and plated the cells onto FN.  Dorsal mesoderm cells were dissected 
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from the dorsal blastopore lips of early gastrula (stage 10.5) embryos.  The cells were 
dissociated in calcium and magnesium-free media, plated onto a FN substrate and 
analyzed by time lapse microscopy.  After one hour, 85% of the dorsal mesoderm cells 
from control embryos spread on FN (Figure 4.15).  In MO13 injected embryos, only 60% 
of the dorsal mesoderm cells spread on FN.  In MO19 injected embryos, only 70% of the 
dorsal mesoderm cells spread on FN.  If both ADAM13 and ADAM19 were knocked 
down by injecting MO13 and MO19, only 60% of the dorsal mesoderm cells spread on 
FN.  Since an additive affect was not observed, this suggests that the function of 
ADAM13 and ADAM19 do not compensate in cell adhesion to fibronectin.   
To determine if the defects were due to the involvement of 51 integrin, I 
repeated the cell adhesion assay by plating the cells on a GST fusion protein containing 
only the RGD and synergy site called 9.11 (Ramos and DeSimone, 1996).  The same 
results as seen on FN were observed for dorsal mesoderm cells to spread on 9.11.  After 
one hour, 85% of the dorsal mesoderm cells from control embryos spread on 9.11 (Figure 
4.15).  In MO13 injected embryos, only 60% of the dorsal mesoderm cells spread on 
9.11.  In MO19 injected embryos, only 70% of the dorsal mesoderm cells spread on 9.11.  
In MO13 and MO19 injected embryos, only 60% of the dorsal mesoderm cells spread on 
9.11 suggesting that the function of ADAM13 and ADAM19 do not compensate in cell 
adhesion to FN.  Therefore, dorsal mesoderm cells from embryos lacking ADAM13 and 
ADAM19 have a reduced ability to spread on a FN substrate.  The defects observed may 
affect the interaction of 51 integrins with fibronectin.   
To investigate if the expression of 1 integrin is affected, I determined the protein 
level of 1 integrin in the dorsal mesoderm of MO13 or MO19 injected embryos.  
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Compared to control embryos, there was no significant change in the overall protein level 
of 1 integrin in the dorsal mesoderm (Figure 4.18).  However, this assay only analyzed 
the total protein level of 1 integrin.  An additional experiment should be completed to 
determine the cell surface expression of 1 integrin.  Immunoprecipitation of 1 integrin 
from cell surface biotinylated dorsal mesoderm cells of CMO, MO13 or MO19 injected 
embryos will determine if ADAM13 or ADAM19 affect the protein level of 1 integrin 
at the plasma membrane. 
 To rescue the cell adhesion defects on FN and 9.11, I injected RNA encoding for 
full length ADAM13 or full length ADAM19 into the two dorsal blastomeres at the four 
cell stage.  ADAM13 RNA was able to partially rescue the MO13 effect on 9.11 but did 
not rescue on FN (Figure 4.16).  ADAM19 RNA was able to partially rescue the MO19 
effect on both FN and 9.11, as well as, the MO13 effect on 9.11 (Figure 4.16B and 4.17).  
The ability of ADAM19 to rescue MO13 cell adhesion on 9.11 further supports the 
intimate relationship between ADAM13 and ADAM19 proteins in the embryo. 
Our lab has shown that the cytoplasmic domain of ADAM13 is cleaved off, 
translocates into the nucleus and promotes cranial neural crest cell migration in vivo 
(Cousin et al., 2010).  Injection of RNA encoding the cytoplasmic domain of ADAM13 
fused to GFP (GFP-C13) in the dorsal mesoderm was able to partially rescue the MO19 
cell adhesion defects on both FN and 9.11 (Figure 4.17).  This suggests that GFP-C13 has 
an independent biological function in the embryo.  GFP-C13 did not rescue the MO13 
effect on FN and 9.11 suggesting that the extracellular domain of ADAM13 is important 
for cell adhesion on FN.  An alternative hypothesis could be explained by GFP-C13 
acting through a positive feedback mechanism important for upregulating ADAM13 
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expression in the embryo (Figure 4.19).  In the presence of a MO13 background, the level 
of ADAM13 could not be rescued because of the effects of the morpholino.  However, in 
the presence of a MO19 background, the protein level of ADAM13 rescues to near 
control levels.  This experiment is preliminary and needs to be repeated.   
When GFP-C13 translocates into the nucleus it regulates gene expression by an 
unknown mechanism.  Xenopus Marginal Coil (Xmc) is a cytoplasmic coiled-coil protein 
that is regulated by GFP-C13 and plays an important role in regulating gastrulation 
movements (Frazzetto et al., 2002).  To determine if Xmc is able to rescue the cell 
adhesion defects in the dorsal mesoderm, I injected RNA encoding full length Xmc 
containing an N-terminal myc tag (Xmc-MT) into the two dorsal blastomeres at the four 
cell stage.  However, Xmc-MT RNA could not rescue dorsal mesoderm cell spreading on 
FN and 9.11 in MO13 or MO19 injected embryos (Figure 4.16 and 4.17).  This result 
suggests that Xmc does not function with ADAM13 or ADAM19 in regulating dorsal 
mesoderm cell adhesion to FN. 
In addition, PI3K signaling and the downstream component AKT are shown to 
regulate cell adhesion to FN (Nie and Chang, 2007a; Somanath and Byzova, 2009; 
Somanath et al., 2007).  To determine if PI3K is able to rescue the cell adhesion defects 
in the dorsal mesoderm, I injected RNA encoding the constitutively active p110 subunit 
of PI3K (Nie and Chang, 2007a).  However, p110 RNA could not rescue dorsal 
mesoderm cell spreading on FN and 9.11 in MO13 or MO19 injected embryos (Figure 
4.16 and 4.17).  Previously at the gastrula stage, I showed a significant reduction in active 
phosphorylated AKT in embryos lacking ADAM19 (Figure 2.9).  Therefore, I analyzed 
the level of phosphorylated AKT (AKTp) in the dorsal mesoderm.  However in MO13 or 
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MO19 injected embryos, there was no significant change in the level of AKTp in the 
dorsal mesoderm (Figure 4.18).  The effects on AKT by ADAM19 were seen previously 
at the late gastrula stage where the expression level of ADAM19 is much higher 
compared to the early gastrula stage in this assay (Figure 2.1 and 2.9).  These results 
suggest that ADAM13 or ADAM19 regulation of cell spreading to fibronectin is not 
mediated by PI3K/AKT. 
 
SECTION VI:  Discussion 
 
In this chapter I have shown that ADAM13 and ADAM19 proteins are important 
for gastrulation.  ADAM19 affects gene expression important for establishing the A-P 
polarity of the notochord, while ADAM13 does not.  Both ADAM13 and ADAM19 are 
important for convergence and extension movements.  Embryos lacking ADAM13 or 
ADAM19 have a delay in mediolateral cell intercalation of the axial mesoderm, resulting 
in a significantly wider notochord compared to control embryos.  The defects seen in 
convergence and extension movements do not appear to affect the activation of the PCP 
signaling pathway.  However, dorsal mesoderm cells from embryos lacking ADAM13 or 
ADAM19 have a reduced ability to spread on fibronectin. 
My results show that a loss of ADAM13 or ADAM19 in the embryo does not 
affect the activation of the PCP signaling pathway by the translocation of dishevelled to 
the plasma membrane.  Dishevelled sub-cellular localization has been studied extensively 
before to determine the activation state of the PCP signaling pathway in Xenopus 
embryos (Axelrod et al., 1998; Marsden and DeSimone, 2001; Tada and Smith, 2000; 
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Wallingford et al., 2000).  However, dishevelled protein is also essential for controlling 
signal transduction of the canonical Wnt signaling pathway via -catenin (Boutros and 
Mlodzik, 1999).  Dishevelled is an intercellular protein that interacts with the Wnt 
receptor Frizzled at the plasma membrane and deciphers the Wnt signal to activate the 
appropriate intracellular signaling cascade (Canonical vs Non-canonical) (Roszko et al., 
2009).  Therefore, to definitively show that the PCP signaling pathway is affected in 
embryos lacking ADAM13 or ADAM19 further experiments need to be done.  I would 
propose to investigate the downstream PCP target genes for any changes in gene 
expression profiles. 
My results suggest that ADAM13, and possibly ADAM19, function by regulating 
dorsal mesoderm cell spreading on fibronectin.  A single knock down of ADAM13 
reduces cell spreading on FN to 60%.  A single knock down of ADAM19 reduces cell 
spreading on FN to 70%.  A double knock down of ADAM13 and ADAM19 reduces cell 
spreading on FN to 60%, showing there is not an additive effect by the loss of both 
ADAM proteins.  This suggests that the function of ADAM13 and ADAM19 do not 
compensate in cell spreading on fibronectin.  Since the double knock down cell adhesion 
levels are similar to the knock down of ADAM13 alone, I propose that dorsal mesoderm 
cell spreading on FN is largely due to ADAM13 with minimal contribution from 
ADAM19.  Moreover, a loss of ADAM19 reduces ADAM13 protein levels at the tailbud 
stage (Figure 3.2) and at the early gastrula stage (Figure 4.19).  Therefore, my results 
suggest that the dorsal mesoderm cell spreading defects observed in MO19 injected 
embryos are an indirect result of a reduction in ADAM13 protein levels.   
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 Dorsal mesoderm cell spreading on the fusion protein 9.11 or full length 
fibronectin were similar.  A single knock down of ADAM13 reduces cell spreading on 
9.11 to 60%.  A single knock down of ADAM19 reduces cell spreading on 9.11 to 70%.  
A double knock down of ADAM13 and ADAM19 reduces cell spreading on 9.11 to 60%, 
showing there is not an additive effect by the loss of both ADAM proteins.  This strongly 
suggests that our defect in dorsal mesoderm cell spreading to FN is mediated through the 
RGD/synergy site via the 51 integrin receptor and not through other cell-ECM 
interactive sites.  Previously, the disintegrin and cysteine rich domains of ADAM13 were 
shown to promote cell adhesion through an interaction with activated 1 integrin 
(Gaultier et al., 2002).  Therefore, ADAM13 (and possibly ADAM19) may function 
through 51 integrin to promote dorsal mesoderm cell adhesion to FN.  Since ADAM13 
or ADAM19 do not appear to affect the overall expression of 1 integrin (Figure 4.18), it 
is likely that either the cell surface protein level of 51 integrin or the activation of 
51 integrin could be regulated by ADAM13.  Integrins are cell surface heterodimers 
functioning as receptors in cell adhesion and migration to the extracellular matrix (Hynes, 
2009).  Using three-dimensional models, it is shown that the integrin  and  tails of 
51 form a heterodimer and exist in a low affinity state or closed conformation.  In this 
inactive state, 51 can bind to the RGD site of fibronectin.  In order to change to a high 
affinity state and to become activated, changes in their three-dimensional conformation 
occur in relation to the position of each tail and relative to the plasma membrane.  Once 
activated, 51 integrin has an open conformation and can bind to both the RGD and 
Synergy sites on fibronectin.  Furthermore, once an integrin heterodimer becomes 
activated this promotes a physical interaction with the intracellular adaptor protein talin 
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to the  cytoplasmic tail (Tadokoro et al., 2003).  The two main kinases downstream of 
an activated integrin heterodimer are focal adhesion kinase (FAK) and Src kinase.  These 
kinases regulate other downstream proteins that control the small GTPases Rac1 and 
RhoA to induce cytoskeletal changes.  This is essential for proper cell adhesion and 
migration on fibronectin. 
Two techniques have been developed in zebrafish and humans to analyze 
activated integrin heterodimers in vivo.  Bimolecular Fluorescence Complementation 
(BiFC) can visualize active integrin heterodimers in vivo (Julich et al., 2009).  The 5 
integrin was tagged at the C-terminus with the N-terminal fragment of Venus yellow 
fluorescent protein (5-nVenus).  The 1 integrin was tagged at the C-terminus with the 
C-terminal fragment of Venus yellow fluorescent protein (1-cVenus).  RNA was 
transcribed for both constructs and injected into zebrafish embryos.  Co-expression of 
5-nVenus and 1-cVenus produced strong fluorescence at the intersomitic boundaries 
compared to weak fluorescence within individual somitic cells.  This suggests an active 
integrin heterodimer forms at the intersomitic boundaries.  The second technique utilizes 
a monoclonal antibody (MAB2079Z) made against human 1 integrin (amino acids 355-
425, Millipore) that specifically recognizes its active conformation (Barberis et al., 2004).  
For our system, injection of human 1 integrin RNA would enable us to visualize 
activated integrin heterodimers in the dorsal mesoderm by immunohistochemistry.  These 
techniques will allow us to investigate if ADAM13 (or ADAM19) affects 51 integrin 
activation.   
Reintroducing ADAM13 RNA (200pg) in the dorsal mesoderm was able to 
partially rescue cell spreading on 9.11 but not on full length FN (Figure 4.16).  ADAM13 
106 
 
is known to bind to the second heparin-binding domain (Hep II) of fibronectin in order to 
cleave and remodel a fibronectin matrix (Alfandari et al., 2001; Gaultier et al., 2002).  It 
is likely that reintroducing ADAM13 in the dorsal mesoderm cells allows ADAM13 to 
bind and cleave FN.  This would cause a decrease in cell adhesion to full length FN.  I 
observed an even further reduction (42%) in cell adhesion when injecting a high dosage 
(400pg) of ADAM13 RNA (Figure 4.16A).  Furthermore, our lab has shown that a loss of 
ADAM13, as well as, ADAM13 overexpression in the embryo delays blastopore closure 
by two hours.  Therefore, it is possible that a finite dosage of ADAM13 is needed to 
obtain a complete rescue on full length FN.  Since the 9.11 substrate does not contain the 
Hep II domain, this might explain why ADAM13 can rescue on the 9.11 substrate but 
cannot rescue cell adhesion on full length FN.  These results suggest that ADAM13 
functions through 51 integrin to regulate cell adhesion on fibronectin, in addition to 
having a role in binding and cleaving fibronectin. 
 Work completed by our lab on ADAM13 and another group on ADAM10 has 
recently shown that the cytoplasmic domains are cleaved off by -secretase and 
translocate into the nucleus to perform an independent function in the embryo (Cousin et 
al., 2010; Tousseyn et al., 2009).  Our lab has shown that overexpression of a GFP fusion 
to the cytoplasmic domain of ADAM13 (GFP-C13) in cranial neural crest cells affects 
gene expression in approximately 2000 genes.  Co-expression with the extracellular 
domain of ADAM13 (ADAM13cyto) is capable of rescuing CNC cell migration in vivo.  
In addition, the cytoplasmic domain of ADAM19 (GFP-C19) co-expressed with the 
ADAM13cyto is capable of rescuing CNC cell migration in vivo.  This suggests that the 
ADAM13 cytoplasmic domain (and possibly ADAM19 cytoplasmic domain) regulates 
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gene expression when inside the nucleus and that the overlapping functions of ADAM13 
and ADAM19 may be explained by the actions of their cytoplasmic domains. 
GFP-C13 can rescue dorsal mesoderm cell spreading on FN and 9.11 in MO19 
injected embryos but not in MO13 injected embryos (Figure 4.17).  In addition, the co-
injection at the one cell stage of MO19 and GFP-C13 RNA (1ng) can upregulate 
ADAM13 protein level to near control levels (Figure 4.19).  This result was not seen by 
co-injection of MO13 and GFP-C13 RNA (1ng) because of the effects of the morpholino.  
Therefore, GFP-C13 may function through a positive feedback mechanism to regulate 
ADAM13 gene expression.  To determine if GFP-C13 can function through a positive 
feedback mechanism to upregulate ADAM13 transcription, I propose to isolate RNA 
from embryos overexpressing GFP-C13.  I will detect ADAM13 gene expression by real 
time PCR.  The PCR primer sets will have to recognize a specific sequence in the 
extracellular domain of ADAM13 to avoid amplification of the cytoplasmic domain and 
cross-reactivity with other ADAM members.  Furthermore, our lab has shown the 
cytoplasmic domain of ADAM19 (GFP-C19) can compensate for GFP-C13 by rescuing 
CNC cell migration in vivo (Cousin et al., 2010).  If GFP-C19 can compensate for GFP-
C13 in CNC cells, it would be interesting to determine if GFP-C19 could rescue dorsal 
mesoderm cell spreading on FN and 9.11 substrates.  Lastly, it would be interesting to 
determine if GFP-C19 may function in a similar positive feedback mechanism. 
Although ADAM13 and ADAM19 proteins are required for normal 
morphogenetic movements during gastrulation, my data suggests they function through 
different mechanisms.  I propose that ADAM19 functions by shedding Neuregulin to 
help establish gene expression for the A-P polarity of the notochord.  I propose that 
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ADAM13 functions to control dorsal mesoderm cell adhesion on fibronectin by 
regulating the activation of 51 integrin.  These hypotheses will be explored further in 
Chapter V of this thesis. 
 
SECTION VII:  Materials and Methods used in Chapter IV 
 
Embryo Dissections - Open Face Explants 
Embryos were injected in the animal pole region at the one-cell stage with either CMO, a 
Morpholino to ADAM13 (MO13), or MO19 to knock down protein expression in the 
entire embryo.  The same embryos were injected again into one blastomere at the two-
cell stage with mRNA encoding a membrane bound Cherry (mbCherry) to visualize 
individual cells.  The resultant embryos were allowed to develop until the end of 
gastrulation (stage 12.5).  At this point, the dorsal mesoderm was dissected from each 
embryo and the resulting open face explant was prepared as described previously 
(Wilson, 1989).  Time lapse movies were made using an Axiovert inverted microscope 
(Zeiss) equipped with a Ludl XY-stage control and an Orca camera (Hamamatsu) and 
controlled by the OpenLab software (Improvision).  The explants were allowed to 
develop until approximately early tailbud (stage 22).  Individual cell tracking and 
notochord measurements were done using the OpenLab software.  At the end of each 
time lapse movie, the explants were fixed in MEMFA and dehydrated in methanol for 
Whole Mount Immunostain analysis. 
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Double Whole Mount Immunostain 
Embryos were fixed at tailbud stage (st. 24) using MEMFA and stored in methanol. 
Whole mount immunostaining was performed as previously described (Dent et al., 1989).  
The Tor70 antibody was a generous gift from Dr. Richard Harland at the University of 
California, Berkeley.  The 12/101 antibody was purchased from the Developmental 
Studies Hybridoma Bank (Iowa City, Iowa).   
 
Cell Adhesion Assay 
Embryos were injected in the animal pole region at the one-cell stage with CMO, MO13, 
or MO19 to knock down protein expression in the entire embryo.  The resultant embryos 
were allowed to develop until the beginning of gastrulation (stage 10.5), at which point 
the dorsal mesoderm was dissected from each embryo.  Dorsal mesoderm cells were 
dissociated on an agarose coated plastic dish in calcium and magnesium free media (1X 
CMF) for 30 minutes.  The cells were plated onto a fibronectin (FN) substrate or a GST-
fusion protein containing only the RGD/synergy site of fibronectin (GST-9.11) as 
described previously (Ramos, 1996).  Time lapse movies were made using an Axiovert 
inverted microscope (Zeiss) equipped with a Ludl XY-stage control and an Orca camera 
(Hamamatsu) and controlled by the OpenLab software (Improvision).  Dorsal mesoderm 
cell spreading was analyzed at the one hour time point for all experiments. 
 
Confocal Microscopy 
GFP-dishevelled RNA was injected into the two dorsal blastomeres at the four-cell stage 
and allowed to develop until late gastrula (stage 12.5/13).  Open face explants were 
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dissected as described above.  The explants were cultured in Danilchik media on glass 
bottom petri dishes.  The live explants were allowed to heal for one hour and then imaged 
at approximately stage 14 using a Zeiss Confocal Scanning Laser Microscope equipped 
with LSM 510M software.  The images were captured under an oil immersion 25x 
magnification objective lens. 
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Figure 4.1:  A-P Polarity Analysis for Xbrachyury Expression at the 
Gastrula Stage.  Embryos were microinjected with 10 ng of MO19 or a 
control MO at the one-cell stage and allowed to develop until gastrula 
stage (stage 12).  Embryos were also co-injected at the one-cell stage with 
RNA encoding full length ADAM19 (250pg), ADAM19E/A (250pg), full 
length Neuregulin1 (NRG-FL) (100pg) or the extracellular region of 
Neuregulin1 (NRG-EC) (100pg).  Whole mount in situ hybridization was 
performed using the marker Xbrachyury.  For all embryos, the dorsal view 
is presented with the anterior up.  The frequencies of the morphotypes 
observed are indicated in the bottom graph. 
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Figure 4.2:  A-P Polarity Analysis for Chordin Expression at the 
Gastrula Stage.  Embryos were microinjected with 10 ng of MO19 or a 
control MO at the one-cell stage and allowed to develop until gastrula 
stage (stage 12).  Embryos were also co-injected at the one-cell stage with 
RNA encoding full length ADAM19 (250pg), ADAM19E/A (250pg), full 
length Neuregulin1 (NRG-FL) (100pg) or the extracellular region of 
Neuregulin1 (NRG-EC) (100pg).  Whole mount in situ hybridization was 
performed using the marker Chordin.  For all embryos, the dorsal view is 
presented with the anterior up and the red bar indicates the relative 
distance from the blastopore.  The frequencies of the morphotypes 
observed are indicated in the bottom graph. 
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Figure 4.3:  ADAM13 affect on the A-P Polarity of the Notochord.  
Embryos were microinjected with 10 ng of MO13, MO19 or a control MO 
at the one-cell stage and allowed to develop until gastrula stage (stage 12).  
MO19 embryos were also co-injected at the one-cell stage with RNA 
encoding full length ADAM13 (200pg).  Whole mount in situ 
hybridization was performed using the marker Xbrachyury and Chordin.  
For all embryos, the dorsal view is presented with the anterior up and the 
red bar indicates the relative distance from the blastopore.  The 
frequencies of the morphotypes observed are indicated in the bottom 
graph. 
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Figure 4.4: Visual Summary showing the A-P Polarity of the Notochord at the 
Gastrula Stage.  Wild type notochords are compared to ADAM13 knock down, 
ADAM19 knock down, and NRG-EC Rescue notochords showing Xbrachyury (blue) and 
Chordin (red) expression profiles.  Anterior (A), posterior (P).  ADAM13 knock down 
notochords do not affect A-P polarity gene expression.  The expression patterns are wider 
compared to control notochords, suggesting possible notochord morphology defects.  
ADAM19 knock down notochords do affect A-P polarity gene expression.  Specifically, 
a loss of Xbrachyury concomitant with an anterior shift in Chordin expression.  Gene 
expression can be rescued by co-injecting the extracellular fragment of Neuregulin1 
RNA, a form that mimics a potential cleavage product of ADAM19. 
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Figure 4.5: Double Whole Mount Immunostain on Embryos Lacking 
ADAM13 or ADAM19.  The monoclonal antibody, Tor70, stains the 
notochord in brown (Kushner, 1984).  The monoclonal antibody, 12/101, 
stains the somites in green (Kintner and Brockes, 1985).  The notochord 
morphologically appears wider in MO13 and MO19 injected embryos.  
The somites morphologically appear normal in MO13 injected embryos 
but show gross morphology in MO19 injected embryos.  The defects 
observed in these two dorsal tissues are also evident in the smaller and 
shorter body size of MO19 injected embryos. 
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Figure 4.6:  Microdissection of an Open Face Explant.  (A) Bisect a late gastrula 
(stage 12.5/13) embryo along the dotted line.  (B) Peel away the underlying „sticky‟ 
endoderm layer, exposing the dorsal mesoderm.  (C) Cut away the ends to shape the 
explant into a rectangle.  (D) Place the explant mesoderm face down onto a glass bottom 
Petri dish filled with Danilchik media.  Place four small droplets of vacuum grease 
around the explant and position a glass coverslip on top.  Press down gently.  (E) All 
Open Face Explants are positioned with the Anterior at the top and Posterior at the 
bottom.  The notochord is in the center surrounded by the developing somites.  This 
figure was adapted from (Wilson et al., 1989). 
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Figure 4.7:  Time Lapse Microscopy of a Control Open Face Explant.  Explants from 
embryos injected with CMO at the one-cell stage.  Membrane bound Cherry RNA was 
injected into one blastomere at the two-cell stage to visualize axial mesoderm cell 
movement from one half of the embryo.  The montage represents an image every 30 
minutes from a ten hour time lapse movie.  The movie file is included with this Thesis. 
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Figure 4.8:  Time Lapse Microscopy of MO13 Injected Open Face Explant.  Explants 
from embryos injected with MO13 at the one-cell stage.  Membrane bound Cherry RNA 
was injected into one blastomere at the two-cell stage to visualize axial mesoderm cell 
movement from one half of the embryo.  The montage represents an image every 30 
minutes from a ten hour time lapse movie.  The movie file is included with this Thesis. 
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Figure 4.9:  Time Lapse Microscopy of MO19 Injected Open Face Explant.  Explants 
from embryos injected with MO19 at the one-cell stage.  Membrane bound Cherry RNA 
was injected into one blastomere at the two-cell stage to visualize axial mesoderm cell 
movement from one half of the embryo.  The montage represents an image every 30 
minutes from a ten hour time lapse movie.  The movie file is included with this Thesis. 
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Figure 4.10: Axial Mesoderm Cell Morphology.  (A) Open face explants from 
embryos injected with CMO, MO13 or MO19 at the one-cell stage.  Membrane 
bound Cherry RNA was injected into one blastomere at the two-cell stage.  Four 
cells are outlined in black to better visualize the axial mesoderm cell morphology.  
(B) Axial mesoderm cell length-to-width ratio.  The mediolateral length and 
anterior-posterior width were measured in axial mesoderm cells of open face 
explants at the end of gastrulation (st. 13).  The graph represents 20 cells from four 
independent experiments.  Control axial mesoderm cells have a bipolar 
morphology.  Axial mesoderm cells from embryos lacking ADAM13 or ADAM19 
have a multipolar morphology with reduced axial mesoderm cell L:W ratios. 
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Figure 4.11:  Mediolateral Cell Intercalation of the Axial Mesoderm.  Open face 
explants from embryos injected with CMO, MO13 or MO19 at the one-cell stage.  
Membrane bound Cherry RNA was injected into one blastomere at the two-cell stage.  
Three cells were outlined in different colors to better visualize the axial mesoderm cell 
movement over an eight hour time period.  The length was measured between two cells at 
each time point and divided by the width of the notochord.  This generated a length-to-
width ratio (L:W).  The graph below represents 14 different L:W measurements from 
three independent experiments.  In embryos lacking ADAM13 or ADAM19, the L:W did 
not change, showing a delay in mediolateral cell intercalation. 
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Figure 4.12:  Notochord-Somite Boundary Analysis.  Open face explants from 
embryos injected with CMO, MO13 or MO19 at the one-cell stage.  The explants were 
allowed to develop in Danilchik media until approximately stage 20 and then fixed.  
Double immunostain was done using antibodies to the extracellular matrix proteins 
fibronectin (4H2, red) and laminin (anti-rabbit-laminin, Sigma, green).  These proteins 
accumulate at the notochord-somite boundary and at the intersomitic boundaries.  In 
MO13 injected embryos, punctate expression of both ECM proteins was found in the 
notochord (white arrowheads).  In MO19 injected embryos, abnormal expression of both 
ECM proteins was found throughout the notochord.  The images represent maximum 
projections taken under fluorescence microscopy using an Apotome and Axiovision 4.5 
software analysis. 
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Figure 4.13:  GFP-Dishevelled Localization in the Dorsal Mesoderm.  Open face 
explants from embryos injected with CMO, MO13 or MO19 at the one-cell stage.  50pg 
of GFP-dishevelled RNA was injected into the two dorsal blastomeres at the four-cell 
stage.  The explants were allowed to develop in Danilchik media while the images were 
captured with confocal microscopy.  The approximate developmental stage of each image 
is stage 14.  The localization of GFP-dishevelled was found at the plasma membrane 
under all three conditions.   
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Figure 4.14:  GFP-Dishevelled Localization Normalized to mRFP in the Dorsal 
Mesoderm.  (A) Open face explants from embryos injected with CMO, MO13 or MO19 
at the one-cell stage.  50pg of GFP-dishevelled RNA and monomeric-RFP RNA was 
injected into one dorsal blastomere at the four-cell stage.  The explants were allowed to 
develop in Danilchik media while the images were captured with confocal microscopy.  
The approximate developmental stage of each image is stage 14.  The localization of 
GFP-dishevelled was found at the plasma membrane under all three conditions with 
mRFP localized throughout the cytosol.  (B) The fluorescence profile of GFP-dishevelled 
is normalized to the fluorescence profile of mRFP and the average ratios are plotted in 
the graph.  (C) All of the ratio data is plotted in a Box and Whisker Plot.  For both data 
representations, the ratio for GFP-dishevelled does not change under all three conditions. 
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Figure 4.15:  Dorsal Mesoderm Cell Adhesion Assay.  (A) Dorsal mesoderm cells 
were taken from CMO, MO13, MO19, or MO13+MO19 (2MO) embryos, dissociated 
and plated onto a fibronectin (FN) or 9.11 substrate.  Cell attachment and spreading was 
analyzed after one hour.  (B) In control embryos, 85% of the cells spread on FN and 9.11.  
In MO13 injected embryos, 60% of the cells spread on FN and 9.11.  In MO19 injected 
embryos, 70% of the cells spread on FN and 9.11.  In 2MO injected embryos, 60% of the 
cells spread on FN and 9.11.  The images represent cells from one experiment.  The 
graphs shown below represent data from twelve experiments. 
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Figure 4.16:  Summary of Rescue Experiments in Dorsal Mesoderm of MO13 
Injected Embryos.  Dorsal mesoderm cells were taken from MO13 embryos injected 
with various rescue RNA constructs into the two dorsal blastomeres at the four-cell stage.  
The cells were dissociated and plated onto a (A) fibronectin (FN) or (B) 9.11 substrate.  
Cell attachment and spreading was analyzed after one hour and compared to Control 
cells.  The rescue RNA is full length ADAM13 (A13), full length ADAM19 (A19), the 
cytoplasmic domain of ADAM13 (C13), Xenopus marginal coil (Xmc-MT), and the 
constitutively active p110 subunit of PI3K (p110).  The dosages are indicated in 
parentheses.   
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Figure 4.17:  Summary of Rescue Experiments in Dorsal Mesoderm of MO19 
Injected Embryos.  Dorsal mesoderm cells were taken from MO19 embryos injected 
with various rescue RNA constructs into the two dorsal blastomeres at the four-cell stage.  
The cells were dissociated and plated onto a (A) fibronectin (FN) or (B) 9.11 substrate.  
Cell attachment and spreading was analyzed after one hour and compared to Control 
cells.  The rescue RNA is full length ADAM13 (A13), full length ADAM19 (A19), the 
cytoplasmic domain of ADAM13 (C13), Xenopus marginal coil (Xmc-MT), and the 
constitutively active p110 subunit of PI3K (p110).  The dosages are indicated in 
parentheses.   
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Figure 4.18:  Protein Expression in the Dorsal Mesoderm.  
Embryos were injected with CMO, MO13 or MO19 at the one-cell 
stage and allowed to develop to early gastrula (stage 10.5).  Total 
protein extract from five dissected dorsal blastopore lips was 
probed for integrin 1 (8C8 antibody) and phosphorylated AKT 
(AKTp, anti-rabbit-AKTp, Cell Signaling Technology).  GAPDH 
(Millipore) was probed as a loading control.  The below graph 
shows percent change from three independent experiments 
normalized to GAPDH expression. 
 
 
 
 
 
 
129 
 
 
 
 
 
 
Figure 4.19:  C13 Affect on ADAM13 Expression.  Embryos were 
injected with CMO, MO13 or MO19 together with GFP-C13 RNA (1ng) at 
the one-cell stage and allowed to develop to early gastrula (stage 10.5).  
Total protein extract from five embryos were immunoprecipitated using our 
goat ADAM13 antibody and probed with our rabbit ADAM13 antibody 
(6615F).  GAPDH (Millipore) was probed as a loading control.  The below 
graph shows the percent change of ADAM13 Proform and ADAM13 
Mature form when normalized to GAPDH. 
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CHAPTER V 
 
EXPLORING THE FUNCTIONS OF ADAM13 AND ADAM19  
IN THE DORSAL MESODERM 
 
All of the work presented in this chapter is data completed by myself and is unpublished. 
 
Abstract 
 This chapter will explore the roles of ADAM13 and ADAM19 in the dorsal 
mesoderm.  I will focus on determining how each protein contributes to convergence and 
extension movements during gastrulation.  Previous data from Chapter IV of this thesis 
suggests that ADAM13 and ADAM19 have different functions during gastrulation.  
ADAM13 appears to function in regulating cell movements while ADAM19 appears to 
function in regulating cell signaling.  In addition, ADAM19 may function to regulate cell 
movements indirectly through the function of ADAM13 or through the function of 
Xbrachyury in the notochord.  I propose and discuss a few models for ADAM13 and 
ADAM19 function in gastrulation. 
 
SECTION I: Introduction 
 
 Gastrulation is a morphogenetic process that reorganizes the primary germ layers 
to shape the internal and external features of an early embryo.  The main focus on this 
thesis is to investigate the roles of ADAM13 and ADAM19 during gastrulation.  Both 
ADAM family members are expressed in the dorsal mesoderm of the dorsal blastopore 
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lip.  This tissue is known as the Spemann Organizer and is essential for regulating 
gastrulation movements and for early tissue patterning in the embryo.  Although 
ADAM13 and ADAM19 are expressed in the same tissue and are required for normal 
morphogenetic movements during gastrulation, my data suggests they have different 
functions.  ADAM13 appears to function in regulating cell movements while ADAM19 
appears to function in regulating cell signaling. 
ADAM13 functions to regulate cell movements during gastrulation.  This 
hypothesis is supported by three main observations.  First, embryos lacking ADAM13 
delay blastopore closure by two hours showing that ADAM13 is required for proper 
blastopore closure.  This is specific to ADAM13 because blastopore closure was not 
affected in embryos lacking ADAM19 (Figure 2.4).  Second, ADAM13 regulates dorsal 
mesoderm cell adhesion to fibronectin cell autonomously.  Dorsal mesoderm cells from 
embryos lacking ADAM13 reduce cell spreading on FN to 60%.  This is compared to 
dorsal mesoderm cells from control embryos that have 85% of the cells spreading on FN.  
In a similar assay, dorsal mesoderm cells from embryos lacking ADAM13 reduce cell 
spreading on the fusion protein 9.11 to 60%.  The 9.11 fusion protein only contains the 
integrin binding domain (RGD and Synergy sites) suggesting that the cell adhesion 
defects involve 51 integrin.  Third, ADAM13 is important for convergence and 
extension movements in the embryo.  Embryos lacking ADAM13 have a delay in 
mediolateral cell intercalation in the axial mesoderm.  This defect results in a wider 
notochord compared to control embryos.  The cell adhesion defects on FN likely 
contribute to the defects observed in convergence and extension as well as blastopore 
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closure in the embryo.  Therefore, I propose that ADAM13 functions to regulate cell 
movements during gastrulation.   
ADAM19 functions to regulate cell signaling during gastrulation.  This 
hypothesis is supported by three main observations.  First, ADAM19 regulates gene 
expression important for the A-P polarity of the notochord.  Embryos lacking ADAM19 
have a specific loss of Xbrachyury expression concomitant with an anterior shift of 
Chordin expression in the notochord (Figure 2.5, 4.1 and 4.2).  Gene expression is 
unaffected in embryos lacking ADAM13 at the gastrula stage, suggesting a specific role 
for ADAM19 (Figure 4.3).  Second, embryos lacking ADAM19 have reduced 
phosphorylated AKT levels (Figure 2.9).  AKT is a downstream target of the EGF 
signaling pathway.  This is specific to ADAM19 because phosphorylated AKT is 
unaffected in embryos lacking ADAM13.  Third, ADAM19 may affect the canonical Wnt 
signaling pathway.  Embryos lacking ADAM19 have reduced total -catenin levels 
(Figure 2.9).  -catenin is an intracellular target of the canonical Wnt signaling pathway.  
This is specific to ADAM19 because -catenin levels are unaffected in embryos lacking 
ADAM13.  Therefore, I propose that ADAM19 functions to regulate cell signaling during 
gastrulation. 
In addition, ADAM19 may have an indirect role in regulating cell movements 
during gastrulation.  This hypothesis is supported by two main observations.  First, 
ADAM19 may function to regulate dorsal mesoderm cell adhesion to FN.  Dorsal 
mesoderm cells from embryos lacking ADAM19 reduce cell spreading on FN and 9.11 to 
70%.  This is compared to dorsal mesoderm cells from control embryos that have 85% of 
the cells spreading on FN and 9.11.  Second, ADAM19 is important for convergence and 
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extension movements in the embryo.  Embryos lacking ADAM19 have a delay in 
mediolateral cell intercalation in the axial mesoderm.  These defects result in a wider 
notochord compared to control embryos.  However, the ADAM19 observations may be 
an indirect result by affecting ADAM13 protein.  Embryos lacking ADAM19 strongly 
reduce ADAM13 protein levels at the early gastrula stage (Figure 4.19) and at the tailbud 
stage (Figure 3.2).  Therefore, I propose that ADAM19 may function to regulate cell 
movements indirectly through the function of ADAM13 or through the function of 
Xbrachyury in the notochord.  Both ADAM13 and ADAM19 functions during 
gastrulation will be explored further in Section II and Section III of this chapter. 
 
SECTION II: ADAM13 Contributes to Convergence and Extension by Regulating 
Dorsal Mesoderm Cell Adhesion to Fibronectin 
 
 Integrin activation and integrin heterodimer clustering at the cell surface are 
important for increased adhesion to a fibronectin matrix (Larsen et al., 2006).  
Disruptions in integrin function with the extracellular matrix have led to defects in cell 
adhesion and cell migration.  Mice null for the 5 integrin subunit die early in gestation 
due to mesoderm defects such as abnormal posterior somite development and 
degeneration of the notochord tissue (Goh et al., 1997).  A loss of FN in the embryo 
results in convergence and extension defects in zebrafish (Latimer and Jessen, 2009) and 
in Xenopus (Rozario and DeSimone, 2010).  Moreover, studies using function blocking 
antibodies to 51 integrin randomize cell protrusions that are important for mediolateral 
cell intercalation, thus causing defects in convergence and extension (Davidson et al., 
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2006).  In addition to the interaction between 51 integrin and FN, the physical state of 
FN fibril assembly also regulates convergence and extension movements in the embryo 
(Rozario et al., 2009).  Therefore, the interaction between 51 and fibronectin plays an 
essential role in the morphogenetic movements during gastrulation.  Dorsal mesoderm 
cells adhere and migrate on a fibronectin matrix along the blastocoel roof.  These cell 
movements are critical for proper blastopore closure during gastrulation.  I propose that 
ADAM13 (and possibly ADAM19) functions to promote dorsal mesoderm cell adhesion 
to a fibronectin matrix.  ADAM13 promotes cell adhesion by regulating the activation of 
51 integrin.  This regulation may occur through two different cell autonomous 
mechanisms; an intracellular mechanism or an extracellular mechanism. 
 
How does ADAM13 Regulate 51 Integrin Activation Cell Autonomously? 
 
  ADAM metalloproteases are regulated through a variety of different post-
translational modifications (Murphy, 2009).  One form of regulation is through 
intracellular binding partners that interact with the ADAM metalloprotease cytoplasmic 
domain.  The proteins physically interact with SH3 binding motifs and proline rich 
domains found in the ADAM cytoplasmic domain.  A large number of the proteins 
identified so far are important for regulating ADAM protein subcellular localization and 
trafficking within a cell.  However, some important intracellular kinases have also been 
identified such as PCK, Src, PI3K and ERK (Diaz-Rodriguez et al., 2002; Izumi et al., 
1998; Kang et al., 2001; Poghosyan et al., 2002).  This suggests that ADAM cytoplasmic 
domains and the attached kinases may have an intracellular function. 
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The Src family of tyrosine kinases are a large protein kinase family that function 
downstream of different cell surface receptors (Bradshaw, 2010).  Src kinases together 
with focal adhesion kinase (FAK) are important for regulating the downstream signaling 
events upon integrin engagement with the ECM (Pellinen and Ivaska, 2006).  Src and 
FAK kinases regulate guanine nucleotide exchange factors (GEF proteins) which activate 
the small GTPases RhoA and Rac1.  RhoA and Rac1 regulate cytoskeletal changes within 
a cell and are essential for cell adhesion and cell migration.  Src kinases were identified 
as binding partners to the cytoplasmic domains of many different ADAM proteins such 
as ADAM9 (Weskamp et al., 1996), ADAM12 (Suzuki et al., 2000), ADAM13 (Cousin 
et al., 2000), and ADAM15 (Poghosyan et al., 2002).   
Src kinases can regulate an ADAM protein through two different mechanisms.  
First, Src kinase binds and phosphorylates the ADAM cytoplasmic domain to regulate the 
extracellular function of the ADAM metalloprotease.  This is important for regulating the 
ectodomain shedding of an ADAM substrate from a cell.  For example, c-Src kinase 
binds and phosphorylates the cytoplasmic domain of ADAM15.  This increases 
ectodomain shedding of the ADAM15 substrate, fibroblast growth factor receptor 2 
(FGFR2) (Maretzky et al., 2009).  FGFR2 was not shed in cells treated with a Src kinase 
inhibitor or in c-Src(-/-) cells but FGFR2 shedding was rescued by reintroducing Src in c-
Src(-/-) cells.  This shows that c-Src regulates the ectodomain shedding of FGFR2 by 
ADAM15.  Second, ADAM proteins may enhance Src kinase activity in cultured cells.  
This occurs when an ADAM protein recruits Src kinase to large protein complexes at the 
cell surface.  For example, ADAM12 and Src kinase co-localize to actin-rich structures 
along membrane ruffles in cultured cells (Stautz et al., 2010).  ADAM12 enhances Src 
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kinase phosphorylation when cells are plated on the extracellular matrix protein 
vitronectin.  This suggests that upon integrin engagement to vitronectin, ADAM12 can 
enhance Src kinase activity.  Therefore, ADAM proteins may recruit Src kinases to 
specific locations in a cell as a way to regulate their own metalloprotease activity.  
My results suggest that ADAM13 promotes dorsal mesoderm cell adhesion to 
fibronectin by regulating the activation of 51 integrin.  This occurs cell autonomously 
because in my assay the dorsal mesoderm cells were dissociated.  Src kinase is capable of 
binding to the cytoplasmic domain of ADAM13 (Cousin et al., 2000).  Therefore, I 
propose that ADAM13 recruits Src kinase to specific adhesion complexes containing 
51 integrin at the cell surface.  Once 51 integrin binds fibronectin and becomes 
activated, Src kinase phosphorylates FAK to regulate downstream Rho/Rac signaling 
events and cytoskeletal changes.  This intracellular mechanism allows the cell to spread 
on a fibronectin substrate and to promote proper cell adhesion (Figure 5.1A).  
Alternatively, ADAM13 may regulate the activation of 51 integrin through an 
extracellular mechanism involving the cleavage of fibronectin (Figure 5.1A).  ADAM13 
binds to the HepII domain of fibronectin and cleaves fibronectin.  This mechanism could 
promote cell migration on a fibronectin matrix.   
 In the absence of ADAM13, Src is not properly recruited to the specific adhesion 
complexes containing 51 integrin.  As a result, Src activity is reduced, FAK activity is 
reduced and ADAM13 is not present to cleave fibronectin (Figure 5.1B).  Therefore, cells 
will remain round and not be able to spread on a fibronectin substrate.  To test the 
ADAM13 model, I propose the following experiments.  First, to investigate Src kinase 
activity in MO13 injected embryos, I propose to determine phosphorylated Src protein 
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levels by western blot.  Second, to investigate FAK kinase activity in MO13 injected 
embryos, I propose to determine phosphorylated FAK protein levels by western blot.  
The ADAM13 model focuses on explaining how ADAM13 could regulate cell adhesion 
on fibronectin cell autonomously.  The next section will discuss the possibility that 
ADAM13 may function in a non-cell autonomous mechanism to regulate dorsal 
mesoderm cell adhesion to fibronectin during convergence and extension movements. 
 
How does ADAM13 Regulate 51 Integrin Activation Non-Cell Autonomously? 
 
 Ephrin receptors (Eph) and ligands (ephrin) have prominent roles in vascular 
development (Wang et al., 1998), repulsive guidance of neurons (Cheng et al., 1995), and 
establishment of tissue boundaries in the embryo (Gale et al., 1996).  For example, the 
differential expression of Eph receptors and ephrin ligands prevents intermixing of cells 
during CNC migration (Smith et al., 1997).  Moreover, it is believed that some ephrins 
can regulate a cell‟s affinity towards different ECM substrates through cross talk with 
integrin receptors.  In forward Eph-ephrin signaling, the EphA2 receptor (de Saint-Vis et 
al., 2003) or EphA4 receptor (Bourgin et al., 2007) regulate dendritic cell adhesion to FN 
via 1 integrin.  In reverse Eph-ephrin signaling, the ephrinB1 ligand (Huynh-Do et al., 
2002) and ephrinB2 ligand (Meyer et al., 2007) regulate endothelial cell adhesion to FN 
via 51 integrin.  Therefore, the cross talk between ephrins and integrin activation 
appears to be mediated through an inside-out signaling mechanism.  Although an exact 
molecular mechanism has yet to be determined, it appears to involve intracellular kinases 
(PI3K, Akt, Src, FAK) and the small GTPases (RhoA and Rac1) to induce cytoskeletal 
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changes that regulate cell-cell adhesion (Arvanitis and Davy, 2008; Pasquale, 2008; 
Somanath and Byzova, 2009).   
  ADAM10 was the first ADAM metalloprotease shown to cleave a member of the 
ephrin signaling pathway.  In neurons, ADAM10 cleaves the ephrinA2 ligand in cis 
important for axon detachment and termination of signaling (Hattori et al., 2000).  
Another group showed that the ADAM10 cysteine-rich domain binds to the EphA3 
receptor in complex with the ephrinA5 ligand (Janes et al., 2005).  This physical 
interaction positions ADAM10 for cleavage of ephrinA5 in trans, with ADAM10 and its 
substrate on opposing cells.  Moreover, ADAM19 can bind the EphA4 receptor in 
complex with the ephrinA5 ligand (Yumoto et al., 2008).  However, no cleavage event 
occurs but this interaction is important for blocking the endocytosis of the EphA4-
ephrinA5 complex.  Therefore, ADAM19 functions to stabilize neuronal synapses in the 
formation of neuromuscular junctions.  ADAM13 can cleave the ephrinB1 and B2 
ligands to regulate forward ephrin signaling in the dorsal mesoderm of a closely related 
species Xenopus tropicalis (Wei et al., 2010).  Regardless of proteolytic activity, the Eph-
ephrin signaling complex may be a physiologically relevant substrate for ADAM 
metalloproteases.  I propose that ADAM13 cleavage of ephrinB1/B2 in the dorsal 
mesoderm may affect the activation of 51 integrin.  Specifically through reverse 
signaling of ephrinB1/B2, cleavage may regulate the intracellular kinase activity of Src 
and FAK in complex with 51 integrin (Figure 5.2).  This cleavage event would be 
important for regulating cell-cell adhesion on a fibronectin matrix.  More importantly, 
ADAM13 cleavage of ephrinB ligands may contribute to the dorsal mesoderm cell 
movements during gastrulation.  
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SECTION III: ADAM19 Mediated Shedding of Neuregulin Contributes to  
Convergence and Extension 
 
 Gene expression is altered in MO19 injected embryos at the late gastrula stage 
(Neuner et al., 2009).  Specifically, Xbrachyury expression is lost concomitant with an 
anterior shift of Chordin expression in the notochord (Figure 2.5, 4.1 and 4.2).  Gene 
expression was unaffected in embryos lacking ADAM13 at the gastrula stage, suggesting 
a specific role for ADAM19 (Figure 4.3).  Xbrachyury and Chordin are known to be 
expressed in a countergradient fashion in the axial mesoderm (Ninomiya et al., 2004).  
Chordin is a marker of anterior notochord and Xbrachyury is a marker of posterior 
notochord.  Together, these two genes help establish the A-P polarity of the developing 
notochord.  Both genes are required for proper convergence and extension movements in 
explants and in the embryo.  This was the first study in Xenopus linking A-P tissue 
polarity to mesoderm convergence and extension (Ninomiya et al., 2004).  Additionally, I 
show that Brachyury and Chordin gene expression are dependent on ADAM19 
proteolytic activity (Figure 4.1 and 4.2).  This is shown by a partial rescue in gene 
expression by co-injection of ADAM19 RNA but not with a catalytically inactive mutant 
ADAM19 E/A RNA.  It is possible that ADAM19 functions by cleaving an unknown 
protein important for establishing A-P polarity of the notochord.  The unknown protein 
may be a growth factor that stimulates signal transduction to activate Xbrachyury and 
Chordin expression in the notochord. 
In mice, ADAM19 can cleave some members of the EGF family of ligands 
including Neuregulin1 (Shirakabe et al., 2001).  Neuregulin1 binds to the ErbB3 or 
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ErbB4 receptors to activate the ErbB signaling pathway (Esper et al., 2006; Eto et al., 
2006).  In Xenopus, the ErbB2/ErbB3 receptors and NRG1 expression begins during 
gastrulation and continues through tailbud formation (Nie and Chang, 2007b; Yang et al., 
1999; Yang et al., 1998a; Yang et al., 1998b).  Purified recombinant NRG1, as well as, 
the overexpression of ErbB2 or ErbB3 receptors can induce naïve animal cap cells to 
become mesoderm and express Xbrachyury (Chung and Chung, 1999; Nie and Chang, 
2007b).  Moreover, blocking ErbB receptors through injection of a Morpholino or 
dominant-negative RNA, can affect the convergence and extension movements during 
gastrulation (Nie and Chang, 2006; Nie and Chang, 2007b).  I show that expression of the 
extracellular domain of NRG1 (NRG-EC) is capable of rescuing Xbrachyury expression 
in the notochord while full length NRG1 does not rescue (Figure 4.1 and 4.2).  
Therefore, it is possible that ADAM19 mediated shedding of NRG1 allows soluble 
NRG-EC to interact with the ErbB receptor to activate signal transduction cell 
autonomously in the axial mesoderm.  The NRG1-ErbB signaling pathway may induce 
Xbrachyury gene expression specifically as the notochord develops. 
Brachyury has been extensively studied in a number of chordates and non-
chordates for its prominent role in the morphogenetic movements during gastrulation 
(Yamada et al., 2010).  For example, Brachyury knockout mice have abnormal primitive 
streaks due to aberrant mesoderm cell migration (Wilson et al., 1995).  In Xenopus, loss 
of Xbrachyury prevents convergence and extension movements during gastrulation 
(Conlon et al., 1996; Conlon and Smith, 1999; Kwan and Kirschner, 2003).  As a 
transcription factor, Xbrachyury controls convergence and extension by activating gene 
expression for Wnt11, a known target gene (Tada and Smith, 2000).  Wnt11 is a Wnt 
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family ligand that binds to the Frizzled receptor and signals through dishevelled to 
regulate downstream RhoA/Rac1 cytoskeletal changes.  Signaling through Wnt11 is 
essential for convergence and extension movements during gastrulation (Smith et al., 
2000; Tada et al., 2002; Tada and Smith, 2000).  The Xbrachyury-Wnt11-PCP Signaling 
pathway is briefly outlined in Figure 5.3.  Therefore in embryos lacking ADAM19, the 
loss of Xbrachyury in the notochord may be indirectly linked to the convergence and 
extension defects.  I propose that ADAM19 functions to cleave NRG1 to maintain 
expression of Xbrachyury in the notochord (Figure 5.4A).  Axial mesoderm cells that 
express Xbrachyury are bipolar and actively undergo mediolateral cell intercalation 
through the Wnt11-PCP Signaling Pathway.  This is a cell autonomous hypothesis 
because ADAM19 and Xbrachyury are both expressed in the notochord. 
In the absence of ADAM19, NRG1 is not cleaved in an axial mesoderm cell.  
This reduces ErbB signaling by reducing phosphorylated AKT levels and Xbrachyury 
gene expression in the notochord (Figure 5.4B).  Furthermore, a loss of Xbrachyury in 
the notochord may reduce the Wnt11-PCP Signaling Pathway important for mediolateral 
cell intercalation.  Therefore, cells will remain round or multipolar and delay mediolateral 
cell intercalation.  To test the ADAM19 model, I will propose the following experiments.  
First, to investigate if the Wnt11-PCP Signaling Pathway is affected in embryos lacking 
ADAM19, I propose to analyze Wnt11 gene expression by real time PCR.  I predict that a 
loss of Xbrachyury in the notochord would result in a loss of Wnt11 gene expression in 
the notochord.  Second, to investigate if the loss of Xbra contributes to mediolateral cell 
intercalation, I propose to inject Xbrachyury RNA in the dorsal mesoderm of MO19 
injected embryos.  Given the known role of Xbrachyury in regulating convergence and 
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extension movements, I predict this experiment should rescue defects in MO19 injected 
embryos.  However, inappropriate expression of Xbrachyury can cause ectopic posterior 
mesoderm formation (Cunliffe and Smith, 1992).  Therefore, a targeted injection of a 
finite dosage of Xbrachyury RNA specifically in the axial mesoderm would need to be 
completed.  Lastly, it would be interesting to determine if expression of NRG1 (NRG-
FL vs NRG-EC) in the dorsal mesoderm could rescue convergence and extension defects 
in embryos lacking ADAM19. 
 
Concluding Remarks 
 
 ADAM metalloproteases function as ectodomain sheddases through the cleavage 
of other membrane bound proteins.  A significant amount of research in the ADAM field 
has focused on identifying a number of substrates to different ADAM family members.  
To a lesser extent, some of the research in the ADAM field has focused on investigating 
the function of ADAM proteins in cell migration.  Most of this work was completed in 
single cell assays investigating the epithelial to mesenchymal transition in vitro.  While 
ADAM proteins appear to be important for individual cell migration, very little is known 
about the role of ADAM metalloproteases in tissue movements.  Tissue movements 
require coordinated cell migration with respect to surrounding cells.  This is the primary 
focus of research in our laboratory. 
 My work has focused on understanding the role of ADAM13 and ADAM19 in 
tissue movements known as convergence and extension.  Although both ADAM proteins 
are required for convergence and extension movements, my data suggests that ADAM13 
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and ADAM19 have different functions.  ADAM13 appears to function in regulating cell 
movements through cell spreading on fibronectin while ADAM19 appears to function in 
regulating cell movements through the transcription factor Brachyury.  The research 
presented in this thesis has furthered our understanding of how ADAM metalloproteases 
can function in coordinated cell movements during early embryogenesis.  More 
importantly, this type of cell migration is recapitulated in abnormal development.  The 
knowledge learned from this research can be applied to better understand disease 
progression such as cancer metastasis. 
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Figure 5.1: Model for the Cell Autonomous Function of ADAM13.  (A) In control 
dorsal mesoderm cells, ADAM13 functions to recruit Src kinase to adhesion complexes 
containing 51 integrin.  Src kinase together with FAK kinase regulates the small 
GTPases RhoA/Rac1 to induce cytoskeletal changes.  In addition, ADAM13 binds to the 
HepII domain of fibronectin to cleave fibronectin.  Both mechanisms regulate the 
activation of 51 integrin and allow a cell to spread properly on fibronectin.  (B) In 
MO13 dorsal mesoderm cells, Src kinase activity is reduced because it is not recruited 
properly to adhesion complexes containing 51 integrin.  This reduces both Src and 
FAK kinase activity causing 51 integrin to not be activated properly.  In addition, 
fibronectin is not cleaved.  These defects cause a cell to round up and reduce cell 
spreading on fibronectin. 
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Figure 5.2:  Model for the Non-cell Autonomous Function of ADAM13.  (A) In 
control dorsal mesoderm cells, upon Eph-ephrin engagement ADAM13 cleaves ephrinB 
ligands.  This promotes dorsal mesoderm cell-cell de-adhesion during the migration on 
the blastocoel roof.  (B) In MO13 dorsal mesoderm cells, Eph-ephrin engagement is not 
properly regulated because ephrinB ligands are not cleaved.  This affects dorsal 
mesoderm cell-cell de-adhesion during the migration on the blastocoel roof.  Eph-
ephrinB signaling may increase Src and FAK kinase activity creating an imbalance in 
RhoA/Rac1 cytoskeletal changes. 
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Figure 5.3:  Xbrachyury Signaling Pathway.  As a transcription 
factor Xbrachyury induces expression of the target gene, Wnt11 
(Tada and Smith, 2000).  Wnt11 is a Wnt family ligand important 
for activating the Non-canonical Wnt (or PCP) Signaling Pathway.  
The PCP Signaling pathway is essential for controlling 
convergence and extension movements during gastrulation. 
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Figure 5.4:  Model for ADAM19 Function in the Axial Mesoderm.  (A) In control 
axial mesoderm cells, ADAM19 cleaves NRG1.  Soluble NRG1 activates ErbB 
signaling cell autonomously.  Through PI3K/AKT signal transduction, Xbrachyury gene 
expression is induced.  This allows a cell to become bipolar and undergo mediolateral 
cell intercalation.  (B) In MO19 axial mesoderm cells, NRG1 is not cleaved.  This 
reduces ErbB signaling, phosphorylated AKT, and Xbrachyury gene expression.  These 
defects cause a cell to become multipolar and delay mediolateral cell intercalation. 
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APPENDIX I   
GENERATION OF ADAM19 ANTIBODIES 
 The goal at the onset of the project was to identify another meltrin subfamily 
member that could compensate for ADAM13 function, specifically in the cranial neural 
crest.  Of the other meltrin subfamily members, ADAM19 had the highest sequence 
homology at the amino acid level to ADAM13 making it an ideal candidate.  At this time, 
there were no ADAM19 antibodies available that could be used to study the endogenous 
protein in Xenopus.  Thus one of the first major objectives was to generate a number of 
antibodies that could recognize different structural domains of the ADAM19 protein.  
Three antibodies were successfully made to the ADAM19 protein and are briefly 
described: 
1. 2C5 E1: Mouse monoclonal antibody directed against the cytoplasmic domain of 
ADAM19 
2. C2 and C3: Rabbit polyclonal antibody directed against both variants (C2 and C3) 
of the cytoplasmic domain of ADAM19 
3. DC19: Goat polyclonal antibody directed against the disintegrin-cysteine rich 
domains of ADAM19 
 
Monoclonal Antibody 2C5 E1 
 To generate the monoclonal antibody 2C5 E1, I cloned cDNA encoding the first 
127 COOH-terminal amino acid residues of the ADAM19 cytoplasmic domain (A19cyto) 
into the pET-His expression vector (Novagen).  Fusion proteins were purified using 
standard methods.  100 microgram of protein was combined with complete Freund‟s 
adjuvant and injected intraperitoneal into Balb/c mice over a series of immunizations.  
After each immunization, blood samples were taken to test for the reactivity against 
A19cyto. 
 A fusion was performed with Splenocytes from an immunoreactive mouse and the 
immortal myeloma SP20 cells.  The fusion protocol was based on “Antibodies: A 
Laboratory Manual” by Ed Harlow and David Lane.  The resulting hybridoma colonies 
were first screened by ELISA for reactivity against A19cyto.  Out of 47 colonies tested, 
33 colonies had an OD value between 0.2 and 0.25, 12 colonies had an OD value 
between 0.25 and 0.3, and two colonies had an OD value greater than 0.3.  The top five 
ELISA hits were further subcloned and re-tested by ELISA.  The top four hits were 1F1, 
2C2, 2C5, and 2C8 having an OD value of greater than 3.0.  There were subcloned again 
and the 2C5 E1 colony was discovered for further testing.  Media from 2C5 E1 colony 
was tested by Western Blot and it strongly recognized the A19cyto fusion protein, as well 
as, a multitude of proteins in stage 45 embryo extract compared to stage 6 embryo extract 
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(Figure A1.1A).  The 2C5 E1 supernatant had minimal cross-reactivity with A9cyto and 
A13cyto, therefore this monoclonal antibody was further used in our experiments.   
 Immune IgG were purified on a His-tag fusion protein column containing the 
same COOH-terminal amino acid residues used for immunization (NHS-sepharose, 
Pharmacia).  The affinity purified 2C5 E1 antibody was tested on ADAM19 transfected 
XTC cells for detection by western blot (Figure A1.1B).  This antibody did not recognize 
endogenous ADAM19 from total embryo extract and glycoproteins purified on 
Concanavalin-A beads from 10 embryos (data not shown).  Further testing by western 
blot should be completed to get the antibody‟s right working conditions.  The 2C5 E1 
antibody is used for ADAM19 overexpression studies and works beautifully for 
immunoprecipitation and immunofluorescence.  The resulting Affinity Purified 
ADAM19 2C5 E1 was used for experiments described in Chapter III of this Dissertation. 
 
 
 
Figure A1.1:  Western Blots using mAb 2C5 E1.  (A) 
First screen using supernatant from 2C5 E1 hybridoma 
colony on total embryo extract (stage 6 vs stage 45) and the 
different ADAM cytoplasmic domains (A9, A13, A19).  
(B) Affinity Purified 2C5 E1 Western Blot on transfected 
XTC cells. 
 
 
Polyclonal Antibody C2 and C3 
 
 To generate the rabbit polyclonal antibody C2 and C3, I cloned cDNA encoding 
the first 146 COOH-terminal amino acid residues of the ADAM19 cytoplasmic domain 
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(A19cyto) into the pGEX-KG vector (Guan and Dixon, 1991).  This construct was called 
A19 C2.  In addition, I cloned cDNA encoding the first 160 COOH-terminal amino acid 
residues of the ADAM19 cytoplasmic domain (A19cyto) into the pGEX-KG vector 
(Guan and Dixon, 1991).  This construct was called A19 C3.  Both cytoplasmic domains 
were used because I discovered both variants in 3‟ RACE PCR from cDNA.  The A19 C3 
construct is most common to the X. tropicalis sequence and was submitted to GenBank 
(EU770696).  Fusion proteins were purified using standard methods.  Prior to 
immunization, I pre-screened six rabbits to select rabbits that had a low immunoreactivity 
in Xenopus embryos.  Through a multi-channel western blot apparatus, I tested the 
preimmune rabbit serum against stage 35 embryos (Figure A1.2).  I selected rabbit #2, #3 
and #5 for further immunization because they had the least immunoreactive background 
by western blot.   
 
 
 
Figure A1.2: Pre-screen of Rabbit serum 
by Western Blot.  Non-immune serum was 
obtained from six New Zealand white 
rabbits.  The serum was tested by western 
blot at primary antibody concentrations of 
1:100 (first lane) and 1:1000 (second lane) 
for each sample against stage 35 Xenopus 
embryo extract.  Rabbits #2, #3, and #5 were 
chosen for further immunization because of 
their low immunoreactivity. 
 
150 microgram of each protein (total = 300 microgram) was combined with 
complete Freund‟s adjuvant and injected into New Zealand white rabbits over a series of 
immunizations.  After each immunization, blood samples were taken to test for 
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immunoreactivity against A19 C2 and C3 by ELISA and western blot.  The ELISA 
results showed an increasing OD value of >1.0 after each immunization.  The 
immunization schedule was monitored by Aileen Thomas at the Immunization Facility 
here at UMass.  Immune IgG were purified on a His-tag fusion protein (pET vectors, 
Novagen) column containing the same COOH-terminal amino acid residues used for 
immunization (NHS-sepharose, Pharmacia).  The A19 C2 and C3 antibodies are used for 
ADAM19 overexpression and endogenous ADAM19 studies.  A western blot example of 
the affinity purified antibody is shown for ADAM19 transfected Cos-7 cells (Figure 
A1.3).  The resulting Affinity Purified ADAM19 C3 was used for experiments described 
in Chapter II and IV of this Dissertation. 
 
 
 
 
Figure A1.3: ADAM19 expression in Cos-
7 cells.  Affinity purified A19 C2 and C3 
were mixed at the primary concentration of 
1:2000 to detect ADAM19FL2 (C2) and 
ADAM19FL3 (C3).  The Proform of 
ADAM19 (120kD) is predominantly 
expressed in Cos-7 cells. 
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Polyclonal Antibody DC19 
 
To generate the polyclonal antibody DC19, I cloned cDNA encoding the 
Disintegrin and Cysteine-Rich amino acid residues of the ADAM19 domains into the 
pET-His vector (Novagen).  Fusion proteins were purified using denaturing standard 
methods.  1.0 milligram of protein was combined with complete Freund‟s adjuvant and 
injected into two Boer goats over a series of immunizations.  Each goat received 0.5 
milligram of fusion protein by Intramuscular injection and multiple subcutaneous 
injections.  The goats were numbered 704 and 711 at the Hadley Farm and weighed 70 
and 80 pounds, respectively.  The immunizations were performed by two undergraduate 
students, Lauryn Benson and Vincent Patanio.  The goats were monitored by Dr. Mark 
Huyler and Alice Newth. 
After each immunization, blood samples were taken to test for immunoreactivity 
against A19 by ELISA and western blot.  The ELISA results showed an increasing OD 
value of >1.5 after each immunization.  Immune IgG were purified on a His-tag fusion 
protein (pET vectors, Novagen) column containing the same disintegrin-cysteine rich 
amino acid residues used for immunization (NHS-sepharose, Pharmacia).  The DC19 
antibody is used for ADAM19 overexpression studies and by immunoprecipitation to 
detect endogenous ADAM19.  A western blot example of the affinity purified antibody is 
shown for ADAM19 transfected Cos-7 cells (Figure A1.4).  The resulting Affinity 
Purified DC19 was used primarily by immunoprecipitation for experiments described in 
Chapter II and IV of this Dissertation. 
 
 
 
Figure A1.4:  ADAM19 expression in Cos-7 cells.  Affinity 
purified DC19 was used at the primary concentration of 1:2000 to 
detect ADAM19FL2 and ADAM19FL3.  The Proform of 
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ADAM19 (120kD) is predominantly expressed in Cos-7 cells.  The 
high background is due to the secondary anti-goat-HRP antibody. 
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APPENDIX II 
MISCELLANEOUS DATA 
 
Xenopus laevis Heart Analysis 
 
 This Appendix will focus on various data that I have completed in my analysis of 
ADAM19 in the early embryo.  The first piece of data that I would like to discuss 
supports the role for ADAM19 in heart development.  Knockout mice for ADAM19 die 
perinatally due to defects seen in heart formation (Zhou et al., 2004), confirming the 
importance of ADAM19 in heart morphogenesis.  Conditional knockout of ADAM19 
specifically in the cardiac neural crest cells reproduced the heart phenotype suggesting 
that ADAM19 is critical for cardiac neural crest cell specification and or function but not 
migration (Komatsu et al., 2007).  I have shown in Xenopus that ADAM19 knock down 
reduces three heart specific genes; NKX2.5 (transcription factor), MLC2 (Myosin Light 
Chain2, terminal differentiation marker), and MHC (Myosin Heavy Chain , terminal 
differentiation marker) (Figure A2.1).  This suggests that ADAM19 is also involved in 
heart development in amphibians. 
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Figure A2.1:  Heart Gene Expression Analysis.  Embryos were injected 
at the one‐cell stage with CMO or MO19 and allowed to develop until 
stage 28 for Whole Mount in situ Hybridization (N=30). Myosin Light 
Chain2 (MLC2), Myosin Heavy Chain‐α (MHCα) and NKX2.5.  
Percentages are of the morphotype shown. 
 
 
Xenopus laevis Neural Response Analysis 
 
In addition to ADAM19‟s prominent role in cardiac morphogenesis, the 
ADAM19 knockout mice have also a minor neural phenotype.  ADAM19 is expressed in 
the peripheral nervous system and plays a regulatory role in the formation of 
neuromuscular junctions (Yumoto et al., 2008).  ADAM19 physically interacts with the 
Ephrin receptor, EphA4, to stabilize the EphA4-ephrinA5 complex (Receptor-ligand) 
from being internalized.  This results in the negative regulation of contact-dependent 
repulsion of neurons at the neuromuscular junction.  I briefly analyzed Xenopus tailbud 
stage embryos for their ability to respond to a touch stimulus and swim away.  This assay 
was performed in MO9 or MO19 injected embryos at stage 27 (Figure A2.2).  MO9 
injected embryos showed a slight reduction in their ability to respond to touch and swim 
away.  MO19 injected embryos showed a more robust inability to respond to touch and 
swim away.  These observations could be a result of poorly developed skeletal muscles 
(reduction in muscle specific genes MLC and 12/101) or poorly developed 
neuromuscular junctions. 
 
 
 
 
 
 
Figure A2.2:  Neural Touch Response Assay.  Embryos were injected at the 
one‐cell stage with CMO, MO9 or MO19 and allowed to develop until stage 27.  
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The embryos ability to respond to touch and whether the embryo was capable of 
swimming away from the stimulus were recorded.  The knockdown embryos 
were compared to CMO and to NI (non-injected) embryos.  The percentages are 
shown in the graph.    
 
 
Neuregulin1
 
 In mice, ADAM19 can cleave some members of the EGF family of ligands 
including Neuregulin1 (Shirakabe et al., 2001).  In Xenopus, the NRG1 expression 
pattern overlaps with the expression pattern of ADAM19 (Neuner et al., 2009; Yang et 
al., 1999; Yang et al., 1998a; Yang et al., 1998b).  Our lab has obtained all three Xenopus 
NRG1 clones; IgNRG1α2, IgNRG1β2, and CRDNRG1β2.  Our initial focus is on 
IgNRG1β2 because it is a known substrate of mouse ADAM19.  I cloned the full length 
gene into the pCS2+ vector and added a Flag epitope after the extracellular Ig-like 
domain but before the EGF-β2 domain.  In addition to the full-length gene, I introduced a 
stop codon immediately before the transmembrane domain to mimic a possible cleavage 
product containing only the extracellular domain (IgNRG1β2-EC).  The Flag epitope 
location was selected in hopes that an extracellular cleavage fragment could be detected.  
This location may not be ideal because detection of IgNRG1β2 by western blot has 
presented some problems.  Transfection into Cos-7 cells and glycoproteins purified by 
Concanavalin-A beads from the cell extract could not detect NRG1 (data not shown).  
Microinjection of RNA for NRG1 into Xenopus embryos has shown a faint band of the 
predicted molecular weight size (Figure A2.3).   
 
 
 
Figure A2.3:  Neuregulin1 Western Blot.  Embryos 
were injected at the one-cell stage with 1ng of RNA 
encoding NRG-FL.  Glycoproteins were purified from 10 
embryos by Concanavalin-A beads, separated by SDS-
PAGE and detected using an antibody to Flag.    
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However, injection of 1ng of RNA from glycoproteins purified from ten embryos 
should yield a much stronger band by western blot.  Cloning of NRG1 into pCS2+MT 
(myc tag) should enable successful detection by western blot.  A successfully tagged 
construct could also be used to determine if any of the Xenopus ADAM members can 
cleave NRG1.   
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APPENDIX III   
LIST OF SUPPLEMENTARY MOVIE FILES (ON CD) 
Movie 1 – Open Face Explant from a CMO embryo 
Explants from embryos injected with CMO at the one-cell stage.  Membrane 
bound Cherry RNA was injected into one blastomere at the two-cell stage to 
visualize axial mesoderm cell movement from one half of the embryo.  The 
time lapse movie lasts ten hours. 
 
Movie 2 – Open Face Explant from a MO13 injected embryo 
Explants from embryos injected with MO13 at the one-cell stage.  Membrane 
bound Cherry RNA was injected into one blastomere at the two-cell stage to 
visualize axial mesoderm cell movement from one half of the embryo.  The 
time lapse movie lasts ten hours. 
 
Movie 3 – Open Face Explant from a MO19 injected embryo 
Explants from embryos injected with MO19 at the one-cell stage.  Membrane 
bound Cherry RNA was injected into one blastomere at the two-cell stage to 
visualize axial mesoderm cell movement from one half of the embryo.  The 
time lapse movie lasts ten hours. 
 
Movie 4 – Dorsal Mesoderm Cell Spreading and Migration on 
Fibronectin 
Dissociated dorsal mesoderm cells from a CMO embryo were plated on a 
fibronectin substrate.  Time lapse analysis of a three hour movie shows cell 
spreading and cell migration on FN. 
 
Movie 5 – Dorsal Mesoderm Cell Spreading and Migration on 
Fibronectin 
Dissociated dorsal mesoderm cells from a MO13 injected embryo were plated 
on a fibronectin substrate.  Time lapse analysis of a three hour movie shows 
cell spreading and cell migration on FN. 
 
Movie 6 – Dorsal Mesoderm Cell Spreading and Migration on 
Fibronectin 
Dissociated dorsal mesoderm cells from a MO19 injected embryo were plated 
on a fibronectin substrate.  Time lapse analysis of a three hour movie shows 
cell spreading and cell migration on FN. 
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Movie 7 – Dorsal Mesoderm Cell Spreading and Migration on 
Fibronectin 
Dissociated dorsal mesoderm cells from a 2MO (MO13+MO19) embryo were 
plated on a fibronectin substrate.  Time lapse analysis of a three hour movie 
shows cell spreading and cell migration on FN. 
 
 
Movie 8 – Dorsal Mesoderm Cell Spreading and Migration on 9.11 
Dissociated dorsal mesoderm cells from a CMO embryo were plated on a 9.11 
substrate.  Time lapse analysis of a three hour movie shows cell spreading and 
cell migration on 9.11. 
 
Movie 9 – Dorsal Mesoderm Cell Spreading and Migration on 9.11 
Dissociated dorsal mesoderm cells from a MO13 injected embryo were plated 
on a 9.11 substrate.  Time lapse analysis of a three hour movie shows cell 
spreading and cell migration on 9.11. 
 
Movie 10 – Dorsal Mesoderm Cell Spreading and Migration on 9.11 
Dissociated dorsal mesoderm cells from a MO19 injected embryo were plated 
on a 9.11 substrate.  Time lapse analysis of a three hour movie shows cell 
spreading and cell migration on 9.11. 
 
Movie 11 – Dorsal Mesoderm Cell Spreading and Migration on 9.11 
Dissociated dorsal mesoderm cells from a 2MO (MO13+MO19) embryo were 
plated on a 9.11 substrate.  Time lapse analysis of a three hour movie shows 
cell spreading and cell migration on 9.11. 
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APPENDIX IV  
REPRINT 1 
 
Mechanism of Development (Neuner et al., 2009) 
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